UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 30, ~~2022~~2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File No. 001-34042

MAIDEN HOLDINGS, LTD.

(Exact name of registrant as specified in its charter)


Bermuda			98-0570192
(State or other jurisdiction of incorporation or organization)			(IRS Employer Identification No.)
94 Pitts Bay Road
Pembroke
Bermuda			HM08
(Address of principal executive offices)			(Zip Code)

(441) 298-4900

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading symbol(s)

Name of Each Exchange on Which Registered

Common Shares, par value $0.01 per share

MHLD

NASDAQ Capital Market

~~Series A Preference Shares, par value $0.01 per share~~

~~MH.PA~~

~~New York Stock Exchange~~

~~Series C Preference Shares, par value $0.01 per share~~

~~MH.PC~~

~~New York Stock Exchange~~

~~Series D Preference Shares, par value $0.01 per share~~

~~MH.PD~~

~~New York Stock Exchange~~

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☒

Non-accelerated filer

☐

Smaller reporting company

☒

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act).

Yes ☐ No ☒

As of ~~November~~August 4, ~~2022,~~2023, 101,605,815 common shares were outstanding. 143,045,163 common shares, par value $0.01 per share, were outstanding when the ~~number~~ownership by our affiliate Maiden Reinsurance Ltd. of 41,738,978 common shares were included. These affiliated shares are treated as treasury shares and are not included in the computation of ~~the Registrant's Common Stock ($.01 par value) outstanding was 87,171,499.~~consolidated book value and earnings per common share.

INDEX






		Page
PART I - Financial Information
Item 1.	Financial Statements

	Condensed Consolidated Balance Sheets as of ~~September~~June ~~30, 2022~~3 0 , 2023 (unaudited) and December 31, ~~2021~~2022 (audited)	3

	Condensed Consolidated Statements of Income for the Three ~~and~~ ~~Nin~~eMonths and Six Months Ended ~~September~~June ~~30,~~3 0 , 2023 and 2022 ~~and 2021~~ (unaudited)	4

	Condensed Consolidated Statements of Comprehensive Income for the Three ~~and~~ ~~Nine~~Months and Six Months Ended ~~September~~June ~~30,~~3 0 , 2023 and 2022 ~~and 2021~~ (unaudited)	5

	Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three ~~and~~ ~~Nine~~Months and Six Months Ended ~~September~~June ~~30,~~3 0 , 2023 and 2022 ~~and 2021~~ (unaudited)	6

	Condensed Consolidated Statements of Cash Flows for the ~~Nine~~Six Months ~~Months~~ Ended ~~September~~June ~~30,~~3 0 , 2023 and 2022 ~~and 2021~~ (unaudited)	7

	Notes to Condensed Consolidated Financial Statements (unaudited)	8

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	3637

Item 4.	Controls and Procedures	6673

PART II - Other Information

Item 1.	Legal Proceedings	6774

Item 1A.	Risk Factors	6774

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	6774

Item 3.	Defaults Upon Senior Securities	6774

Item 4.	Mine Safety Disclosures	6774

Item 5.	Other Information	6774

Item 6.	Exhibits	6775

	Signatures	6876

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

MAIDEN HOLDINGS, LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars, except share and per share data)


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
ASSETS	ASSETS	(Unaudited)		(Audited)		ASSETS	(Unaudited)		(Audited)
Investments:	Investments:					Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost 2022 - $432,314; 2021 - $595,344)		$	371,973	$	597,145
Equity securities, at fair value (cost 2022 - $38,819; 2021 - $23,315)		42,600		24,003
Fixed maturities, available-for-sale, at fair value (Amortized cost: 2023 - $300,453; 2022 - $330,439)						Fixed maturities, available-for-sale, at fair value (Amortized cost: 2023 - $300,453; 2022 - $330,439)	$	287,324	$	314,527
Equity securities, at fair value (cost: 2023 - $41,040; 2022 - $40,509)						Equity securities, at fair value (cost: 2023 - $41,040; 2022 - $40,509)	45,251		43,621
Equity method investments	Equity method investments	80,165		83,742		Equity method investments	73,216		80,159
Other investments		140,804		117,722
Other investments (Allowance for expected credit losses: 2023 - $1,023)						Other investments (Allowance for expected credit losses: 2023 - $1,023)	150,149		148,753
Total investments	Total investments	635,542		822,612		Total investments	555,940		587,060
Cash and cash equivalents	Cash and cash equivalents	24,376		26,668		Cash and cash equivalents	17,242		30,986
Restricted cash and cash equivalents	Restricted cash and cash equivalents	48,122		39,419		Restricted cash and cash equivalents	10,220		15,638
Accrued investment income	Accrued investment income	4,655		5,695		Accrued investment income	5,751		4,122
Reinsurance balances receivable, net (includes $10,207 and $17,471 from related parties in 2022 and 2021, respectively)		12,368		19,507
Reinsurance recoverable on unpaid losses		547,975		562,845
Reinsurance balances receivable, net: (includes $8,375 and $8,395 from related parties in 2023 and 2022, respectively. Allowance for expected credit losses: 2023 - $196)						Reinsurance balances receivable, net: (includes $8,375 and $8,395 from related parties in 2023 and 2022, respectively. Allowance for expected credit losses: 2023 - $196)	11,182		10,707
Reinsurance recoverable on unpaid losses (Allowance for expected credit losses: 2023 - $4,530)						Reinsurance recoverable on unpaid losses (Allowance for expected credit losses: 2023 - $4,530)	561,576		556,116
Loan to related party	Loan to related party	167,975		167,975		Loan to related party	167,975		167,975
Deferred commission and other acquisition expenses (includes $25,854 and $34,170 from related parties in 2022 and 2021, respectively)		27,295		36,703
Funds withheld receivable (includes $490,603 and $601,460 from related parties in 2022 and 2021, respectively)		516,589		636,412
Deferred commission and other acquisition expenses (includes $19,477 and $23,632 from related parties in 2023 and 2022, respectively)						Deferred commission and other acquisition expenses (includes $19,477 and $23,632 from related parties in 2023 and 2022, respectively)	20,522		24,976
Funds withheld receivable: (includes $286,900 and $416,835 from related parties in 2023 and 2022, respectively. Allowance for expected credit losses: 2023 - $19)						Funds withheld receivable: (includes $286,900 and $416,835 from related parties in 2023 and 2022, respectively. Allowance for expected credit losses: 2023 - $19)	307,031		441,412
Other assets	Other assets	4,717		4,774		Other assets	7,474		7,874

Total assets	Total assets	$	1,989,614	$	2,322,610	Total assets	$	1,664,913	$	1,846,866
LIABILITIES	LIABILITIES					LIABILITIES
Reserve for loss and loss adjustment expenses (includes $1,013,374 and $1,338,269 from related parties in 2022 and 2021, respectively)		$	1,146,084	$	1,489,373
Unearned premiums (includes $69,407 and $91,730 from related parties in 2022 and 2021, respectively)		73,760		100,131
Reserve for loss and loss adjustment expenses (includes $867,975 and $988,684 from related parties in 2023 and 2022, respectively)						Reserve for loss and loss adjustment expenses (includes $867,975 and $988,684 from related parties in 2023 and 2022, respectively)	$	1,001,261	$	1,131,408
Unearned premiums (includes $52,286 and $63,443 from related parties in 2023 and 2022, respectively)						Unearned premiums (includes $52,286 and $63,443 from related parties in 2023 and 2022, respectively)	54,620		67,081
Deferred gain on retroactive reinsurance	Deferred gain on retroactive reinsurance	39,270		48,960		Deferred gain on retroactive reinsurance	60,025		47,708

Accrued expenses and other liabilities (includes $128,443 and $29,408 from related parties in 2022 and 2021, respectively)		147,591		44,542
Accrued expenses and other liabilities (includes $10,765 and $33,278 from related parties in 2023 and 2022, respectively)						Accrued expenses and other liabilities (includes $10,765 and $33,278 from related parties in 2023 and 2022, respectively)	25,196		60,518
Senior notes - principal amount	Senior notes - principal amount	262,500		262,500		Senior notes - principal amount	262,361		262,500
Less: unamortized debt issuance costs	Less: unamortized debt issuance costs	6,984		7,153		Less: unamortized debt issuance costs	7,840		6,928
Senior notes, net	Senior notes, net	255,516		255,347		Senior notes, net	254,521		255,572

Total liabilities	Total liabilities	1,662,221		1,938,353		Total liabilities	1,395,623		1,562,287
Commitments and Contingencies	Commitments and Contingencies					Commitments and Contingencies
EQUITY	EQUITY					EQUITY
Preference shares		119,672		159,210
Common shares ($0.01 par value; 93,414,080 and 92,316,107 shares issued in 2022 and 2021, respectively; 87,161,499 and 86,467,242 shares outstanding in 2022 and 2021, respectively)		934		923

Common shares ($0.01 par value; 2023: 149,726,105 and 2022: 149,224,080 shares issued; 2023: 101,605,815 and 2022: 101,532,151 shares outstanding)						Common shares ($0.01 par value; 2023: 149,726,105 and 2022: 149,224,080 shares issued; 2023: 101,605,815 and 2022: 101,532,151 shares outstanding)	1,497		1,492
Additional paid-in capital	Additional paid-in capital	772,474		768,650		Additional paid-in capital	885,462		884,259
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(51,553)		(12,215)		Accumulated other comprehensive loss	(37,136)		(41,234)
Accumulated deficit	Accumulated deficit	(479,109)		(498,295)		Accumulated deficit	(462,637)		(442,863)
Treasury shares, at cost (6,252,581 and 5,848,865 shares in 2022 and 2021, respectively)		(35,025)		(34,016)
Treasury shares, at cost (2023: 48,120,290 shares and 2022: 47,691,929 shares)						Treasury shares, at cost (2023: 48,120,290 shares and 2022: 47,691,929 shares)	(117,896)		(117,075)
Total shareholders’ equity	Total shareholders’ equity	327,393		384,257		Total shareholders’ equity	269,290		284,579

Total liabilities and equity	Total liabilities and equity	$	1,989,614	$	2,322,610	Total liabilities and equity	$	1,664,913	$	1,846,866

See accompanying notes to the unaudited Condensed Consolidated Financial Statements.

MAIDEN HOLDINGS, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(in thousands of U.S. dollars, except per share data)


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Revenues	Revenues									Revenues
Gross premiums written	Gross premiums written	$	5,380	$	6,821	$	(1,451)	$	7,865	Gross premiums written	$	6,875	$	3,339	$	7,711	$	(6,831)
Net premiums written	Net premiums written	$	5,222	$	6,953	$	(1,915)	$	7,518	Net premiums written	$	6,875	$	3,186	$	7,635	$	(7,137)
Change in unearned premiums	Change in unearned premiums	7,029		8,077		25,731		32,588		Change in unearned premiums	4,164		7,257		12,406		18,702
Net premiums earned	Net premiums earned	12,251		15,030		23,816		40,106		Net premiums earned	11,039		10,443		20,041		11,565
Other insurance revenue		368		138		888		946
Other insurance revenue, net										Other insurance revenue, net	78		469		19		520
Net investment income	Net investment income	6,637		7,477		20,871		24,596		Net investment income	10,518		7,667		20,063		14,234
Net realized and unrealized investment (losses) gains		(1,572)		(937)		2,848		8,013
Net realized and unrealized investment gains										Net realized and unrealized investment gains	1,145		2,111		2,150		4,420

Total revenues	Total revenues	17,684		21,708		48,423		73,661		Total revenues	22,780		20,690		42,273		30,739
Expenses	Expenses									Expenses
Net loss and loss adjustment expenses	Net loss and loss adjustment expenses	17,426		10,514		22,017		7,546		Net loss and loss adjustment expenses	11,532		6,874		21,347		4,591
Commission and other acquisition expenses	Commission and other acquisition expenses	5,398		6,313		12,811		19,154		Commission and other acquisition expenses	4,945		4,885		9,180		7,413
General and administrative expenses	General and administrative expenses	6,491		6,650		24,671		29,553		General and administrative expenses	6,839		7,294		16,947		18,180
Interest and amortization expenses	Interest and amortization expenses	4,833		4,832		14,498		14,495		Interest and amortization expenses	4,773		4,833		8,597		9,665

Foreign exchange and other gains		(8,586)		(4,116)		(19,121)		(6,070)
Foreign exchange and other losses (gains)										Foreign exchange and other losses (gains)	2,621		(6,586)		5,437		(10,535)
Total expenses	Total expenses	25,562		24,193		54,876		64,678		Total expenses	30,710		17,300		61,508		29,314
(Loss) income before income taxes and interest in (loss) income of equity method investments		(7,878)		(2,485)		(6,453)		8,983
(Loss) income before income taxes and interest in income (loss) of equity method investments										(Loss) income before income taxes and interest in income (loss) of equity method investments	(7,930)		3,390		(19,235)		1,425
Less: income tax (benefit) expense	Less: income tax (benefit) expense	(91)		(155)		451		(363)		Less: income tax (benefit) expense	(194)		(713)		(222)		542
Interest in (loss) income of equity method investments		(373)		(810)		(2,143)		4,912
Interest in income (loss) of equity method investments										Interest in income (loss) of equity method investments	4,803		(3,041)		4,752		(1,770)

Net (loss) income	Net (loss) income	(8,160)		(3,140)		(9,047)		14,258		Net (loss) income	(2,933)		1,062		(14,261)		(887)

Gain from repurchase of preference shares	Gain from repurchase of preference shares	—		6,004		28,233		87,168		Gain from repurchase of preference shares	—		24,690		—		28,233
Net (loss) income available to Maiden common shareholders		$	(8,160)	$	2,864	$	19,186	$	101,426
Net (loss) income (attributable) available to Maiden common shareholders										Net (loss) income (attributable) available to Maiden common shareholders	$	(2,933)	$	25,752	$	(14,261)	$	27,346

Basic and diluted (loss) earnings per share attributable to common shareholders		$	(0.09)	$	0.03	$	0.22	$	1.17
Basic and diluted (loss) earnings per share (attributable) available to common shareholders										Basic and diluted (loss) earnings per share (attributable) available to common shareholders	$	(0.03)	$	0.29	$	(0.14)	$	0.31

Weighted average number of common shares - basic	Weighted average number of common shares - basic	87,161,499		86,433,780		86,935,823		85,937,012		Weighted average number of common shares - basic	101,754,218		87,092,045		101,653,848		86,821,114
Adjusted weighted average number of common shares and assumed conversions - diluted	Adjusted weighted average number of common shares and assumed conversions - diluted	87,161,499		86,438,232		86,937,552		85,941,418		Adjusted weighted average number of common shares and assumed conversions - diluted	101,754,218		87,093,912		101,653,848		86,823,825

See accompanying notes to the unaudited Condensed Consolidated Financial Statements.

MAIDEN HOLDINGS, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in thousands of U.S. dollars)

For the Three Months Ended September 30, For the Nine Months Ended September 30,
2022 2021 2022 2021
Net (loss) income $ (8,160) $ (3,140) $ (9,047) $ 14,258
Other comprehensive loss
Net unrealized holdings losses on fixed maturity investments arising during period (14,864) (10,539) (56,446) (27,864)
Net unrealized holdings gains (losses) on equity method investments arising during period — (4,078) 4,414 (7,497)
Adjustment for reclassification of net realized gains recognized in net (loss) income (48) (2,007) (5,696) (7,032)
Foreign currency translation adjustment 2,246 6,036 18,094 13,627
Other comprehensive loss, before tax (12,666) (10,588) (39,634) (28,766)
Income tax benefit related to components of other comprehensive loss 53 6 296 50
Other comprehensive loss, after tax (12,613) (10,582) (39,338) (28,716)
Comprehensive loss $ (20,773) $ (13,722) $ (48,385) $ (14,458)


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2023		2022		2023		2022
Net (loss) income	$	(2,933)	$	1,062	$	(14,261)	$	(887)
Other comprehensive income (loss)
Net unrealized holdings gains (losses) on AFS securities arising during period	847		(24,118)		2,783		(41,582)
Net unrealized holdings gains on equity method investments arising during period	—		—		—		4,414

Adjustment for reclassification of net realized gains recognized in net (loss) income	—		(410)		—		(5,648)
Foreign currency translation adjustment	766		10,256		1,334		15,848
Other comprehensive income (loss), before tax	1,613		(14,272)		4,117		(26,968)
Income tax benefit (expense) related to components of other comprehensive income (loss)	11		114		(19)		243
Other comprehensive income (loss), after tax	1,624		(14,158)		4,098		(26,725)
Comprehensive loss	$	(1,309)	$	(13,096)	$	(10,163)	$	(27,612)

See accompanying notes to the unaudited Condensed Consolidated Financial Statements.

MAIDEN HOLDINGS, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)

(in thousands of U.S. dollars)


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Preference shares - Series A, C and D	Preference shares - Series A, C and D									Preference shares - Series A, C and D
Beginning balance	Beginning balance	$	119,672	$	181,384	$	159,210	$	394,310	Beginning balance	$	—	$	152,338	$	—	$	159,210
Repurchase of Preference Shares – Series A	Repurchase of Preference Shares – Series A	—		(3,384)		(10,891)		(87,978)		Repurchase of Preference Shares – Series A	—		(10,891)		—		(10,891)
Repurchase of Preference Shares – Series C	Repurchase of Preference Shares – Series C	—		(6,037)		(15,644)		(72,931)		Repurchase of Preference Shares – Series C	—		(11,144)		—		(15,644)
Repurchase of Preference Shares – Series D	Repurchase of Preference Shares – Series D	—		(4,545)		(13,003)		(65,983)		Repurchase of Preference Shares – Series D	—		(10,631)		—		(13,003)
Ending balance	Ending balance	119,672		167,418		119,672		167,418		Ending balance	—		119,672		—		119,672
Common shares	Common shares									Common shares
Beginning balance	Beginning balance	934		922		923		898		Beginning balance	1,496		933		1,492		923

Issuance of common shares from vesting of stock based compensation	Issuance of common shares from vesting of stock based compensation	—		1		11		25		Issuance of common shares from vesting of stock based compensation	1		1		5		11
Ending balance	Ending balance	934		923		934		923		Ending balance	1,497		934		1,497		934
Additional paid-in capital	Additional paid-in capital									Additional paid-in capital
Beginning balance	Beginning balance	772,241		767,452		768,650		756,122		Beginning balance	885,125		770,910		884,259		768,650
Issuance of common shares from vesting of stock based compensation	Issuance of common shares from vesting of stock based compensation	—		(1)		(11)		(25)		Issuance of common shares from vesting of stock based compensation	(1)		(1)		(5)		(11)
Share-based compensation expense	Share-based compensation expense	233		253		2,504		4,568		Share-based compensation expense	338		231		1,115		2,271
Repurchase of Preference Shares		—		467		1,321		7,571
Repurchase of preference shares										Repurchase of preference shares	—		1,091		93		1,321
Cash settlement of restricted shares/options granted	Cash settlement of restricted shares/options granted	—		—		10		(65)		Cash settlement of restricted shares/options granted	—		10		—		10

Ending balance	Ending balance	772,474		768,171		772,474		768,171		Ending balance	885,462		772,241		885,462		772,241
Accumulated other comprehensive (loss) income
Accumulated other comprehensive loss										Accumulated other comprehensive loss
Beginning balance	Beginning balance	(38,940)		5,723		(12,215)		23,857		Beginning balance	(38,760)		(24,782)		(41,234)		(12,215)
Change in net unrealized investment losses		(14,859)		(16,618)		(57,432)		(42,343)
Change in net unrealized investment gains (losses)										Change in net unrealized investment gains (losses)	858		(24,414)		2,764		(42,573)
Foreign currency translation adjustment	Foreign currency translation adjustment	2,246		6,036		18,094		13,627		Foreign currency translation adjustment	766		10,256		1,334		15,848
Ending balance	Ending balance	(51,553)		(4,859)		(51,553)		(4,859)		Ending balance	(37,136)		(38,940)		(37,136)		(38,940)
Accumulated deficit	Accumulated deficit									Accumulated deficit
Beginning balance	Beginning balance	(470,949)		(517,376)		(498,295)		(615,837)		Beginning balance	(459,704)		(496,701)		(442,863)		(498,295)
Cash settlement of restricted shares granted		—		—		—		(101)
Opening allowance for expected credit losses										Opening allowance for expected credit losses	—		—		(5,513)		—
Net (loss) income	Net (loss) income	(8,160)		(3,140)		(9,047)		14,258		Net (loss) income	(2,933)		1,062		(14,261)		(887)
Gain on repurchase of preference shares		—		6,004		28,233		87,168
Gain from repurchase of preference shares										Gain from repurchase of preference shares	—		24,690		—		28,233

Ending balance	Ending balance	(479,109)		(514,512)		(479,109)		(514,512)		Ending balance	(462,637)		(470,949)		(462,637)		(470,949)
Treasury shares	Treasury shares									Treasury shares
Beginning balance	Beginning balance	(35,025)		(33,893)		(34,016)		(31,534)		Beginning balance	(117,363)		(35,025)		(117,075)		(34,016)

Shares repurchased	Shares repurchased	—		(74)		(1,009)		(2,433)		Shares repurchased	(533)		—		(821)		(1,009)
Ending balance	Ending balance	(35,025)		(33,967)		(35,025)		(33,967)		Ending balance	(117,896)		(35,025)		(117,896)		(35,025)

Total shareholders' equity	Total shareholders' equity	$	327,393	$	383,174	$	327,393	$	383,174	Total shareholders' equity	$	269,290	$	347,933	$	269,290	$	347,933

See accompanying notes to the unaudited Condensed Consolidated Financial Statements.

MAIDEN HOLDINGS, LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands of U.S. dollars)


For the Nine Months Ended September 30,		2022		2021
For the Six Months Ended June 30,						For the Six Months Ended June 30,	2023		2022
Cash flows from operating activities	Cash flows from operating activities					Cash flows from operating activities
Net (loss) income		$	(9,047)	$	14,258
Net loss						Net loss	$	(14,261)	$	(887)

Adjustments to reconcile net (loss) income to net cash flows from operating activities:
Adjustments to reconcile net loss to net cash flows from operating activities:						Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation, amortization and share-based compensation	Depreciation, amortization and share-based compensation	1,628		7,798		Depreciation, amortization and share-based compensation	(801)		1,845
Interest in loss (income) of equity method investments		2,143		(4,912)
Interest in (income) loss of equity method investments						Interest in (income) loss of equity method investments	(4,752)		1,770
Net realized and unrealized investment gains	Net realized and unrealized investment gains	(2,848)		(8,013)		Net realized and unrealized investment gains	(2,150)		(4,420)

Foreign exchange and other gains		(19,121)		(6,070)
Change in allowance for expected credit losses						Change in allowance for expected credit losses	250		—
Foreign exchange and other losses (gains)						Foreign exchange and other losses (gains)	5,437		(10,535)
Changes in assets – (increase) decrease:	Changes in assets – (increase) decrease:					Changes in assets – (increase) decrease:
Reinsurance balances receivable, net	Reinsurance balances receivable, net	6,163		(12,039)		Reinsurance balances receivable, net	(420)		5,751
Reinsurance recoverable on unpaid losses	Reinsurance recoverable on unpaid losses	6,238		6,590		Reinsurance recoverable on unpaid losses	2,289		4,937
Accrued investment income	Accrued investment income	635		3,663		Accrued investment income	(1,607)		(2,943)
Deferred commission and other acquisition expenses	Deferred commission and other acquisition expenses	9,192		11,460		Deferred commission and other acquisition expenses	4,431		6,644
Funds withheld receivable	Funds withheld receivable	1,037		9,916		Funds withheld receivable	708		2,410
Other assets	Other assets	(235)		(385)		Other assets	373		(1,541)
Changes in liabilities – increase (decrease):	Changes in liabilities – increase (decrease):					Changes in liabilities – increase (decrease):
Reserve for loss and loss adjustment expenses	Reserve for loss and loss adjustment expenses	(179,627)		(304,385)		Reserve for loss and loss adjustment expenses	(4,661)		(182,760)
Unearned premiums	Unearned premiums	(25,725)		(33,424)		Unearned premiums	(12,406)		(18,706)
Deferred gain on retroactive reinsurance	Deferred gain on retroactive reinsurance	(270)		—		Deferred gain on retroactive reinsurance	—		673
Accrued expenses and other liabilities	Accrued expenses and other liabilities	110,004		15,793		Accrued expenses and other liabilities	(36,092)		109,006

Net cash used in operating activities	Net cash used in operating activities	(99,833)		(299,750)		Net cash used in operating activities	(63,662)		(88,756)
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:
Purchases of fixed maturities	Purchases of fixed maturities	(34,022)		(208,969)		Purchases of fixed maturities	(37,739)		(32,602)
Purchases of other investments	Purchases of other investments	(28,225)		(23,647)		Purchases of other investments	(17,248)		(20,290)
Purchases of equity method investments	Purchases of equity method investments	(26,483)		(42,551)		Purchases of equity method investments	(3,585)		(13,723)
Purchases of equity securities	Purchases of equity securities	(15,592)		(13,694)		Purchases of equity securities	(1,000)		(10,784)
Proceeds from sales of fixed maturities	Proceeds from sales of fixed maturities	139,645		332,636		Proceeds from sales of fixed maturities	44,783		104,538
Proceeds from maturities, paydowns and calls of fixed maturities	Proceeds from maturities, paydowns and calls of fixed maturities	48,003		294,878		Proceeds from maturities, paydowns and calls of fixed maturities	27,123		43,572
Proceeds from sale and redemption of other investments	Proceeds from sale and redemption of other investments	3,794		341		Proceeds from sale and redemption of other investments	16,666		2,414
Proceeds from sale and redemption of equity method investments	Proceeds from sale and redemption of equity method investments	32,332		4,802		Proceeds from sale and redemption of equity method investments	15,746		23,263
Proceeds from sale and redemption of equity securities	Proceeds from sale and redemption of equity securities	—		441		Proceeds from sale and redemption of equity securities	469		—

Others, net	Others, net	(73)		(31)		Others, net	(32)		(55)

Net cash provided by investing activities	Net cash provided by investing activities	119,379		344,206		Net cash provided by investing activities	45,183		96,333
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Repurchase of common shares	Repurchase of common shares	(1,009)		(2,433)		Repurchase of common shares	(821)		(1,009)

Repurchase of preference shares	Repurchase of preference shares	(9,984)		(132,153)		Repurchase of preference shares	—		(9,984)
Change in other liabilities due to bank overdraft		—		5,764
Repurchase of senior notes						Repurchase of senior notes	(95)		—
Cash settlement of restricted shares granted and options exercised	Cash settlement of restricted shares granted and options exercised	10		(166)		Cash settlement of restricted shares granted and options exercised	—		10
Net cash used in financing activities	Net cash used in financing activities	(10,983)		(128,988)		Net cash used in financing activities	(916)		(10,983)
Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents	Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents	(2,152)		(333)		Effect of exchange rate changes on foreign currency cash, restricted cash and equivalents	233		(1,213)
Net increase (decrease) in cash, restricted cash and cash equivalents		6,411		(84,865)
Net decrease in cash, restricted cash and cash equivalents						Net decrease in cash, restricted cash and cash equivalents	(19,162)		(4,619)
Cash, restricted cash and cash equivalents, beginning of period	Cash, restricted cash and cash equivalents, beginning of period	66,087		135,826		Cash, restricted cash and cash equivalents, beginning of period	46,624		66,087
Cash, restricted cash and cash equivalents, end of period	Cash, restricted cash and cash equivalents, end of period	$	72,498	$	50,961	Cash, restricted cash and cash equivalents, end of period	$	27,462	$	61,468

Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets:	Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets:					Reconciliation of cash and restricted cash reported within Condensed Consolidated Balance Sheets:
Cash and cash equivalents, end of period	Cash and cash equivalents, end of period	$	24,376	$	29,310	Cash and cash equivalents, end of period	$	17,242	$	37,766
Restricted cash and cash equivalents, end of period	Restricted cash and cash equivalents, end of period	48,122		21,651		Restricted cash and cash equivalents, end of period	10,220		23,702
Total cash, restricted cash and cash equivalents, end of period	Total cash, restricted cash and cash equivalents, end of period	$	72,498	$	50,961	Total cash, restricted cash and cash equivalents, end of period	$	27,462	$	61,468

See accompanying notes to the unaudited Condensed Consolidated Financial Statements.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

1. Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of Maiden Holdings, Ltd. ("Parent Company" or "Maiden Holdings") and its subsidiaries (the "Company" or "Maiden"). They have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X as promulgated by the U.S. Securities and Exchange Commission ("SEC"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. All significant intercompany transactions and accounts have been eliminated.

These interim unaudited Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, necessary for a fair presentation of the results for the interim period and all such adjustments are of a normal recurring nature. The results of operations for the interim period are not necessarily indicative, if annualized, of those to be expected for the full year. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

These unaudited Condensed Consolidated Financial Statements, including these notes, should be read in conjunction with the Company's audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022. Certain prior year comparatives have been reclassified to conform to the current period presentation. The effect of these reclassifications had no impact on previously reported shareholders' equity or net income.

Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets primarily in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. We are currently underwriting reinsurance risks on a retroactive basis through our indirect wholly owned subsidiary Genesis Legacy Solutions ("GLS") which provides a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer ~~core.~~core to operations. GLS works with clients to develop and implement finality solutions including acquiring entire companies that enable our clients to meet their capital and risk management objectives. We expect this legacy solutions business to contribute to our active asset and capital management strategies. The Company does not presently underwrite prospective reinsurance risks.

Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets. Insurance support services are provided to Maiden LF and Maiden GF by our wholly owned subsidiary services company, Maiden Global Holdings Ltd. (“Maiden Global”), which is also a licensed intermediary in the United Kingdom. Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in the European Union ("EU") and other global ~~markets.~~markets ("IIS business"). These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden Reinsurance Ltd. (“Maiden Reinsurance”).

WeThe Company also ~~have~~has various historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off, including the liabilities associated with AmTrust Financial Services, Inc. ("AmTrust") reinsurance agreements which were terminated in 2019 as discussed in "Note 10. Related Party Transactions". In addition, ~~we have~~the Company has a retroactive reinsurance agreement and a commutation agreement that further reduces ~~our~~its exposure and limits the potential volatility related to AmTrust liabilities, which are discussed in "Note 8. Reinsurance". Please see the Company's audited Consolidated Financial Statements, and related notes thereto, included in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 for further details.

~~Genesis Legacy Solutions~~

Effective October 1, 2021, GLS completed its first loss portfolio transfer transaction which includes an adverse development cover. Since then GLS continues to develop additional opportunities consistent with its business plan which should further enhance our ability to pursue the asset and capital management pillars of our business strategy. GLS and its subsidiaries have completed additional transactions, and as of September 30, 2022, GLS and its subsidiaries have insurance related liabilities totaling $29,510 which included total reserves of $16,343, derivative liability on retroactive reinsurance of $9,035 and deferred gains on retroactive reinsurance of $4,132.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

2. Significant Accounting Policies

There have been no material changes to the significant accounting policies as described in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, except for the following:

~~Derivative Instruments~~ - The Company has recently entered into reinsurance contracts that are accounted for as derivatives. These reinsurance contracts provide indemnification to an insured or cedant as a result of a change in a variable as opposed to an identifiable insurable event. The Company considers these contracts to be part of its underwriting operations. The derivatives are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair values of these derivatives are determined using internally developed discounted cash flow models using appropriate discount rates. Net asset and liability derivatives are classified within other assets and other liabilities, as applicable, in the consolidated balance sheets. Changes in fair value prior to settlement of the derivative instruments are unrealized and recognized in net income for those derivatives not designated as hedges. The unrealized gains (losses) are included in other insurance revenue as the derivative instruments held are related to the Company's underwriting portfolio and are not investment related. Please refer to ~~"Note 5. Fair Value Measurements" for further disclosures regarding the derivative instruments held by the Company.~~

Recently ~~Issued~~Adopted Accounting Standards ~~Not Yet Adopted~~

~~Fair Value~~Accounting for Measurement of ~~Equity Securities Subject to Contractual Sale Restrictions~~Credit Losses on Financial Instruments

In June ~~2022,~~2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") ~~2022-03 "~~2016-13 ~~Fair Value Measurement~~"Financial Instruments: Credit Losses (Topic 326)" replacing the "incurred loss" impairment methodology with an approach based on "expected losses" to estimate credit losses on certain types of ~~Equity~~financial instruments and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance requires financial assets to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the cost of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset.

ASU 2016-13 also modified the accounting for available-for-sale ("AFS") debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments: Credit Losses Available-for-Sale Debt Securities ~~Subject~~. Credit losses relating to ~~Contractual Sale Restrictions"~~AFS debt securities will be recorded through an allowance for credit losses rather than under the previous OTTI methodology.

In April 2019, the FASB issued ASU 2019-04 for targeted improvements related to ASU 2016-13 which clarify that an entity should include all expected recoveries in its estimate of the allowance for credit losses. In addition, for collateral dependent financial assets, the amendments mandate that an allowance for credit losses that is added to the amortized cost basis of the financial asset should not exceed amounts previously written off. It also clarifies FASB’s intent to include all reinsurance recoverables within the scope of Topic 944 ~~an amendment~~to be within the scope of ~~Fair Value Measurement (Topic 820).~~Subtopic 326-20, regardless of the measurement basis of those recoverables. The ~~amendments in this~~Company's reinsurance recoverable on unpaid losses is currently the most significant financial asset within the scope of ASU ~~require~~2016-13.

Topic 326 was adopted by the Company ~~to provide disclosures~~on January 1, 2023 and an opening allowance for ~~equity securities subject to contractual sale restrictions under 820-10-50-6B including~~expected credit losses of $5,513 was recognized by the Company in the beginning retained earnings on January 1, 2023.

Credit Losses - AFS Fixed Maturity Securities

An AFS fixed maturity security is considered impaired if the fair value of ~~equity~~the investment is below its amortized cost. On a quarterly basis, the Company evaluates all AFS fixed maturities for impairment losses. If an AFS fixed maturity security is impaired and the Company intends to sell the security or it is more likely than not that the Company will be required to sell the security before its anticipated recovery, the full amount of the impairment loss is charged immediately to net income (loss) and is included in net investment gains (losses).

If the Company does not intend to sell or will not be required to sell the impaired security before its anticipated recovery, the Company determines whether the decline in fair value below the amortized cost basis has resulted from a credit loss impairment or other factors. If the Company does not anticipate to fully recover the amortized cost, an allowance for expected credit losses is established. The allowance for expected credit losses is limited to the difference between a security's amortized cost basis and its fair value. The allowance for expected credit losses is charged to net income (loss) and is included in net investment gains (losses).

On a quarterly basis, the Company assesses whether unrealized losses on its AFS fixed maturity securities represent credit impairments by considering the following factors: the extent to which its fair value is less than its amortized cost; adverse conditions related to the specific security, industry, or geographical area; any recent downgrades in the security's credit rating by a credit rating agency; and if failure of the issuer to make scheduled principal or interest payments exists.

The length of time a security has been in an unrealized loss position no longer impacts the determination of whether a credit loss impairment exists. If a security is assessed to be credit impaired, it is subject to ~~contractual sale restrictions reflected~~discounted cash flow analysis by comparing the present value of expected future cash flows with the amortized cost basis. If the present value of expected cash flows is less than the amortized cost, then a credit loss exists and an allowance for expected credit losses is recognized. If the present value of expected future cash flows is equal to or greater than the amortized cost basis, an expected credit loss does not exist. The non-credit impairment amount of the loss related to changes in interest rates and market conditions is recognized in other comprehensive income. The Company reports accrued interest receivable related to AFS securities separately and has elected not to measure an allowance for expected credit losses for accrued interest receivable. Write-offs of accrued interest receivable balances are recognized in net investment gains and losses in the ~~balance sheet;~~period in which they are deemed uncollectible.

Based on the ~~nature~~Company's analysis, there was no allowance for expected credit losses recognized on AFS securities held at June 30, 2023.

Credit Losses - Other Investments

The Company's investments in direct lending entities are carried at cost less an allowance for expected credit losses, with any indication of credit loss recognized in net income or loss when determined to be needed from the Company's analysis of expected future cash flows. As of June 30, 2023, the total allowance for expected credit losses on the Company's investment in direct lending entities was $1,023. Please see "Note 5(d). Fair Value Measurements" for additional information regarding this investment.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and ~~remaining duration~~per share data)

2. Significant Accounting Policies (continued)

Credit Losses - Reinsurance Recoverable on Unpaid Losses

Reinsurance recoverable balances are reviewed for impairment on a quarterly basis and are presented net of an allowance for expected credit losses. A case-specific allowance for expected credit losses against reinsurance recoverables that the Company deems unlikely to be collected in full, is estimated based on the Company's analysis of amounts due, historical delinquencies and write-offs. In addition, a default analysis is used to estimate an allowance for expected credit losses on the remainder of the ~~restrictions;~~reinsurance recoverable balance. The principal components of the default analysis are reinsurance recoverable balances by reinsurer and ~~any circumstances that could cause~~default factors applied to estimate uncollectible amounts based on reinsurers’ credit ratings and the length of collection periods. The default factors are based on a ~~lapse~~model developed by a major rating agency. The default analysis considers both current and forecasted economic conditions in the ~~restrictions. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years.~~

~~Certain~~determination of the ~~Company's equity securities~~credit loss allowance.

The Company records credit loss expenses related to reinsurance recoverable in net incurred losses and loss adjustment expenses in the Company’s condensed consolidated statements of income. Any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of reinsurance recoverable balances, together with associated allowances for expected credit losses, are ~~subject to restrictions on redemptions and sales that~~recognized in the period in which balances are ~~determined by~~deemed uncollectible. The Company does not have a history of significant write-offs. As of June 30, 2023, the ~~governing documents, which could limit our ability to liquidate those investments. These restrictions may include lock-ups, redemption gates, restricted share classes, restrictions~~total allowance for expected credit losses on the ~~frequency of redemption and notice periods as described~~Company's reinsurance recoverable balance was $4,530 which is discussed in "~~Note 4. (b) Investments".~~ ~~The Company is currently assessing the required disclosures for equity securities that may be subject to contractual sales restrictions. These amendments only impact disclosures made~~more detail in "Note ~~4. Investments"~~8. Reinsurance" ~~therefore,~~.

Credit Losses - Reinsurance Balances Receivable

Reinsurance balances receivable are reviewed for impairment on a quarterly basis and are presented net of an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the ~~adoption~~Company's analysis of ~~this standard will~~amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions. The allowance for expected credit losses is recognized in net income (loss) and any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of premium balances receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not ~~impact~~have a history of significant write-offs. As of June 30, 2023, the ~~Company’s consolidated balance sheets, results~~total allowance for expected credit losses on the Company's reinsurance balances receivable was $196.

Credit Losses - Funds Withheld Receivable

Funds withheld receivable are reviewed for impairment on a quarterly basis and are presented net of ~~operations or statement~~an allowance for expected credit losses. The allowance for expected credit losses is estimated based on the Company's analysis of ~~cash flows.~~amounts due, historical delinquencies and write-offs, and current economic conditions, together with reasonable and supportable forecasts of short-term economic conditions. The allowance for expected credit losses is recognized in net income (loss) and any adjustment to the allowance for expected credit losses is recognized in the period in which it is determined. Write-offs of funds withheld receivable, together with associated allowances for expected credit losses, are recognized in the period in which balances are deemed uncollectible. The Company does not have a history of significant write-offs. As of June 30, 2023, the total allowance for expected credit losses on the Company's funds withheld receivable was $19.

910

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

3. Segment Information

The Company currently has two reportable segments: Diversified Reinsurance and AmTrust Reinsurance. Our Diversified Reinsurance segment consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies located primarily in Europe. This segment also includes transactions entered into by GLS ~~which was formed in November 2020~~ as described in "Note 1. Basis of Presentation. Our AmTrust Reinsurance segment includes all business ceded to Maiden Reinsurance by AmTrust, primarily the quota share reinsurance agreement (“AmTrust Quota Share”) between Maiden Reinsurance and AmTrust’s wholly owned subsidiary, AmTrust International Insurance, Ltd. (“AII”) and the European hospital liability quota share reinsurance contract ("European Hospital Liability Quota Share") with AmTrust’s wholly owned subsidiaries, AmTrust Europe Limited ("AEL") and AmTrust International Underwriters DAC ("AIU DAC"), which are both in run-off effective January 1, 2019. Please refer to "Note 10. Related Party Transactions" for additional information regarding the AmTrust Reinsurance segment.

The Company evaluates segment performance based on segment profit separately from the results of our investment portfolio. General and administrative expenses are allocated to the segments on an actual basis except salaries and benefits where management’s judgment is applied; however, general corporate expenses are not allocated to the segments. In determining total assets by reportable segment, the Company identifies those assets that are attributable to a particular segment such as reinsurance balances receivable, reinsurance recoverable on unpaid losses, deferred commission and other acquisition expenses, funds withheld receivable, loan to related party and restricted cash and investments. All remaining assets are allocated to Corporate.

The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net ~~loss~~(loss) income for the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively:

For the Three Months Ended September 30, 2022 Diversified Reinsurance AmTrust Reinsurance Total
Gross premiums written $ 6,185 $ (805) $ 5,380
Net premiums written $ 6,027 $ (805) $ 5,222
Net premiums earned $ 6,932 $ 5,319 $ 12,251
Other insurance revenue 368 — 368
Net loss and LAE (1,965) (15,461) (17,426)
Commission and other acquisition expenses (3,394) (2,004) (5,398)
General and administrative expenses (1,901) (521) (2,422)
Underwriting income (loss) $ 40 $ (12,667) (12,627)
Reconciliation to net loss
Net investment income and net realized and unrealized investment losses 5,065
Interest and amortization expenses (4,833)
Foreign exchange and other gains, net 8,586
Other general and administrative expenses (4,069)
Income tax benefit 91
Interest in loss of equity method investments (373)
Net loss $ (8,160)

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~3. Segment Information (continued)~~

For the Three Months Ended September 30, 2021 Diversified Reinsurance AmTrust Reinsurance Total
Gross premiums written $ 5,684 $ 1,137 $ 6,821
Net premiums written $ 5,816 $ 1,137 $ 6,953
Net premiums earned $ 7,521 $ 7,509 $ 15,030
Other insurance revenue 138 — 138
Net loss and LAE (554) (9,960) (10,514)
Commission and other acquisition expenses (3,461) (2,852) (6,313)
General and administrative expenses (1,583) (407) (1,990)
Underwriting income (loss) $ 2,061 $ (5,710) (3,649)
Reconciliation to net loss
Net investment income and net realized and unrealized investment losses 6,540
Interest and amortization expenses (4,832)
Foreign exchange and other gains, net 4,116
Other general and administrative expenses (4,660)
Income tax benefit 155
Interest in loss from equity method investments (810)
Net loss $ (3,140)

The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net (loss) income for the nine months ended September 30, 2022 and 2021, respectively:

For the Nine Months Ended September 30, 2022 Diversified Reinsurance AmTrust Reinsurance Total
Gross premiums written $ 17,069 $ (18,520) $ (1,451)
Net premiums written $ 16,605 $ (18,520) $ (1,915)
Net premiums earned $ 20,012 $ 3,804 $ 23,816
Other insurance revenue 888 — 888
Net loss and LAE (2,945) (19,072) (22,017)
Commission and other acquisition expenses (10,684) (2,127) (12,811)
General and administrative expenses (7,007) (2,281) (9,288)
Underwriting income (loss) $ 264 $ (19,676) (19,412)
Reconciliation to net loss
Net investment income and net realized and unrealized investment gains 23,719
Interest and amortization expenses (14,498)
Foreign exchange and other gains, net 19,121
Other general and administrative expenses (15,383)
Income tax expense (451)
Interest in loss from equity method investments (2,143)
Net loss $ (9,047)


For the Three Months Ended June 30, 2023	Diversified Reinsurance		AmTrust Reinsurance		Total
Gross premiums written	$	6,652	$	223	$	6,875
Net premiums written	$	6,652	$	223	$	6,875
Net premiums earned	$	7,204	$	3,835	$	11,039
Other insurance revenue	78		—		78
Net loss and LAE	(3,828)		(7,704)		(11,532)
Commission and other acquisition expenses	(3,514)		(1,431)		(4,945)
General and administrative expenses	(3,058)		(844)		(3,902)
Underwriting loss	$	(3,118)	$	(6,144)	(9,262)
Reconciliation to net loss
Net investment income and net realized and unrealized investment gains					11,663

Interest and amortization expenses					(4,773)


Foreign exchange and other losses, net					(2,621)
Other general and administrative expenses					(2,937)
Income tax benefit					194
Interest in income of equity method investments					4,803
Net loss					$	(2,933)

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

3. Segment Information (continued)


For the Nine Months Ended September 30, 2021		Diversified Reinsurance		AmTrust Reinsurance		Total
For the Three Months Ended June 30, 2022								For the Three Months Ended June 30, 2022	Diversified Reinsurance		AmTrust Reinsurance		Total
Gross premiums written	Gross premiums written	$	10,947	$	(3,082)	$	7,865	Gross premiums written	$	6,148	$	(2,809)	$	3,339
Net premiums written	Net premiums written	$	10,600	$	(3,082)	$	7,518	Net premiums written	$	5,995	$	(2,809)	$	3,186
Net premiums earned	Net premiums earned	$	20,723	$	19,383	$	40,106	Net premiums earned	$	7,125	$	3,318	$	10,443
Other insurance revenue	Other insurance revenue	946		—		946		Other insurance revenue	469		—		469
Net loss and LAE	Net loss and LAE	(3,216)		(4,330)		(7,546)		Net loss and LAE	(2,340)		(4,534)		(6,874)
Commission and other acquisition expenses	Commission and other acquisition expenses	(11,668)		(7,486)		(19,154)		Commission and other acquisition expenses	(3,519)		(1,366)		(4,885)
General and administrative expenses	General and administrative expenses	(6,190)		(1,785)		(7,975)		General and administrative expenses	(3,008)		(1,275)		(4,283)
Underwriting income		$	595	$	5,782	6,377
Underwriting loss								Underwriting loss	$	(1,273)	$	(3,857)	(5,130)
Reconciliation to net income	Reconciliation to net income							Reconciliation to net income
Net investment income and net realized and unrealized investment gains	Net investment income and net realized and unrealized investment gains					32,609		Net investment income and net realized and unrealized investment gains					9,778

Interest and amortization expenses	Interest and amortization expenses					(14,495)		Interest and amortization expenses					(4,833)

Foreign exchange and other gains, net	Foreign exchange and other gains, net					6,070		Foreign exchange and other gains, net					6,586
Other general and administrative expenses	Other general and administrative expenses					(21,578)		Other general and administrative expenses					(3,011)
Income tax benefit	Income tax benefit					363		Income tax benefit					713
Interest in income from equity method investments						4,912
Interest in loss from equity method investments								Interest in loss from equity method investments					(3,041)
Net income	Net income					$	14,258	Net income					$	1,062

The following tables summarize the underwriting results of our reportable segments and the reconciliation of our reportable segments' underwriting results to consolidated net loss for the six months ended June 30, 2023 and 2022, respectively:


For the Six Months Ended June 30, 2023	Diversified Reinsurance		AmTrust Reinsurance		Total
Gross premiums written	$	13,501	$	(5,790)	$	7,711
Net premiums written	$	13,425	$	(5,790)	$	7,635
Net premiums earned	$	14,675	$	5,366	$	20,041
Other insurance revenue	19		—		19
Net loss and LAE	(6,984)		(14,363)		(21,347)
Commission and other acquisition expenses	(7,170)		(2,010)		(9,180)
General and administrative expenses	(5,647)		(1,401)		(7,048)
Underwriting loss	$	(5,107)	$	(12,408)	(17,515)
Reconciliation to net loss
Net investment income and net realized and unrealized investment gains					22,213

Interest and amortization expenses					(8,597)


Foreign exchange and other losses, net					(5,437)
Other general and administrative expenses					(9,899)
Income tax benefit					222
Interest in income from equity method investments					4,752
Net loss					$	(14,261)

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

3. Segment Information (continued)


For the Six Months Ended June 30, 2022	Diversified Reinsurance		AmTrust Reinsurance		Total
Gross premiums written	$	10,884	$	(17,715)	$	(6,831)
Net premiums written	$	10,578	$	(17,715)	$	(7,137)
Net premiums earned	$	13,080	$	(1,515)	$	11,565
Other insurance revenue	520		—		520
Net loss and LAE	(980)		(3,611)		(4,591)
Commission and other acquisition expenses	(7,290)		(123)		(7,413)
General and administrative expenses	(5,106)		(1,760)		(6,866)
Underwriting income (loss)	$	224	$	(7,009)	(6,785)
Reconciliation to net loss
Net investment income and net realized and unrealized investment gains					18,654

Interest and amortization expenses					(9,665)


Foreign exchange and other gains, net					10,535
Other general and administrative expenses					(11,314)
Income tax expense					(542)
Interest in loss from equity method investments					(1,770)
Net loss					$	(887)

The following tables summarize the financial position of the Company's reportable segments including the reconciliation to the Company's consolidated total assets at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


September 30, 2022		Diversified Reinsurance		AmTrust Reinsurance		Total
June 30, 2023								June 30, 2023	Diversified Reinsurance		AmTrust Reinsurance		Total

Total assets - reportable segments	Total assets - reportable segments	$	96,068	$	1,481,705	$	1,577,773	Total assets - reportable segments	$	85,563	$	1,161,547	$	1,247,110
Corporate assets	Corporate assets	—		—		411,841		Corporate assets	—		—		417,803

Total Assets	Total Assets	$	96,068	$	1,481,705	$	1,989,614	Total Assets	$	85,563	$	1,161,547	$	1,664,913

December 31, 2021		Diversified Reinsurance		AmTrust Reinsurance		Total
December 31, 2022								December 31, 2022	Diversified Reinsurance		AmTrust Reinsurance		Total

Total assets - reportable segments	Total assets - reportable segments	$	126,116	$	1,810,940	$	1,937,056	Total assets - reportable segments	$	97,290	$	1,342,852	$	1,440,142
Corporate assets	Corporate assets	—		—		385,554		Corporate assets	—		—		406,724

Total Assets	Total Assets	$	126,116	$	1,810,940	$	2,322,610	Total Assets	$	97,290	$	1,342,852	$	1,846,866

1213

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

3. Segment Information (continued)

The following tables set forth financial information relating to net premiums written by major line of business and reportable segment for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


For the Three Months Ended September 30,		2022		2021
For the Three Months Ended June 30,							For the Three Months Ended June 30,	2023		2022
Net premiums written	Net premiums written	Total			Total		Net premiums written	Total			Total
Diversified Reinsurance	Diversified Reinsurance						Diversified Reinsurance

International	International	$	6,027		$	5,816	International	$	6,652		$	5,995

Total Diversified Reinsurance	Total Diversified Reinsurance	6,027			5,816		Total Diversified Reinsurance	6,652			5,995
AmTrust Reinsurance	AmTrust Reinsurance						AmTrust Reinsurance
Small Commercial Business	Small Commercial Business	(636)			(1,309)		Small Commercial Business	(75)			(2,649)
Specialty Program	Specialty Program	(43)			22		Specialty Program	1			(62)
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	(126)			2,424		Specialty Risk and Extended Warranty	297			(98)
Total AmTrust Reinsurance	Total AmTrust Reinsurance	(805)			1,137		Total AmTrust Reinsurance	223			(2,809)

Total Net Premiums Written	Total Net Premiums Written	$	5,222		$	6,953	Total Net Premiums Written	$	6,875		$	3,186

For the Nine Months Ended September 30,		2022		2021
For the Six Months Ended June 30,							For the Six Months Ended June 30,	2023		2022
Net premiums written	Net premiums written	Total			Total		Net premiums written	Total			Total
Diversified Reinsurance	Diversified Reinsurance						Diversified Reinsurance

International	International	$	16,605		$	10,600	International	$	13,425		$	10,578

Total Diversified Reinsurance	Total Diversified Reinsurance	16,605			10,600		Total Diversified Reinsurance	13,425			10,578
AmTrust Reinsurance	AmTrust Reinsurance						AmTrust Reinsurance
Small Commercial Business	Small Commercial Business	(15,007)			(5,381)		Small Commercial Business	(158)			(14,371)
Specialty Program	Specialty Program	732			(7)		Specialty Program	157			775
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	(4,245)			2,306		Specialty Risk and Extended Warranty	(5,789)			(4,119)
Total AmTrust Reinsurance	Total AmTrust Reinsurance	(18,520)			(3,082)		Total AmTrust Reinsurance	(5,790)			(17,715)

Total Net Premiums Written	Total Net Premiums Written	$	(1,915)		$	7,518	Total Net Premiums Written	$	7,635		$	(7,137)

1314

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

3. Segment Information (continued)

The following tables set forth financial information for net premiums earned by major line of business and reportable segment for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


For the Three Months Ended September 30,		2022				2021
For the Three Months Ended June 30,										For the Three Months Ended June 30,	2023		2022
Net premiums earned	Net premiums earned	Total		% of Total		Total		% of Total		Net premiums earned	Total			Total
Diversified Reinsurance	Diversified Reinsurance									Diversified Reinsurance

International	International	$	6,932	56.6	%	$	7,521	50.0	%	International	$	7,204			$	7,125

Total Diversified Reinsurance	Total Diversified Reinsurance	6,932		56.6	%	7,521		50.0	%	Total Diversified Reinsurance	7,204				7,125
AmTrust Reinsurance	AmTrust Reinsurance									AmTrust Reinsurance
Small Commercial Business	Small Commercial Business	(636)		(5.2)	%	(1,227)		(8.1)	%	Small Commercial Business	(75)				(2,649)
Specialty Program	Specialty Program	(43)		(0.4)	%	28		0.2	%	Specialty Program	1				(62)
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	5,998		49.0	%	8,708		57.9	%	Specialty Risk and Extended Warranty	3,909				6,029
Total AmTrust Reinsurance	Total AmTrust Reinsurance	5,319		43.4	%	7,509		50.0	%	Total AmTrust Reinsurance	3,835				3,318

Total Net Premiums Earned	Total Net Premiums Earned	$	12,251	100.0	%	$	15,030	100.0	%	Total Net Premiums Earned	$	11,039			$	10,443

For the Nine Months Ended September 30,		2022				2021
For the Six Months Ended June 30,										For the Six Months Ended June 30,	2023		2022
Net premiums earned	Net premiums earned	Total		% of Total		Total		% of Total		Net premiums earned	Total			Total
Diversified Reinsurance	Diversified Reinsurance									Diversified Reinsurance

International	International	$	20,012	84.0	%	$	20,723	51.7	%	International	$	14,675			$	13,080

Total Diversified Reinsurance	Total Diversified Reinsurance	20,012		84.0	%	20,723		51.7	%	Total Diversified Reinsurance	14,675				13,080
AmTrust Reinsurance	AmTrust Reinsurance									AmTrust Reinsurance
Small Commercial Business	Small Commercial Business	(14,995)		(63.0)	%	(5,073)		(12.6)	%	Small Commercial Business	(158)				(14,359)
Specialty Program	Specialty Program	733		3.1	%	12		—	%	Specialty Program	157				776
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	18,066		75.9	%	24,444		60.9	%	Specialty Risk and Extended Warranty	5,367				12,068
Total AmTrust Reinsurance	Total AmTrust Reinsurance	3,804		16.0	%	19,383		48.3	%	Total AmTrust Reinsurance	5,366				(1,515)

Total Net Premiums Earned	Total Net Premiums Earned	$	23,816	100.0	%	$	40,106	100.0	%	Total Net Premiums Earned	$	20,041			$	11,565

1415

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

4. Investments

The Company holds: (i) available-for-sale ("AFS") portfolios of fixed maturity and equity securities, carried at fair value; (ii) other investments, of which certain investments are carried at fair value and investments in direct lending entities are carried at cost less impairment; (iii) equity method investments; and (iv) funds held - directly managed.

a)Fixed Maturities

The amortized cost, gross unrealized gains and losses, and fair value of fixed maturities at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 are as follows:


September 30, 2022		Original or amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value
June 30, 2023										June 30, 2023	Original or amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value
U.S. treasury bonds	U.S. treasury bonds	$	58,464	$	—	$	(241)	$	58,223	U.S. treasury bonds	$	62,802	$	3	$	(121)	$	62,684
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	73,874		—		(7,682)		66,192		U.S. agency bonds – mortgage-backed	37,175		—		(4,321)		32,854
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	7,199		—		(397)		6,802		Collateralized mortgage-backed securities	7,199		—		(406)		6,793
Non-U.S. government bonds	Non-U.S. government bonds	12,586		—		(1,605)		10,981		Non-U.S. government bonds	14,834		—		(786)		14,048
Collateralized loan obligations	Collateralized loan obligations	175,047		—		(30,514)		144,533		Collateralized loan obligations	98,260		—		(3,100)		95,160
Corporate bonds	Corporate bonds	105,144		—		(19,902)		85,242		Corporate bonds	80,183		—		(4,398)		75,785

Total fixed maturity investments	Total fixed maturity investments	$	432,314	$	—	$	(60,341)	$	371,973	Total fixed maturity investments	$	300,453	$	3	$	(13,132)	$	287,324


December 31, 2021		Original or amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value
December 31, 2022										December 31, 2022	Original or amortized cost		Gross unrealized gains		Gross unrealized losses		Fair value
U.S. treasury bonds	U.S. treasury bonds	$	59,989	$	—	$	(110)	$	59,879	U.S. treasury bonds	$	55,647	$	1	$	(116)	$	55,532
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	96,554		2,429		(193)		98,790		U.S. agency bonds – mortgage-backed	38,767		—		(4,402)		34,365
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	14,972		565		—		15,537		Collateralized mortgage-backed securities	7,199		—		(432)		6,767
Non-U.S. government bonds	Non-U.S. government bonds	3,163		113		—		3,276		Non-U.S. government bonds	12,643		—		(825)		11,818
Collateralized loan obligations	Collateralized loan obligations	183,974		140		(5,093)		179,021		Collateralized loan obligations	119,120		—		(5,028)		114,092
Corporate bonds	Corporate bonds	236,692		10,094		(6,144)		240,642		Corporate bonds	97,063		—		(5,110)		91,953

Total fixed maturity investments	Total fixed maturity investments	$	595,344	$	13,341	$	(11,540)	$	597,145	Total fixed maturity investments	$	330,439	$	1	$	(15,913)	$	314,527

The contractual maturities of our fixed maturities are shown below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.


September 30, 2022		Amortized cost		Fair value
June 30, 2023						June 30, 2023	Amortized cost		Fair value
Due in one year or less	Due in one year or less	$	65,624	$	64,525	Due in one year or less	$	76,632	$	76,256
Due after one year through five years	Due after one year through five years	92,969		77,117		Due after one year through five years	72,144		68,153
Due after five years through ten years	Due after five years through ten years	17,601		12,804		Due after five years through ten years	9,043		8,108

		176,194		154,446			157,819		152,517
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	73,874		66,192		U.S. agency bonds – mortgage-backed	37,175		32,854
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	7,199		6,802		Collateralized mortgage-backed securities	7,199		6,793
Collateralized loan obligations	Collateralized loan obligations	175,047		144,533		Collateralized loan obligations	98,260		95,160
Total fixed maturity investments	Total fixed maturity investments	$	432,314	$	371,973	Total fixed maturity investments	$	300,453	$	287,324

1516

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

4. Investments (continued)

The following tables summarize fixed maturities in an unrealized loss position and the aggregate fair value and gross unrealized loss by length of time the security has continuously been in an unrealized loss position:


		Less than 12 Months				12 Months or More				Total					Less than 12 Months				12 Months or More				Total
September 30, 2022		Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses
June 30, 2023														June 30, 2023	Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses
U.S. treasury bonds	U.S. treasury bonds	$	58,076	$	(239)	$	147	$	(2)	$	58,223	$	(241)	U.S. treasury bonds	$	48,615	$	(95)	$	975	$	(26)	$	49,590	$	(121)
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	63,136		(6,982)		3,056		(700)		66,192		(7,682)		U.S. agency bonds – mortgage-backed	—		—		32,854		(4,321)		32,854		(4,321)
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	6,802		(397)		—		—		6,802		(397)		Collateralized mortgage-backed securities	—		—		6,793		(406)		6,793		(406)
Non-U.S. government bonds	Non-U.S. government bonds	10,981		(1,605)		—		—		10,981		(1,605)		Non-U.S. government bonds	—		—		12,088		(786)		12,088		(786)
Collateralized loan obligations	Collateralized loan obligations	63,813		(6,602)		80,720		(23,912)		144,533		(30,514)		Collateralized loan obligations	—		—		95,160		(3,100)		95,160		(3,100)
Corporate bonds	Corporate bonds	63,739		(11,718)		21,503		(8,184)		85,242		(19,902)		Corporate bonds	1,756		(65)		74,029		(4,333)		75,785		(4,398)

Total temporarily impaired fixed maturities	Total temporarily impaired fixed maturities	$	266,547	$	(27,543)	$	105,426	$	(32,798)	$	371,973	$	(60,341)	Total temporarily impaired fixed maturities	$	50,371	$	(160)	$	221,899	$	(12,972)	$	272,270	$	(13,132)

At ~~September~~June 30, ~~2022,~~2023, there were ~~120~~79 securities in an unrealized loss position with a fair value of ~~$371,973~~$272,270 and unrealized losses of ~~$60,341.~~$13,132. Of these securities in an unrealized loss position, there were 3174 securities in our portfolio that have been in an unrealized loss position for twelve months or greater with a fair value of ~~$105,426~~$221,899 and unrealized losses of ~~$32,798.~~$12,972.


		Less than 12 Months				12 Months or More				Total					Less than 12 Months				12 Months or More				Total
December 31, 2021		Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses
December 31, 2022														December 31, 2022	Fair value		Unrealized losses		Fair value		Unrealized losses		Fair value		Unrealized losses
U.S. treasury bonds	U.S. treasury bonds	$	59,879	$	(110)	$	—	$	—	$	59,879	$	(110)	U.S. treasury bonds	$	53,094	$	(114)	$	148	$	(2)	$	53,242	$	(116)
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	4,415		(193)		—		—		4,415		(193)		U.S. agency bonds – mortgage-backed	31,394		(3,697)		2,971		(705)		34,365		(4,402)

Collateralized mortgage-backed securities														Collateralized mortgage-backed securities	6,767		(432)		—		—		6,767		(432)
Non-U.S. government bonds														Non-U.S. government bonds	11,818		(825)		—		—		11,818		(825)
Collateralized loan obligations	Collateralized loan obligations	117,148		(5,057)		5,064		(36)		122,212		(5,093)		Collateralized loan obligations	17,959		(1,032)		96,133		(3,996)		114,092		(5,028)
Corporate bonds	Corporate bonds	38,537		(2,775)		27,852		(3,369)		66,389		(6,144)		Corporate bonds	87,213		(4,325)		4,740		(785)		91,953		(5,110)

Total temporarily impaired fixed maturities	Total temporarily impaired fixed maturities	$	219,979	$	(8,135)	$	32,916	$	(3,405)	$	252,895	$	(11,540)	Total temporarily impaired fixed maturities	$	208,245	$	(10,425)	$	103,992	$	(5,488)	$	312,237	$	(15,913)

At December 31, ~~2021,~~2022, there were 4488 securities in an unrealized loss position with a fair value of ~~$252,895~~$312,237 and unrealized losses of ~~$11,540.~~$15,913. Of these securities in an unrealized loss position, there were 826 securities in our portfolio that have been in an unrealized loss position for twelve months or greater with a fair value of ~~$32,916~~$103,992 and unrealized losses of ~~$3,405.~~$5,488.

~~Other-than-temporarily impaired ("OTTI")~~Allowance for Expected Credit Losses & Non-Credit Related Impairment Costs

The Company ~~performs quarterly reviews of its fixed maturities in order to determine whether declines in~~evaluates AFS securities for impairment when fair value is below ~~the~~ amortized cost ~~basis were considered other-than-temporary in accordance with applicable guidance. At September 30, 2022, we determined that unrealized losses~~ on ~~fixed maturities were primarily due~~a quarterly basis. If the Company intends to ~~changes in interest rates as well as~~sell or will be required to sell the ~~impact of foreign exchange rate changes on certain foreign currency denominated fixed maturities since their date of purchase. All fixed maturity securities continue to pay~~security before its anticipated recovery, the ~~expected coupon payments under the contractual terms~~full amount of the ~~securities. Any credit-related~~ impairment ~~related~~loss is charged to ~~fixed maturity securities that~~net income (loss) and included in net investment gains (losses). If the Company does not intend to sell or iswill not ~~more likely than not that the Company will~~ be required to sell the security before its anticipated recovery, an allowance for expected credit losses is established and the portion of ~~their amortized cost basis~~the loss relating to credit factors is recorded in net income (loss). The non-credit impairment amount of the loss (which could be related to interest rates and/or market conditions) is recognized in ~~net income, with~~other comprehensive income.

To estimate the ~~non-credit~~allowance for expected credit losses for most of the AFS securities, the Company analyzes projected cash flows which are primarily driven by assumptions regarding loss severity, probability of default and projected recovery rates. The Company's determination of default and loss severity rates are based on credit rating, credit analysis and macroeconomic forecasts. Unrealized losses on securities issued or backed, either explicitly or implicitly by the U.S. government are not analyzed for credit losses. The Company has concluded that any possibility of a credit loss on these securities is highly unlikely due to the explicit U.S. government guarantee related to certain securities (e.g., Government National Mortgage Association issuances) and the implicit guarantee related to other securities that has been validated by past actions (e.g., U.S. government bailout of Federal National Mortgage Association and Federal Home Loan Mortgage Corporation during the 2008 credit crisis). Although these securities are not analyzed for credit losses, they are evaluated for impairment ~~recognized in comprehensive income.~~based on the Company's intention to sell and likely requirement to sell.

Based on the Company's analysis ~~our~~at June 30, 2023 and 2022, respectively, the Company did not recognize any impairment on its AFS fixed maturity ~~portfolio is of high credit quality and we believe~~securities as the Company expects the amortized cost basis ~~of the securities~~ will ultimately be ~~recovered.~~recovered based on projected cash flows as the related securities approach maturity. The Company ~~continually monitors~~continues to monitor the credit quality of the ~~fixed maturity investments~~AFS securities to assess if it is probable that it will receive contractual or estimated cash flows in the form of principal and interest. ~~There~~Therefore, as the unrealized losses were due to non-credit factors, there was no ~~impairment~~allowance recorded for expected credit losses on AFS securities for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022 and 2021, respectively.~~

2023.

1617

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

4. Investments (continued)

The following tables summarize the credit ratings of our fixed maturities as at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


September 30, 2022		Amortized cost		Fair value		% of Total fair value
June 30, 2023								June 30, 2023	Amortized cost		Fair value		% of Total fair value
U.S. treasury bonds	U.S. treasury bonds	$	58,464	$	58,223	15.6	%	U.S. treasury bonds	$	62,802	$	62,684	21.8	%
U.S. agency bonds	U.S. agency bonds	73,874		66,192		17.8	%	U.S. agency bonds	37,175		32,854		11.4	%
AAA	AAA	147,990		119,653		32.2	%	AAA	91,830		88,911		31.0	%
AA+, AA, AA-	AA+, AA, AA-	44,766		40,812		11.0	%	AA+, AA, AA-	26,254		25,102		8.7	%
A+, A, A-	A+, A, A-	46,912		37,616		10.1	%	A+, A, A-	37,126		34,720		12.1	%
BBB+, BBB, BBB-	BBB+, BBB, BBB-	54,535		45,066		12.1	%	BBB+, BBB, BBB-	39,811		37,980		13.2	%
BB+ or lower	BB+ or lower	5,773		4,411		1.2	%	BB+ or lower	5,455		5,073		1.8	%
Total fixed maturities (1)	Total fixed maturities (1)	$	432,314	$	371,973	100.0	%	Total fixed maturities (1)	$	300,453	$	287,324	100.0	%


December 31, 2021		Amortized cost		Fair value		% of Total fair value
December 31, 2022								December 31, 2022	Amortized cost		Fair value		% of Total fair value
U.S. treasury bonds	U.S. treasury bonds	$	59,989	$	59,879	10.0	%	U.S. treasury bonds	$	55,647	$	55,532	17.7	%
U.S. agency bonds	U.S. agency bonds	96,554		98,790		16.6	%	U.S. agency bonds	38,767		34,365		10.9	%
AAA	AAA	161,179		156,706		26.2	%	AAA	112,775		108,136		34.4	%
AA+, AA, AA-	AA+, AA, AA-	38,999		39,140		6.6	%	AA+, AA, AA-	23,974		22,640		7.2	%
A+, A, A-	A+, A, A-	99,748		99,962		16.7	%	A+, A, A-	38,549		35,996		11.4	%
BBB+, BBB, BBB-	BBB+, BBB, BBB-	126,770		129,618		21.7	%	BBB+, BBB, BBB-	55,374		53,094		16.9	%
BB+ or lower	BB+ or lower	12,105		13,050		2.2	%	BB+ or lower	5,353		4,764		1.5	%
Total fixed maturities(1)	Total fixed maturities(1)	$	595,344	$	597,145	100.0	%	Total fixed maturities(1)	$	330,439	$	314,527	100.0	%

(1)Ratings above are based on Standard & Poor’s ("S&P"), or equivalent, ratings.

b)Other Investments, Equity Securities and Equity Method Investments

Certain of the Company's other investments and equity method investments are subject to restrictions on redemptions and sales that are determined by the governing documents, which could limit our ability to liquidate those investments. These restrictions may include lock-ups, redemption gates, restricted share classes, restrictions on the frequency of redemption and notice periods. A gate is the ability to deny or delay a redemption request. Certain other investments and equity method investments may not have any restrictions governing their sale, but there is no active market and no guarantee that we will be able to execute a sale in a timely manner. In addition, even if certain other investments and equity method investments are not eligible for redemption or sales are restricted, the Company may still receive income distributions from those investments.

Other investments

The table shows the composition of the Company's other investments as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


		September 30, 2022				December 31, 2021					June 30, 2023				December 31, 2022
		Carrying value		% of Total		Carrying value		% of Total			Carrying value		% of Total		Carrying value		% of Total
Private equity funds	Private equity funds	$	31,777	22.6	%	$	23,324	19.8	%	Private equity funds	$	36,284	24.2	%	$	32,298	21.7	%
Private credit funds	Private credit funds	24,129		17.1	%	20,922		17.8	%	Private credit funds	17,620		11.7	%	26,354		17.7	%
Other privately held investments		32,115		22.8	%	30,500		25.9	%
Privately held equity investments										Privately held equity investments	34,845		23.2	%	34,014		22.9	%

Total other investments at fair value	Total other investments at fair value	88,021		62.5	%	74,746		63.5	%	Total other investments at fair value	88,749		59.1	%	92,666		62.3	%
Investments in direct lending entities (at cost)	Investments in direct lending entities (at cost)	52,783		37.5	%	42,976		36.5	%	Investments in direct lending entities (at cost)	61,400		40.9	%	56,087		37.7	%
Total other investments	Total other investments	$	140,804	100.0	%	$	117,722	100.0	%	Total other investments	$	150,149	100.0	%	$	148,753	100.0	%

The Company's investments in direct lending entities of ~~$52,783~~$61,400 at ~~September~~June 30, ~~2022~~2023 (December 31, ~~2021~~2022 - ~~$42,976)~~$56,087) are carried at cost less ~~impairment, if any,~~an allowance for expected credit losses, with any indication of ~~impairment~~credit loss recognized in net income when determined. ~~No impairment~~An allowance for expected credit losses of $1,023 was ~~recognized for~~reported on the ~~three~~investments in direct lending entities as at June 30, 2023 and ~~nine months ended September 30, 2022 and 2021.~~recorded in opening retained earnings on January 1, 2023. Please see "Note 5(d). Fair Value Measurements" for additional information regarding this investment.

1718

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

4. Investments (continued)

Equity Securities

Equity securities include publicly traded equity investments in common stocks and privately held equity investments in common and preferred ~~stocks and publicly traded common~~ stocks. The Company's publicly traded equity investments in common stocks trade on major exchanges. The Company's privately held equity investments in common and preferred stocks are direct investments in companies that the Company believes offer attractive risk adjusted returns or offer other strategic advantages. Each investment may have its own unique terms and conditions and there may be restrictions on disposals. There is no active market for these investments.

The following table provides the cost and fair values of the equity securities held at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

September 30, 2022 December 31, 2021
Cost Fair Value Cost Fair Value
Privately held equity securities $ 38,260 $ 42,002 $ 22,756 $ 22,829
Publicly traded equity securities 559 598 559 1,174
Total equity securities $ 38,819 $ 42,600 $ 23,315 $ 24,003


	June 30, 2023				December 31, 2022
	Cost		Fair Value		Cost		Fair Value
Publicly traded equity investments in common stocks	$	90	$	84	$	559	$	386
Privately held common stocks	32,775		32,214		32,775		32,290
Privately held preferred stocks	8,175		12,953		7,175		10,945
Total equity securities	$	41,040	$	45,251	$	40,509	$	43,621

Equity Method Investments

The ~~Company's~~ equity method investments include real estate investments, hedge fund investments, and other investments. The table below shows the carrying value of ~~our~~the Company's equity method investments as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


		September 30, 2022				December 31, 2021					June 30, 2023				December 31, 2022
		Carrying Value		% of Total		Carrying Value		% of Total			Carrying Value		% of Total		Carrying Value		% of Total
Real estate investments	Real estate investments	$	44,925	56.0	%	$	44,050	52.6	%	Real estate investments	$	42,602	58.2	%	$	40,944	51.1	%
Hedge fund investments	Hedge fund investments	15,447		19.3	%	32,929		39.3	%	Hedge fund investments	—		—	%	5,376		6.7	%
Other investments	Other investments	19,793		24.7	%	6,763		8.1	%	Other investments	30,614		41.8	%	33,839		42.2	%
Total equity method investments	Total equity method investments	$	80,165	100.0	%	$	83,742	100.0	%	Total equity method investments	$	73,216	100.0	%	$	80,159	100.0	%

The equity method investments above include limited partnerships which are variable interests issued by variable interest entities ("VIEs"). The Company does not have the power to direct the activities that are most significant to the economic performance of these VIEs, therefore, the Company is not the primary beneficiary of these VIEs. The Company is deemed to have limited influence over the operating and financial policies of the investee and accordingly, these investments are reported under the equity method of accounting. In applying the equity method of accounting, the investments are initially recorded at cost and are subsequently adjusted based on the Company’s proportionate share of the investee's net income or loss. Generally, the maximum exposure to loss on these interests is limited to the amount of commitment made by the Company as more fully described in "Note 11 - Commitments, Contingencies and Guarantees" in these condensed consolidated financial statements.

c)Net Investment Income

Net investment income was derived from the following sources for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Fixed maturities	Fixed maturities	$	2,259	$	4,449	$	7,074	$	15,535	Fixed maturities	$	2,780	$	2,161	$	5,198	$	4,815
Income on funds withheld	Income on funds withheld	2,616		2,708		8,753		7,928		Income on funds withheld	3,187		3,513		6,522		6,137
Interest income from loan to related party	Interest income from loan to related party	1,771		885		3,808		2,611		Interest income from loan to related party	2,927		1,158		5,625		2,037
Cash and cash equivalents and other investments	Cash and cash equivalents and other investments	930		377		2,292		613		Cash and cash equivalents and other investments	1,813		989		3,006		1,582
		7,576		8,419		21,927		26,687			10,707		7,821		20,351		14,571

Investment expenses	Investment expenses	(939)		(942)		(1,056)		(2,091)		Investment expenses	(189)		(154)		(288)		(337)
Net investment income	Net investment income	$	6,637	$	7,477	$	20,871	$	24,596	Net investment income	$	10,518	$	7,667	$	20,063	$	14,234

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

4. Investments (continued)

d) Net Realized and Unrealized Investment Gains (Losses)

Realized gains or losses on the sale of investments are determined on the basis of the first in first out cost method. The following tables show the net realized and unrealized investment gains (losses) included in the Condensed Consolidated Statements of Income for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~4. Investments (continued)~~


For the Three Months Ended September 30, 2022		Gross gains		Gross losses		Net
For the Three Months Ended June 30, 2023								For the Three Months Ended June 30, 2023	Gross gains		Gross losses		Net
Fixed maturities	Fixed maturities	$	591	$	(495)	$	96	Fixed maturities	$	—	$	(786)	$	(786)
Equity securities	Equity securities	217		(63)		154		Equity securities	454		(1)		453
Other investments	Other investments	393		(2,215)		(1,822)		Other investments	2,234		(756)		1,478
Net realized and unrealized investment gains (losses)	Net realized and unrealized investment gains (losses)	$	1,201	$	(2,773)	$	(1,572)	Net realized and unrealized investment gains (losses)	$	2,688	$	(1,543)	$	1,145

For the Three Months Ended September 30, 2021		Gross gains		Gross losses		Net
For the Three Months Ended June 30, 2022								For the Three Months Ended June 30, 2022	Gross gains		Gross losses		Net
Fixed maturities	Fixed maturities	$	1,890	$	(99)	$	1,791	Fixed maturities	$	—	$	(47)	$	(47)
Equity securities	Equity securities	106		(3,001)		(2,895)		Equity securities	3,659		(321)		3,338
Other investments	Other investments	297		(130)		167		Other investments	519		(1,699)		(1,180)
Net realized and unrealized investment gains (losses)	Net realized and unrealized investment gains (losses)	$	2,293	$	(3,230)	$	(937)	Net realized and unrealized investment gains (losses)	$	4,178	$	(2,067)	$	2,111

For the Nine Months Ended September 30, 2022		Gross gains		Gross losses		Net
For the Six Months Ended June 30, 2023								For the Six Months Ended June 30, 2023	Gross gains		Gross losses		Net
Fixed maturities	Fixed maturities	$	1,829	$	(637)	$	1,192	Fixed maturities	$	—	$	(786)	$	(786)
Equity securities	Equity securities	3,876		(875)		3,001		Equity securities	1,478		(379)		1,099
Other investments	Other investments	2,825		(4,170)		(1,345)		Other investments	3,875		(2,038)		1,837
Net realized and unrealized investment gains (losses)	Net realized and unrealized investment gains (losses)	$	8,530	$	(5,682)	$	2,848	Net realized and unrealized investment gains (losses)	$	5,353	$	(3,203)	$	2,150

For the Nine Months Ended September 30, 2021		Gross gains		Gross losses		Net
For the Six Months Ended June 30, 2022								For the Six Months Ended June 30, 2022	Gross gains		Gross losses		Net
Fixed maturities	Fixed maturities	$	6,137	$	(343)	$	5,794	Fixed maturities	$	1,238	$	(142)	$	1,096
Equity securities	Equity securities	5,168		(3,638)		1,530		Equity securities	3,659		(808)		2,851
Other investments	Other investments	838		(149)		689		Other investments	2,432		(1,959)		473
Net realized and unrealized investment gains (losses)	Net realized and unrealized investment gains (losses)	$	12,143	$	(4,130)	$	8,013	Net realized and unrealized investment gains (losses)	$	7,329	$	(2,909)	$	4,420

Realized and unrealized gains and losses from equity securities detailed above include both sales of equity securities and unrealized gains and losses coming from fair value changes. The unrealized gains ~~and losses~~ recognized in net loss or income for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 for investments ~~still~~ held at ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively, were as follows:

For the Three Months Ended September 30, For the Nine Months Ended September 30,
2022 2021 2022 2021
Net gains (losses) recognized for equity securities $ 154 $ (2,895) $ 3,001 $ 1,530
Net gains recognized for equity securities divested — — — (441)
Unrealized gains (losses) recognized for equity securities still held at reporting date $ 154 $ (2,895) $ 3,001 $ 1,089


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2023		2022		2023		2022
Net gains recognized for equity securities	$	453	$	3,338	$	1,099	$	2,851
Net gains recognized for equity securities divested	(10)		—		(186)		—
Unrealized gains recognized for equity securities still held at reporting date	$	443	$	3,338	$	913	$	2,851

Proceeds from sales of fixed maturity investments were ~~$35,107~~$43,829 and ~~$139,645 for~~$44,783 in the three and ~~nine~~six months ended ~~September~~June 30, ~~2022, respectively (2021~~2023 (2022 - ~~$126,282~~$2,934 and ~~$332,636,~~$104,538, respectively).

Net unrealized ~~gains (losses) were as follows~~losses at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021, respectively:~~2022 included:


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Fixed maturity investments	Fixed maturity investments	$	(60,341)	$	1,801	Fixed maturity investments	$	(13,129)	$	(15,912)
Equity method investments		—		(4,414)

Total net unrealized losses	Total net unrealized losses	(60,341)		(2,613)		Total net unrealized losses	(13,129)		(15,912)
Deferred income tax	Deferred income tax	216		(80)		Deferred income tax	225		244
Net unrealized losses, net of deferred income tax	Net unrealized losses, net of deferred income tax	$	(60,125)	$	(2,693)	Net unrealized losses, net of deferred income tax	$	(12,904)	$	(15,668)
Change, net of deferred income tax	Change, net of deferred income tax	$	(57,432)	$	(52,050)	Change, net of deferred income tax	$	2,764	$	(12,975)

1920

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

4. Investments (continued)

e)Restricted Cash and Cash Equivalents and Investments

The Company is required to provide collateral for its reinsurance liabilities under various reinsurance agreements and utilizes trust accounts to collateralize business with reinsurance counterparties. The assets in trust as collateral are primarily cash and highly rated fixed maturities. The fair values of restricted assets at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 are:


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Restricted cash – third party agreements	Restricted cash – third party agreements	$	15,297	$	19,177	Restricted cash – third party agreements	$	6,481	$	13,122
Restricted cash – related party agreements	Restricted cash – related party agreements	32,825		20,242		Restricted cash – related party agreements	3,739		2,516
Total restricted cash	Total restricted cash	48,122		39,419		Total restricted cash	10,220		15,638
Restricted investments – in trust for third party agreements at fair value (amortized cost: 2022 – $50,394; 2021 – $48,860)		50,235		48,845
Restricted investments – in trust for related party agreements at fair value (amortized cost: 2022 – $327,148; 2021 – $493,128)		274,103		493,883
Restricted investments – in trust for third party agreements at fair value (amortized cost: 2023 – $49,536; 2022 – $48,181)						Restricted investments – in trust for third party agreements at fair value (amortized cost: 2023 – $49,536; 2022 – $48,181)	49,494		48,101
Restricted investments – in trust for related party agreements at fair value (amortized cost: 2023 – $180,755; 2022 – $246,325)						Restricted investments – in trust for related party agreements at fair value (amortized cost: 2023 – $180,755; 2022 – $246,325)	172,886		233,091

Total restricted investments	Total restricted investments	324,338		542,728		Total restricted investments	222,380		281,192
Total restricted cash and investments	Total restricted cash and investments	$	372,460	$	582,147	Total restricted cash and investments	$	232,600	$	296,830

5. Fair Value of Financial Instruments

(a) Fair Values of Financial Instruments

Fair Value Measurements — Accounting Standards Codification Topic 820, "Fair Value Measurements and Disclosures" ("ASC 820") defines fair value as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between open market participants at the measurement date. Additionally, ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy is broken down into three levels based on the reliability of inputs:

•Level 1 — Valuations based on unadjusted quoted market prices for identical assets or liabilities that we have the ability to access. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Examples of assets and liabilities utilizing Level 1 inputs include: U.S. Treasury bonds; and publicly traded equity securities;

•Level 2 — Valuations based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in inactive markets, or valuations based on models where the significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severity, etc.) or can be corroborated by observable market data. Examples of assets and liabilities utilizing Level 2 inputs include: U.S. government-sponsored agency securities; non-U.S. government and supranational obligations; commercial mortgage-backed securities ("CMBS"); collateralized loan obligations ("CLO"); corporate and municipal bonds; and

•Level 3 — Valuations based on models where significant inputs are not observable. The unobservable inputs reflect our own assumptions about assumptions that market participants would use developed on the basis of the best information available in the particular circumstances. Examples of assets and liabilities utilizing Level 3 inputs include: an investment in preference shares of a start-up insurance producer.

The availability of observable inputs can vary and is affected by a wide variety of factors, including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in the Level 3 hierarchy.

The Company uses prices and inputs that are current as at the measurement date. In periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This condition could cause an instrument to be reclassified between hierarchy levels.

For investments that have quoted market prices in active markets, the Company uses the quoted market prices as fair value and includes these in the Level 1 hierarchy. The Company receives the quoted market prices from a third party nationally recognized provider ("the Pricing Service"). When quoted market prices are unavailable, the Company utilizes the Pricing Service to determine an estimate of fair value. The fair value estimates are included in the Level 2 hierarchy. The Company will challenge any prices for its investments which are considered not to be representative of fair value.

If quoted market prices and an estimate from the Pricing Service are unavailable, the Company produces an estimate of fair value based on dealer quotations for recent activity in positions with the same or similar characteristics to that being valued. The Company determines whether the fair value estimate is in the Level 2 or Level 3 hierarchy depending on the level of observable inputs available when estimating the fair value. The Company bases its estimates of fair values for assets on the bid price as it represents what a third party market participant would be willing to pay in an orderly transaction.

2021

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

5. Fair Value of Financial Instruments (continued)

ASC 825, "Disclosure About Fair Value of Financial Instruments", requires all entities to disclose the fair value of their financial instruments for assets and liabilities recognized and not recognized in the balance sheet, for which it is practicable to estimate fair value. The following describes the valuation techniques used by the Company to determine the fair value of financial instruments that are measured at fair value on a recurring basis held at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022.

U.S. government and U.S. agency bonds — Bonds issued by the U.S. Treasury, the Federal Home Loan Bank, the Federal Home Loan Mortgage Corporation, Government National Mortgage Association, Federal National Mortgage Association and the Federal Farm Credit Banks Funding Corporation. The fair values of U.S. treasury bonds are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy. We believe the market for U.S. treasury bonds is an actively traded market given the high level of daily trading volume. The fair values of U.S. agency bonds are determined using the spread above the risk-free yield curve. As the yields for the risk-free yield curve and the spreads for these securities are observable market inputs, the fair values of U.S. agency bonds are included in the Level 2 fair value hierarchy.

Non-U.S. government bonds — These securities are generally priced by independent pricing services. The Pricing Service may use current market trades for securities with similar quality, maturity and coupon. If no such trades are available, the Pricing Service typically uses analytical models which may incorporate spreads, interest rate data and market/sector news. As the significant inputs used to price non-U.S. government bonds are observable market inputs, the fair values of non-U.S. government bonds are included in the Level 2 fair value hierarchy.

Collateralized loan obligations ("CLO") - These asset backed securities are originated by a variety of financial institutions that on acquisition are rated BBB-/Baa3 or higher. These securities are priced by independent pricing services and brokers. The pricing provider applies dealer quotes and other available trade information, prepayment speeds, yield curves and credit spreads to the valuation. As the significant inputs used to price the CLO are observable market inputs, the fair values are included in the Level 2 fair value hierarchy.

Commercial mortgage-backed securities ("CMBS") - These asset backed securities are originated by a variety of financial institutions that on acquisition are rated BBB-/Baa3 or higher. These securities are priced by independent pricing services and brokers. The pricing provider applies dealer quotes and other available trade information, prepayment speeds, yield curves and credit spreads to the valuation. As the significant inputs used to price the CMBS are observable market inputs, the fair values are included in the Level 2 fair value hierarchy.

Corporate and municipal bonds — Bonds issued by corporations, U.S. state and municipality entities or agencies that on acquisition are rated BBB-/Baa3 or higher. These securities are generally priced by independent pricing services. The credit spreads are sourced from broker/dealers, trade prices and new issue market. Where pricing is unavailable from pricing services, custodian pricing or non-binding quotes are obtained from broker-dealers to estimate fair values. As significant inputs used to price corporate and municipal bonds are observable market inputs, fair values are included in the Level 2 fair value hierarchy.

Equity securities - Equity securities include publicly traded common and preferred stocks, and privately held common and preferred stocks. The fair value of publicly traded common and preferred stocks is primarily priced by pricing services, reflecting the closing price quoted for the final trading day of the period. These investments are carried at fair value using observable market pricing data and is included in the Level 1 fair value hierarchy. Any unrealized gains or losses on the investment is recorded in net income in the reporting period in which it occurs. The privately held common and preferred stocks are valued using significant inputs that are unobservable where there is little or no market activity. Unadjusted third party pricing sources or management's assumptions and internal valuation models may be used to determine the fair values, therefore, these investments are classified as Level 3 in the fair value hierarchy.

Other investments — Includes unquoted investments comprised of the following types of investments:

•Privately held investments: These are direct equity investments in common and preferred shares of privately held entities. The fair values are estimated using quarterly financial statements and/or recent private market transactions and thus are included under Level 3 of the fair value hierarchy due to unobservable market data used for valuation.

•Private credit funds: These are privately held equity investments in common stock of entities that lend money valued using the most recently available or quarterly net asset value ("NAV") statements as provided by the external fund manager or third-party administrator and therefore measured using the NAV as a practical expedient.

•Private equity funds: These are comprised of private equity funds, private equity co-investments with sponsoring entities and investments in real estate limited partnerships and joint ventures. The fair value is estimated based on the most recently available NAV as advised by the external fund manager or third-party administrator. The fair values are therefore measured using the NAV as a practical expedient.

Derivative Instruments - The Company has ~~recently~~ entered into reinsurance contracts that are accounted for as derivatives. These reinsurance contracts provide indemnification to an insured or cedant as a result of a change in a variable as opposed to an identifiable insurable event. The Company considers these contracts to be part of its underwriting operations. The derivatives are initially valued at cost which approximates fair value. In subsequent measurement periods, the fair values of these derivatives are determined using internally developed discounted cash flow models using appropriate discount rates. The selection of an appropriate discount rate is judgmental and is the most significant unobservable input used in the valuation of these derivatives. The fair value changes in underwriting-related derivative instruments is included within other insurance revenue (expense), net.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

5. Fair Value of Financial Instruments (continued)

The derivative liability on retroactive reinsurance is presented as part of accrued expenses and other liabilities. A significant increase (decrease) in this input in isolation ~~could~~may result in a significantly lower (higher) fair value measurement for the derivative contract. As the significant inputs used to price these derivatives are unobservable, the fair values of these contracts are classified as Level 3.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

(3 in ~~thousands of U.S. dollars, except share and per share data)~~

~~5. Fair Value of Financial Instruments (continued)~~the fair value hierarchy.

(b) Fair Value Hierarchy

The Company’s estimates of fair value for financial assets and financial liabilities are based on the framework established in ASC 820. The framework is based on the inputs used in valuation and gives the highest priority to quoted prices in active markets and requires that observable inputs be used in the valuation methodology whenever available. In determining the level of the hierarchy in which the estimate is disclosed, the highest priority is given to unadjusted quoted prices in active trading markets and the lowest priority to unobservable inputs that reflect significant market assumptions.

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company classified its financial instruments measured at fair value on a recurring basis in the following valuation hierarchy:

September 30, 2022 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Fair Value Based on NAV Practical Expedient Total Fair Value
Fixed maturities
U.S. treasury bonds $ 58,223 $ — $ — $ — $ 58,223
U.S. agency bonds – mortgage-backed — 66,192 — — 66,192
Collateralized mortgage-backed bonds — 6,802 — — 6,802
Non-U.S. government bonds — 10,981 — — 10,981
Collateralized loan obligations — 144,533 — — 144,533
Corporate bonds — 85,242 — — 85,242
Equity securities 598 — 17,305 24,697 42,600
Other investments — — — 88,021 88,021
Total investments $ 58,821 $ 313,750 $ 17,305 $ 112,718 $ 502,594
As a percentage of total assets 3.0% 15.8% 0.9% 5.7% 25.4%
Derivative liability on retroactive reinsurance $ — $ — $ 9,035 $ — $ 9,035
December 31, 2021 Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Fair Value Based on NAV Practical Expedient Total Fair Value
Fixed maturities
U.S. treasury bonds $ 59,879 $ — $ — $ — $ 59,879
U.S. agency bonds – mortgage-backed — 98,790 — — 98,790
Collateralized mortgage-backed bonds — 15,537 — — 15,537
Non-U.S. government bonds — 3,276 — — 3,276
Collateralized loan obligations — 179,021 — — 179,021
Corporate bonds — 240,642 — — 240,642
Equity securities 1,174 — 5,094 17,735 24,003
Other investments — — 1,000 73,746 74,746
Total investments $ 61,053 $ 537,266 $ 6,094 $ 91,481 $ 695,894
As a percentage of total assets 2.6% 23.1% 0.3% 3.9% 29.9%


June 30, 2023	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value Based on NAV Practical Expedient		Total Fair Value
Fixed maturities
U.S. treasury bonds	$	62,684	$	—	$	—	$	—	$	62,684
U.S. agency bonds – mortgage-backed	—		32,854		—		—		32,854
Collateralized mortgage-backed bonds	—		6,793		—		—		6,793
Non-U.S. government bonds	—		14,048		—		—		14,048
Collateralized loan obligations	—		95,160		—		—		95,160
Corporate bonds	—		75,785		—		—		75,785

Equity securities	84		—		20,013		25,154		45,251
Other investments	—		—		1,385		87,364		88,749
Total investments	$	62,768	$	224,640	$	21,398	$	112,518	$	421,324
As a percentage of total assets	3.8%		13.5%		1.3%		6.7%		25.3%

Underwriting-related derivative liability	$	—	$	—	$	3,984	$	—	$	3,984


December 31, 2022	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Fair Value Based on NAV Practical Expedient		Total Fair Value
Fixed maturities
U.S. treasury bonds	$	55,532	$	—	$	—	$	—	$	55,532
U.S. agency bonds – mortgage-backed	—		34,365		—		—		34,365
Collateralized mortgage-backed bonds	—		6,767		—		—		6,767
Non-U.S. government bonds	—		11,818		—		—		11,818
Collateralized loan obligations	—		114,092		—		—		114,092
Corporate bonds	—		91,953		—		—		91,953

Equity securities	386		—		17,806		25,429		43,621
Other investments	—		1,000		1,000		90,666		92,666
Total investments	$	55,918	$	259,995	$	18,806	$	116,095	$	450,814
As a percentage of total assets	3.0%		14.1%		1.0%		6.3%		24.4%

Underwriting-related derivative liability	$	—	$	—	$	14,559	$	—	$	14,559

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

5. Fair Value of Financial Instruments (continued)

The Company utilizes the Pricing Service to assist in determining the fair value of its investments; however, management is ultimately responsible for all fair values presented in the Company’s consolidated financial statements. This includes responsibility for monitoring the fair value process, ensuring objective and reliable valuation practices, and pricing of assets and liabilities and use of pricing sources. The Company analyzes and reviews the information and prices received from the Pricing Service to ensure that the prices provided represent a reasonable estimate of fair value.

The Pricing Service was utilized to estimate fair value measurements for ~~98.8%~~98.2% and ~~99.0%~~98.5% of our fixed maturities at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. The Pricing Service utilizes market quotations for fixed maturity securities that have quoted market prices in active markets. Since fixed maturities other than U.S. treasury bonds generally do not trade actively on a daily basis, the Pricing Service prepares estimates of fair value measurements using relevant market data, benchmark curves, sector groupings and matrix pricing and these have been classified as Level 2 within the fair value hierarchy.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~5. Fair Value of Financial Instruments (continued)~~

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, approximately ~~1.2%~~1.8% and ~~1.0%~~1.5%, respectively, of our fixed maturities were valued using the market approach. At ~~September~~June 30, ~~2022,~~2023, one security or ~~$4,411 (2021~~$5,073 (December 31, 2022 - one security or ~~$6,225)~~$4,764) of our fixed maturity investment portfolio classified as Level 2 ~~were~~in the table above was priced using a quotation from a broker and/or custodian as opposed to the Pricing Service due to lack of information available.

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company has not adjusted any pricing provided to it based on the review performed by its investment managers.

During the nine months ended September 30, 2021, the Company transferred its equity investment in an insurtech start-up company focused on technological advancement in the automobile insurance industry out of Level 3 within the fair value hierarchy and into Level 1 due to the recent completion of its initial public offering. There were no transfers to or from Level 3 during the ~~nine~~six months ended ~~September~~June 30, 2023 and 2022.

At ~~September~~June 30, ~~2022,~~2023, the Company holds Level 3 financial instruments which include privately held equity investments of ~~$17,305~~$21,398 (December 31, ~~2021~~2022 - ~~$6,094)~~$18,806) which are included in total investments and an underwriting-related derivative liability of $3,984 (December 31, 2022 - $14,559) on ~~retroactive~~a reinsurance ~~of $9,035.~~ contract written by GLS which is included in accrued expenses and other liabilities.

The fair value of privately held equity ~~investments~~securities are estimated using quarterly unaudited capital or financial statements provided by the investee or recent private market transactions, where applicable. Any changes to the financial information provided by the investee could result in a significantly higher or lower valuation at the reporting date. The fair value of underwriting-related derivative instruments ~~are~~is determined using a discounted cash flow model in which the Company examines current market conditions, historical results as well as contract specific information that may impact future cash flows in order to assess the reasonableness of inputs used in the valuation ~~model.~~ model. Due to significant unobservable inputs in these valuations, the Company classifies the fair values as Level 3 within the fair value ~~hierarchy.~~hierarchy

. The following table provides a summary of quantitative information regarding the significant unobservable inputs used in determining the fair value of other investments measured at fair value on a recurring basis under the Level 3 classification at ~~September~~June 30, ~~2022:~~2023:

Fair Value Valuation Technique Unobservable Inputs Range
Private equity investments $ 6,860 Quarterly financial statements Estimated maturity dates 1.0 years to 3.0 years
Others including start-ups 10,445 Recent market transactions Liquidity discount rates
Total Level 3 investments $ 17,305
Derivative liability on retroactive reinsurance $ 9,035 Discounted cash flows Duration matched discount rates 2.0% to 3.0%

Fair Value

Valuation Technique

Unobservable Inputs

Range

Privately held equity securities - common shares

7,060

Quarterly financial statements

Price/book ratios of comparable public companies

Privately held equity securities - preferred shares

14,338

Quarterly financial statements

Privately calculated enterprise valuations

Total Level 3 investments

21,398

Underwriting-related derivative liability

3,984

Discounted cash flows

Duration matched discount rates

5.0%

6.0%

The following table shows the reconciliation of beginning and ending balances for investments measured at fair value on a recurring basis using Level 3 inputs for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021.~~2022. The Company includes any related interest and dividend income in net investment income and are excluded from the reconciliation in the table below:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Balance - beginning of period	Balance - beginning of period	$	15,194	$	6,094	$	6,094	$	2,844	Balance - beginning of period	$	21,198	$	9,660	$	18,806	$	7,094
Sales	Sales	—		—		(1,000)		—		Sales	—		(1,000)		—		(1,000)
Net unrealized gains		111		—		3,770		—
Net realized and unrealized gains recognized in the statement of income										Net realized and unrealized gains recognized in the statement of income	200		3,659		1,592		3,659
Purchases	Purchases	2,000		—		8,441		4,250		Purchases	—		3,875		1,000		6,441
Transfers out of Level 3		—		—		—		(1,000)

Total Level 3 investments - end of period	Total Level 3 investments - end of period	$	17,305	$	6,094	$	17,305	$	6,094	Total Level 3 investments - end of period	$	21,398	$	16,194	$	21,398	$	16,194

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

5. Fair Value of Financial Instruments (continued)

(d) Financial Instruments Disclosed, But Not Carried, at Fair Value

The fair value of financial instruments accounting guidance also applies to financial instruments disclosed, but not carried, at fair value, except for certain financial instruments related to insurance contracts.

At ~~September~~June 30, ~~2022,~~2023, the carrying values of cash equivalents (including restricted amounts), accrued investment income, reinsurance balances receivable, loan to related party, ~~liability for securities purchased~~ and certain other assets and liabilities approximate fair values due to their inherent short duration. As these financial instruments are not actively traded, the fair values of these financial instruments are classified as Level 2.

The investments made by direct lending entities are carried at cost less ~~impairment, if~~an allowance for expected credit losses, with any indication of credit loss recognized in net income when determined. The net carrying value of which approximates fair value. The fair value estimates of these investments are not based on observable market data and, as a result, are classified as Level 3.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~5. Fair Value of Financial Instruments (continued)~~

The fair values of the Senior Notes (as defined in "Note 7. Long-Term Debt") are based on indicative market pricing obtained from a third-party pricing service which uses observable market inputs, and therefore the fair values of these liabilities are classified as Level 2. The following table presents the respective carrying value and fair value for the Senior Notes as at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

September 30, 2022 December 31, 2021
Carrying Value Fair Value Carrying Value Fair Value
Senior Notes - MHLA – 6.625% $ 110,000 $ 66,880 $ 110,000 $ 94,820
Senior Notes - MHNC – 7.75% 152,500 108,885 152,500 140,300
Total Senior Notes $ 262,500 $ 175,765 $ 262,500 $ 235,120


	June 30, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value

Senior Notes - MHLA – 6.625%	$	110,000	$	82,148	$	110,000	$	76,560
Senior Notes - MHNC – 7.75%	152,361		121,340		152,500		113,826
Total Senior Notes	$	262,361	$	203,488	$	262,500	$	190,386

6. Shareholders' Equity

a)Common Shares

On May 3, 2023 at its Annual General Meeting of Shareholders, the Company's common shareholders approved the increase in the authorized share capital of the Company from $1,500 divided into 150,000,000 shares of par value $0.01 each, to $2,000 divided into 200,000,000 shares of par value $0.01 each.

At ~~September~~June 30, ~~2022,~~2023, the aggregate authorized share capital of the Company is ~~150,000,000~~200,000,000 shares from which ~~93,414,080~~149,726,105 common shares were issued, of which ~~87,161,499~~101,605,815 common shares are outstanding, and ~~18,600,000 preference~~48,120,290 shares ~~were issued, all of which~~ are ~~outstanding.~~ treasury shares.

The remaining ~~37,985,920~~50,273,895 shares are undesignated at ~~September~~June 30, ~~2022. Excluding the preference~~2023. At June 30, 2023, 1,020,027 common shares ~~held by Maiden Reinsurance, a total~~will be issued and outstanding upon vesting of ~~4,786,884 preference shares are held by non-affiliates.~~restricted shares.

b)~~Preference~~Treasury Shares

On ~~March 3, 2021 and May 6, 2021,~~February 21, 2017, the Company's Board of Directors approved the repurchase ~~including the repurchase by Maiden Reinsurance in accordance with its investment guidelines,~~ of up to $100,000 ~~and~~ ~~$50,000, respectively,~~of the Company's ~~preference~~common shares from time to time at market ~~prices in open market purchases or as may be privately negotiated~~prices. During the three and six months ended June 30, 2023, Maiden Reinsurance repurchased 299,630 common shares at an average price per share of $2.07 under the Company's share repurchase plan (2022 - none). The ~~authorizations are collectively referred to~~Company has a remaining authorization of $73,626 for common share repurchases at June 30, 2023 (December 31, 2022 - $74,245).

During the six months ended June 30, 2023, the Company also repurchased 128,731 common shares (2022 - 403,716) at an average price per share of $2.25 (2022 - $2.50) from employees, which represent tax withholding in respect of tax obligations on the vesting of both non-performance-based and discretionary performance-based restricted shares.

Treasury shares include 41,738,978 common shares owned by Maiden Reinsurance which includes 41,439,348 shares issued as ~~the "2021 Preference Share Repurchase Program".~~

~~The following table shows the summary~~part of the ~~Company's preference shares repurchases made~~exchange for ~~the nine months ended September 30, 2022 and three and nine months ended September 30, 2021; no preference shares were repurchased during the three months ended September 30, 2022:~~

For the Three Months Ended September 30, 2021 For the Nine Months Ended September 30, 2022 For the Nine Months Ended September 30, 2021
Number of shares purchased Average price of shares purchased Number of shares purchased Average price of shares purchased Number of shares purchased Average price of shares purchased

Series A 135,353 $ 13.51 435,639 $ 5.27 3,519,093 $ 14.74
Series C 241,466 13.42 625,742 7.08 2,917,244 14.44
Series D 181,817 13.34 520,128 6.26 2,639,336 14.45
Total 558,636 13.42 1,581,509 6.31 9,075,673 14.56

Total price paid $ 7,495 $ 9,983 $ 132,153
Gain on purchase $ 6,004 $ 28,233 $ 87,168

~~The following table shows the summary of changes for the Company's preference shares outstanding (including the total of the Company's~~ preference shares held ("Exchange") and 299,630 shares directly purchased on the open market by Maiden Reinsurance ~~pursuant to~~which are not treated as outstanding common shares on the ~~cash tender offer in December 2020~~Condensed Consolidated Balance Sheet at June 30, 2023. Please see further information on the Exchange and ~~the 2021 Preference Share Repurchase Program) at September 30, 2022:~~

As of September 30, 2022 Series A Series C Series D Total
Outstanding shares issued by Maiden Holdings 6,000,000 6,600,000 6,000,000 18,600,000
Less: Total shares held by Maiden Reinsurance 4,499,950 4,855,972 4,457,194 13,813,116
Total shares held by non-affiliates 1,500,050 1,744,028 1,542,806 4,786,884
Percentage held by Maiden Reinsurance 75.0 % 73.6 % 74.3 % 74.3 %

~~The Company's remaining authorization for~~related preference share repurchases ~~was $3,861 at September 30, 2022. Please refer to~~in the ~~Company's~~ Annual Report on Form 10-K for the year ended December 31, ~~2021 for more details~~2022, filed with the SEC on ~~preference shares.~~ March 15, 2023.

The ~~Company has announced its intention to exchange all~~table below includes the total number of treasury shares outstanding ~~preference shares for the Company's common shares subsequent to September~~at June 30, ~~2022. Please see~~ 2023 and December 31, 2022:


	June 30, 2023	December 31, 2022
Number of shares held by Maiden Reinsurance treated as treasury shares	41,738,978	41,439,348
Number of treasury shares due to common share repurchases by Maiden Holdings	6,381,312	6,252,581
Total number of treasury shares at the end of the reporting period	48,120,290	47,691,929

~~"Note 14. Subsequent Events"~~ ~~for details.~~

2425

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

6. Shareholders' Equity (continued)

c)~~Treasury Shares~~

On February 21, 2017, the Company's Board of Directors approved the repurchase of up to $100,000 of the Company's common shares from time to time at market prices. The Company has a remaining authorization of $74,245 for common share repurchases at September 30, 2022 (December 31, 2021 - $74,245). No repurchases were made during the three and nine months ended September 30, 2022 and 2021 under the common share repurchase plan.

During the three months ended September 30, 2021, the Company repurchased a total of 21,509 common shares at an average price per share of $3.43 from employees, which represent withholding in respect of tax obligations on the vesting of both non-performance-based and discretionary performance-based restricted shares. There were no repurchases made during the three months ended September 30, 2022. During the nine months ended September 30, 2022, the Company repurchased 403,716 common shares (2021 - 821,057) at an average price per share of $2.50 (2021 - $2.96) from employees, which represent withholding in respect of tax obligations on the vesting of both non-performance-based and discretionary performance-based restricted shares.

d)Accumulated Other Comprehensive ~~Income (Loss)~~Loss ("AOCI")

The following tables set forth financial information regarding the changes in the balances of each component of AOCI:


For the Three Months Ended September 30, 2022		Change in net unrealized gains on investment		Foreign currency translation		Total
For the Three Months Ended June 30, 2023								For the Three Months Ended June 30, 2023	Change in net unrealized gains on investment		Foreign currency translation		Total
Beginning balance								Beginning balance	$	(13,762)	$	(24,998)	$	(38,760)
Other comprehensive income before reclassifications								Other comprehensive income before reclassifications	858		766		1,624

Net current period other comprehensive income								Net current period other comprehensive income	858		766		1,624

Ending balance, Maiden shareholders								Ending balance, Maiden shareholders	$	(12,904)	$	(24,232)	$	(37,136)

For the Three Months Ended June 30, 2022								For the Three Months Ended June 30, 2022	Change in net unrealized gains on investment		Foreign currency translation		Total
Beginning balance	Beginning balance	$	(45,266)	$	6,326	$	(38,940)	Beginning balance	$	(20,852)	$	(3,930)	$	(24,782)
Other comprehensive (loss) income before reclassifications	Other comprehensive (loss) income before reclassifications	(14,811)		2,246		(12,565)		Other comprehensive (loss) income before reclassifications	(24,004)		10,256		(13,748)
Amounts reclassified from AOCI to net income, net of tax	Amounts reclassified from AOCI to net income, net of tax	(48)		—		(48)		Amounts reclassified from AOCI to net income, net of tax	(410)		—		(410)
Net current period other comprehensive (loss) income	Net current period other comprehensive (loss) income	(14,859)		2,246		(12,613)		Net current period other comprehensive (loss) income	(24,414)		10,256		(14,158)

Ending balance, Maiden shareholders	Ending balance, Maiden shareholders	$	(60,125)	$	8,572	$	(51,553)	Ending balance, Maiden shareholders	$	(45,266)	$	6,326	$	(38,940)
For the Six Months Ended June 30, 2023								For the Six Months Ended June 30, 2023	Change in net unrealized gains on investment		Foreign currency translation		Total
Beginning balance								Beginning balance	$	(15,668)	$	(25,566)	$	(41,234)
Other comprehensive income before reclassifications								Other comprehensive income before reclassifications	2,764		1,334		4,098

For the Three Months Ended September 30, 2021		Change in net unrealized gains on investment		Foreign currency translation		Total
Net current period other comprehensive income								Net current period other comprehensive income	2,764		1,334		4,098

Ending balance, Maiden shareholders								Ending balance, Maiden shareholders	$	(12,904)	$	(24,232)	$	(37,136)
For the Six Months Ended June 30, 2022								For the Six Months Ended June 30, 2022	Change in net unrealized gains on investment		Foreign currency translation		Total
Beginning balance	Beginning balance	$	23,632	$	(17,909)	$	5,723	Beginning balance	$	(2,693)	$	(9,522)	$	(12,215)
Other comprehensive (loss) income before reclassifications	Other comprehensive (loss) income before reclassifications	(14,611)		6,036		(8,575)		Other comprehensive (loss) income before reclassifications	(36,925)		15,848		(21,077)
Amounts reclassified from AOCI to net income, net of tax	Amounts reclassified from AOCI to net income, net of tax	(2,007)		—		(2,007)		Amounts reclassified from AOCI to net income, net of tax	(5,648)		—		(5,648)
Net current period other comprehensive (loss) income	Net current period other comprehensive (loss) income	(16,618)		6,036		(10,582)		Net current period other comprehensive (loss) income	(42,573)		15,848		(26,725)

Ending balance, Maiden shareholders	Ending balance, Maiden shareholders	$	7,014	$	(11,873)	$	(4,859)	Ending balance, Maiden shareholders	$	(45,266)	$	6,326	$	(38,940)
For the Nine Months Ended September 30, 2022		Change in net unrealized gains on investment		Foreign currency translation		Total
Beginning balance		$	(2,693)	$	(9,522)	$	(12,215)
Other comprehensive (loss) income before reclassifications		(51,736)		18,094		(33,642)
Amounts reclassified from AOCI to net income, net of tax		(5,696)		—		(5,696)
Net current period other comprehensive (loss) income		(57,432)		18,094		(39,338)

Ending balance, Maiden shareholders		$	(60,125)	$	8,572	$	(51,553)
For the Nine Months Ended September 30, 2021		Change in net unrealized gains on investment		Foreign currency translation		Total
Beginning balance		$	49,357	$	(25,500)	$	23,857
Other comprehensive (loss) income before reclassifications		(35,311)		13,627		(21,684)
Amounts reclassified from AOCI to net income, net of tax		(7,032)		—		(7,032)
Net current period other comprehensive (loss) income		(42,343)		13,627		(28,716)

Ending balance, Maiden shareholders		$	7,014	$	(11,873)	$	(4,859)

2526

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

7. Long-Term Debt

Senior Notes

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, Maiden Holdings had outstanding publicly-traded senior notes which were issued in 2016 ("2016 Senior Notes") and its wholly owned subsidiary, Maiden Holdings North America, Ltd. ("Maiden NA") had outstanding publicly-traded senior notes which were issued in 2013 ("2013 Senior Notes") (collectively "Senior Notes"). The 2013 Senior Notes issued by Maiden NA are fully and unconditionally guaranteed by Maiden Holdings. The Senior Notes are unsecured and unsubordinated obligations of the Company.

The following tables detail the issuances of Senior Notes outstanding at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


September 30, 2022		2016 Senior Notes			2013 Senior Notes			Total
June 30, 2023										June 30, 2023	2016 Senior Notes			2013 Senior Notes			Total
Principal amount	Principal amount	$	110,000		$	152,500		$	262,500	Principal amount	$	110,000		$	152,361		$	262,361
Less: unamortized issuance costs	Less: unamortized issuance costs	3,420			3,564			6,984		Less: unamortized issuance costs	3,376			4,464			7,840
Carrying value	Carrying value	$	106,580		$	148,936		$	255,516	Carrying value	$	106,624		$	147,897		$	254,521

December 31, 2021		2016 Senior Notes			2013 Senior Notes			Total
December 31, 2022										December 31, 2022	2016 Senior Notes			2013 Senior Notes			Total
Principal amount	Principal amount	$	110,000		$	152,500		$	262,500	Principal amount	$	110,000		$	152,500		$	262,500
Less: unamortized issuance costs	Less: unamortized issuance costs	3,463			3,690			7,153		Less: unamortized issuance costs	3,406			3,522			6,928
Carrying value	Carrying value	$	106,537		$	148,810		$	255,347	Carrying value	$	106,594		$	148,978		$	255,572

Other details:	Other details:									Other details:
Original debt issuance costs		$	3,715		$	5,054
Original debt issuance costs pertaining to remaining outstanding principal amount										Original debt issuance costs pertaining to remaining outstanding principal amount	$	3,715		$	5,050
Maturity date	Maturity date	June 14, 2046			December 1, 2043					Maturity date	June 14, 2046			December 1, 2043
Earliest redeemable date (for cash)	Earliest redeemable date (for cash)	June 14, 2021			December 1, 2018					Earliest redeemable date (for cash)	June 14, 2021			December 1, 2018
Coupon rate	Coupon rate	6.625		%	7.75		%			Coupon rate	6.625		%	7.75		%
Effective interest rate	Effective interest rate	7.07		%	8.04		%			Effective interest rate	7.07		%	8.04		%

~~The~~Total interest and amortization expense incurred on the Senior Notes for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$4,776~~$4,813 and ~~$14,329,~~$8,637, respectively ~~(2021~~(2022 - ~~$4,776~~$4,833 and ~~$14,329,~~$9,665, respectively), of which $1,342 was accrued as interest payable at both ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. The issuance costs related to the Senior Notes were capitalized and are ~~being~~ amortized over the effective life of the Senior ~~Notes. The amortization expense for~~Notes using the ~~three and nine months ended September 30, 2022 was $57 and $169, respectively (2021 - $56 and $166, respectively).~~effective interest method of amortization.

Under the terms of the 2013 Senior Notes, the 2013 Senior Notes can be redeemed, in whole or in part, at Maiden NA's option at any time and from time to time, until maturity at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued but unpaid interest on the principal amount being redeemed to, but not including, the redemption date. Maiden NA is required to give at least thirty days and not more than sixty days notice prior to the redemption date.

Under the terms of the 2016 Senior Notes, the 2016 Senior Notes can be redeemed, in whole or in part, at Maiden Holdings' option at any time and from time to time, until maturity at a redemption price equal to 100% of the principal amount of the notes to be redeemed plus accrued but unpaid interest on the principal amount being redeemed to, but not including, the redemption date. Maiden Holdings is required to give at least thirty days and not more than sixty days notice prior to the redemption date.

On May 3, 2023, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines, of up to $100,000 of the Company's Senior Notes from time to time at market prices in open market purchases or as may be privately negotiated.

During the three and six months ended June 30, 2023, the Company repurchased 5,567 notes of the 2013 Senior Notes at an average price per unit of $17.10 for a total cost of $95. Total interest and amortization expenses were partly offset by a gain of $40 that was realized on the repurchase of the 2013 Senior Notes during the three and six months ended June 30, 2023. The Company has a remaining authorization of $99,905 for Senior Notes repurchases at June 30, 2023.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

8. Reinsurance

The Company uses reinsurance and retrocessional agreements ("ceded reinsurance") to mitigate volatility, reduce its exposure to certain risks and provide capital support. Ceded reinsurance provides for the recovery of a portion of loss and LAE under certain circumstances without relieving the Company of its obligations to the policyholders. The Company remains liable to the extent that any of its reinsurers or retrocessionaires fails to meet their obligations. Loss and LAE incurred and premiums earned are reported after deduction for ceded reinsurance. In the event that one or more of our reinsurers or retrocessionaires are unable to meet their obligations under these agreements, the Company would not realize the full value of the reinsurance recoverable balances.

The effect of ceded reinsurance on net premiums written and earned and on net loss and LAE for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 was as follows:


For the Nine Months Ended September 30,		2022		2021
For the Six Months Ended June 30,						For the Six Months Ended June 30,	2023		2022
Premiums written	Premiums written					Premiums written
Direct	Direct	$	17,383	$	16,181	Direct	$	13,515	$	10,890
Assumed	Assumed	(18,834)		(8,316)		Assumed	(5,804)		(17,721)
Ceded	Ceded	(464)		(347)		Ceded	(76)		(306)
Net	Net	$	(1,915)	$	7,518	Net	$	7,635	$	(7,137)
Premiums earned	Premiums earned					Premiums earned
Direct	Direct	$	17,332	$	17,186	Direct	$	13,365	$	10,845
Assumed	Assumed	6,942		24,103		Assumed	6,752		1,031
Ceded	Ceded	(458)		(1,183)		Ceded	(76)		(311)
Net	Net	$	23,816	$	40,106	Net	$	20,041	$	11,565
Loss and LAE	Loss and LAE					Loss and LAE
Gross loss and LAE	Gross loss and LAE	$	22,511	$	6,132	Gross loss and LAE	$	20,991	$	4,951
Loss and LAE ceded	Loss and LAE ceded	(494)		1,414		Loss and LAE ceded	356		(360)
Net	Net	$	22,017	$	7,546	Net	$	21,347	$	4,591

The Company's reinsurance recoverable on unpaid losses balance as at ~~September~~June 30, ~~2022~~2023 was ~~$547,975~~$561,576 (December 31, ~~2021~~2022 - ~~$562,845)~~$556,116) presented in the Condensed Consolidated Balance Sheets. ~~At September~~As of June 30, ~~2022 and December 31, 2021,~~2023, the ~~Company had no valuation~~total allowance ~~against~~for expected credit losses on the Company's reinsurance recoverable balance was $4,530.

The following table provides a reconciliation of the beginning and ending balances of the allowance for expected credit losses on ~~unpaid losses.~~reinsurance recoverable for the three and six months ended June 30, 2023:



	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2023			2023
Allowance for expected credit losses on reinsurance recoverable, beginning of period	$	4,254		4,277

Increase in allowance for expected credit losses on reinsurance recoverable where credit losses were previously recognized	276			253

Allowance for expected credit losses on reinsurance recoverable, end of period	$	4,530		4,530

On December 27, 2018, Cavello Bay Reinsurance Limited ("Cavello") and Maiden Reinsurance entered into a retrocession agreement pursuant to which certain assets and liabilities associated with the U.S. treaty reinsurance business held by Maiden Reinsurance were 100.0% retroceded to Cavello in exchange for a ceding commission. The reinsurance recoverable on unpaid losses due from Cavello under this retrocession agreement was ~~$67,181~~$54,880 at ~~September~~June 30, ~~2022~~2023 (December 31, ~~2021~~2022 - ~~$69,006)~~$60,112). The recoverable due from Cavello is net of an allowance for expected credit losses of $4,008 as at June 30, 2023.

On July 31, 2019, Maiden Reinsurance and Cavello entered into a Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") pursuant to which Cavello assumed the loss reserves as of December 31, 2018 associated with the AmTrust Quota Share in excess of a $2,178,535 retention up to $600,000, in exchange for a retrocession premium of $445,000. The $2,178,535 retention is subject to adjustment for paid losses subsequent to December 31, 2018. The LPT/ADC Agreement provides Maiden Reinsurance with $155,000 in adverse development cover over its carried AmTrust Quota Share loss reserves at December 31, 2018. The LPT/ADC Agreement meets the criteria for risk transfer and is thus accounted for as retroactive reinsurance. Cumulative ceded losses exceeding $445,000 are recognized as a deferred gain liability and amortized into income over the settlement period of the ceded reserves in proportion to cumulative losses collected over the estimated ultimate reinsurance recoverable.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

8. Reinsurance (continued)

The amount of the deferral is recalculated each period based on loss payments and updated estimates. Consequently, cumulative adverse development subsequent to December 31, 2018 may result in significant losses from operations until periods when the deferred gain is recognized as a benefit to earnings.

As of ~~September~~June 30, ~~2022,~~2023, the reinsurance recoverable on unpaid losses under the LPT/ADC Agreement was ~~$480,138~~$502,195 while the deferred gain liability under the LPT/ADC Agreement was ~~$35,138~~$57,708 (December 31, ~~2021~~2022 - ~~$490,860~~$490,408 and ~~$45,860,~~$45,408, respectively). The recoverable due under the LPT/ADC Agreement is net of an allowance for expected credit losses of $513 as at June 30, 2023. Amortization of the deferred gain will not occur until paid losses have exceeded the minimum retention under the LPT/ADC Agreement, which is estimated to be in 2025.

Cavello provided collateral in the form of a letter of credit in the amount of $445,000 to AmTrust under the LPT/ADC Agreement. Cavello is subject to additional collateral funding requirements as explained in "Note 10. Related Party Transactions". As of ~~September~~June 30, ~~2022,~~2023, the amount of collateral required was ~~$424,588.~~$471,636. Under the terms of the LPT/ADC Agreement, the covered losses associated with the Commutation and Release Agreement with AmTrust are eligible to be covered but recoverable only when such losses are paid or settled by AII or its affiliates, provided such losses and other related amounts shall not exceed $312,786. Cavello's parent company, Enstar, has credit ratings of BBB from both Standard & Poor's and Fitch Ratings at ~~September~~June 30, ~~2022.~~2023.

2729

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

9. Reserve for Loss and Loss Adjustment Expenses

The Company uses both historical experience and industry-wide loss development factors to provide a reasonable basis for estimating future losses. In the future, certain events may be beyond the control of management, such as changes in law, judicial interpretations of law, and rates of inflation, which may favorably or unfavorably impact the ultimate settlement of the Company’s loss and LAE reserves.

The anticipated effect of inflation is implicitly considered when estimating liabilities for loss and LAE. While anticipated changes in claim costs due to inflation are considered in estimating the ultimate claim costs, changes in the average severity of claims are caused by a number of factors that vary with the individual type of policy written. Ultimate losses are projected based on historical trends adjusted for implemented changes in underwriting standards, claims handling, policy provisions, and general economic trends. Those anticipated trends are monitored based on actual development and are modified if necessary.

The reserving process begins with the collection and analysis of paid losses and incurred claims data for each of the Company's contracts. While reserves are mostly reviewed on a contract by contract basis, paid loss and incurred claims data is also aggregated into reserving segments. The segmental data is disaggregated by reserving class and further disaggregated by either accident year (i.e. the year in which the loss event occurred) or by underwriting year (i.e. the year in which the contract generating the premium and losses incepted). In cases where the Company uses underwriting year information, reserves are subsequently allocated to the respective accident year. The reserve for loss and LAE consists of:


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Reserve for reported loss and LAE	Reserve for reported loss and LAE	$	692,881	$	851,950	Reserve for reported loss and LAE	$	639,275	$	702,691
Reserve for losses incurred but not reported ("IBNR")	Reserve for losses incurred but not reported ("IBNR")	453,203		637,423		Reserve for losses incurred but not reported ("IBNR")	361,986		428,717
Reserve for loss and LAE	Reserve for loss and LAE	$	1,146,084	$	1,489,373	Reserve for loss and LAE	$	1,001,261	$	1,131,408

The following table represents a reconciliation of our beginning and ending gross and net loss and LAE reserves:


For the Nine Months Ended September 30,		2022		2021
For the Six Months Ended June 30,						For the Six Months Ended June 30,	2023		2022
Gross loss and LAE reserves, January 1	Gross loss and LAE reserves, January 1	$	1,489,373	$	1,893,299	Gross loss and LAE reserves, January 1	$	1,131,408	$	1,489,373
Less: reinsurance recoverable on unpaid losses, January 1	Less: reinsurance recoverable on unpaid losses, January 1	562,845		592,571		Less: reinsurance recoverable on unpaid losses, January 1	556,116		562,845
Net loss and LAE reserves, January 1	Net loss and LAE reserves, January 1	926,528		1,300,728		Net loss and LAE reserves, January 1	575,292		926,528
Net incurred losses related to:	Net incurred losses related to:					Net incurred losses related to:
Current year	Current year	27,510		31,259		Current year	13,197		10,918
Prior years	Prior years	(5,493)		(23,713)		Prior years	8,150		(6,327)
		22,017		7,546			21,347		4,591
Net paid losses related to:	Net paid losses related to:					Net paid losses related to:
Current year	Current year	(334)		(17,137)		Current year	(266)		(196)
Prior years	Prior years	(319,132)		(288,202)		Prior years	(156,361)		(192,248)
		(319,466)		(305,339)			(156,627)		(192,444)
Change in deferred gain on retroactive reinsurance	Change in deferred gain on retroactive reinsurance	12,024		24,296		Change in deferred gain on retroactive reinsurance	(12,317)		5,288
Assumed retroactive reinsurance business		7,580		—
GLS run-off business acquired or assumed						GLS run-off business acquired or assumed	767		7,554
Opening allowance for expected credit loss on reinsurance recoverable on unpaid losses						Opening allowance for expected credit loss on reinsurance recoverable on unpaid losses	4,277		—
Effect of foreign exchange rate movements	Effect of foreign exchange rate movements	(50,574)		(21,332)		Effect of foreign exchange rate movements	6,946		(31,256)
Net loss and LAE reserves, September 30		598,109		1,005,899
Reinsurance recoverable on unpaid losses, September 30		547,975		561,627
Gross loss and LAE reserves, September 30		$	1,146,084	$	1,567,526
Net loss and LAE reserves, June 30						Net loss and LAE reserves, June 30	439,685		720,261
Reinsurance recoverable on unpaid losses, June 30						Reinsurance recoverable on unpaid losses, June 30	561,576		554,846
Gross loss and LAE reserves, June 30						Gross loss and LAE reserves, June 30	$	1,001,261	$	1,275,107

Prior period development arises from changes to loss estimates recognized in the current year that relate to loss reserves established in previous calendar years. The favorable or unfavorable development reflects changes in management's best estimate of the ultimate losses under the relevant reinsurance policies after considerable review of changes in actuarial assessments. The Company recognized net adverse prior year loss development of $~~834~~4,494 and $8,150 for the three and six months ended ~~September~~June 30, ~~2022~~2023, respectively (2022 - adverse $958 and favorable ~~prior year loss development of $5,493 for the nine months ended September 30, 2022 (2021 - favorable $5,352 and $23,713,~~$6,327, respectively).

In the Diversified Reinsurance segment, there was ~~favorable~~adverse prior year loss development of ~~$590~~$1,317 and ~~$1,975~~$2,074 for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022 (2021~~2023, respectively (2022 - adverse $826 and favorable ~~$1,676 and $2,613,~~$1,385, respectively). Prior year loss development for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was driven by adverse development primarily due to ~~favorable reserve~~a German auto program in run-off from the International unit along with development in German Auto Programs and GLS policies partly offset by adverse development in European Capital Solutions. Prior year loss development for the three and nine months ended September 30, 2021 was due to favorable reserve development in German Auto Programs, European Capital Solutions andfrom other runoff ~~business.~~business lines and included the recognition of expected credit losses on reinsurance recoverable on unpaid losses.

2830

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

9. Reserve for Loss and Loss Adjustment Expenses (continued)

Prior year loss development for the three and six months ended June 30, 2022 was driven by favorable reserve development in German Auto Programs and GLS partly offset by adverse development in European Capital Solutions that occurred in the second quarter of 2022.

In the AmTrust Reinsurance segment, net adverse prior year loss development was ~~$1,424~~$3,177 and $6,076 during the three and six months ended ~~September~~June 30, ~~2022, compared to~~2023, respectively (2022 - adverse $132 and favorable $4,942, respectively). Net adverse prior year loss development ~~of $3,676~~ for the ~~same period~~three and six months ended June 30, 2023 was primarily from General Liability and Commercial Auto Liability partly offset by continued favorable development in ~~2021.~~Workers Compensation. Net adverse prior year loss development for the three months ended ~~September~~June 30, 2022 was driven by modest unfavorable movements in ~~European Hospital~~General Liability ~~due to higher than expected loss emergence in Italian Hospital~~and Commercial Auto Liability ~~policies as well as the agreed exit cost of $3,666 (€3,444) for the commutation of French Hospital Liability policies as described in~~ ~~"Note 10. Related Party Transactions";~~ partly offset by continued favorable ~~runoff of~~development in Workers ~~Compensation business. Net~~Compensation. The net favorable prior year loss development for the ~~three~~six months ended ~~September 30, 2021 was experienced in Workers Compensation and Commercial Auto Liability.~~

~~In the AmTrust Reinsurance segment, net favorable prior year loss development was $3,518 during the nine months ended September~~June 30, 2022 compared to net favorable prior year loss development of $21,100 for the same period in 2021. Net favorable prior year loss development of $3,518 during the nine months ended September 30, 2022 included $5,346 of favorable reserve adjustments for estimated surcharges on Workers' Compensation policies and inuring AmTrust reinsurance for programs in Specialty Risk and Extended Warranty cessions ("AmTrust Cession Adjustments"). Excluding the AmTrust Cession Adjustments, there was ~~adverse development of $1,828 for the nine months ended September 30, 2022 driven by unfavorable movements in European Hospital Liability~~primarily due to higher than expected loss emergence in Italian Hospital Liability policies as well as the agreed exit cost of $3,666 (€3,444) for the commutation of French Hospital Liability policies as described in ~~"Note 10. Related Party Transactions";~~favorable development from Workers Compensation partly offset by ~~favorable runoff of Workers Compensation business. Prior year favorable loss development~~deterioration in ~~2021 in Workers Compensation~~General Liability and to a lesser extent Commercial Auto ~~Liability was partly offset by adverse development in Hospital~~ Liability.

The ~~change~~increase in the deferred gain on retroactive reinsurance was ~~$12,024~~$12,317 for the ~~nine~~six months ended ~~September~~June 30, ~~2022 (2021~~2023 (2022 - ~~$24,296)~~$5,288 decrease). This ~~change~~ included ~~a decrease~~an increase in the deferred gain liability and related reinsurance recoverable on unpaid losses under the LPT/ADC Agreement with Cavello of ~~$10,722~~$12,300 for the ~~nine~~six months ended ~~September~~June 30, ~~2022 (2021~~2023 (2022 - ~~$24,296) due to favorable~~$4,463 decrease) caused by adverse development on loss reserves covered under the LPT/ADC ~~Agreement.~~Agreement (2022 - favorable). The deferred gain on retroactive reinsurance under the LPT/ADC Agreement represents the cumulative adverse development for covered risks in the AmTrust Quota Share as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021.~~2022. Amortization of the deferred gain will not occur until paid losses have exceeded the minimum retention under the LPT/ADC Agreement, which is estimated to be in 2025.

10. Related Party Transactions

The Founding Shareholders of the Company were Michael Karfunkel, George Karfunkel and Barry Zyskind. Based on each individual's most recent public filing, Leah Karfunkel (wife of the late Michael Karfunkel) ~~owns or controls approximately 7.7% of the Company's outstanding common shares~~, George Karfunkel and Barry Zyskind (the Company's non-executive chairman) ~~owns~~each own or ~~controls approximately 7.3% of the Company's outstanding common shares. George Karfunkel owns or controls~~control less than 5.0% of the Company's outstanding common shares. Leah Karfunkel and George Karfunkel are directors of AmTrust, and Barry Zyskind is the chief executive officer and chairman of AmTrust. Leah Karfunkel, George Karfunkel and Barry Zyskind own or control approximately 55.2% of the ownership interests of Evergreen Parent, ~~LP,~~L.P., the ultimate parent of AmTrust. The following describes transactions that have transpired between the Company and AmTrust:

AmTrust Quota Share

Effective July 1, 2007, the Company and AmTrust entered into a master agreement, as amended ("Master Agreement"), by which they caused Maiden Reinsurance and AII to enter into the AmTrust Quota Share by which AII retroceded to Maiden Reinsurance an amount equal to 40% of the premium written by subsidiaries of AmTrust, net of the cost of unaffiliated inuring reinsurance and 40% of losses. The Master Agreement further provided that AII receive a ceding commission of 31% of ceded written premiums. On June 11, 2008, Maiden Reinsurance and AII amended the AmTrust Quota Share to add Retail Commercial Package Business to the Covered Business (as defined in the AmTrust Quota Share). AII receives a ceding commission of 34.375% on Retail Commercial Package Business. On July 1, 2016, the agreement was renewed through June 30, 2019. Effective July 1, 2018, the amount AEL ceded to Maiden Reinsurance was reduced to 20%.

Effective July 1, 2013, for the Specialty Program portion of Covered Business only, AII was responsible for ultimate net loss otherwise recoverable from Maiden Reinsurance to the extent that the loss ratio to Maiden Reinsurance, which shall be determined on an inception to date basis from July 1, 2007 through the date of calculation, is between 81.5% and 95% ("Loss Corridor"). Above and below the Loss Corridor, Maiden Reinsurance continued to reinsure losses at its proportional 40% share of the AmTrust Quota Share. Effective July 31, 2019, the Loss Corridor was amended such that the maximum amount covered is $40,500, the amount calculated by Maiden Reinsurance for the Loss Corridor coverage as of March 31, 2019. Any development above this maximum amount will be subject to the coverage of the LPT/ADC Agreement.

Effective January 1, 2019, Maiden Reinsurance and AII entered into a partial termination amendment ("Partial Termination Amendment") which amended the AmTrust Quota Share. The Partial Termination Amendment provided for the cut-off of the ongoing and unearned premium of AmTrust’s Small Commercial Business ~~comprising workers’ compensation, general liability, umbrella liability, professional liability (including cyber liability) insurance coverages,~~ and U.S. Specialty Risk and Extended Warranty ("Terminated Business") as of December 31, 2018. Under the Partial Termination Amendment, the ceding commission payable by Maiden Reinsurance for its remaining in-force business immediately prior to January 1, 2019 increased by five percentage points with respect to in-force remaining business (excluding Terminated Business) and related unearned premium as of January 1, 2019. The Partial Termination Amendment resulted in Maiden Reinsurance returning $647,980 in unearned premium to AII, or $436,760 net of applicable ceding commission and brokerage during the second quarter of 2019.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~10. Related Party Transactions (continued)~~

Subsequently, on January 30, 2019, Maiden Reinsurance and AII agreed to terminate the remaining business subject to the AmTrust Quota Share on a run-off basis effective as of January 1, 2019.

Effective July 31, 2019, Maiden Reinsurance and AII entered into a Commutation and Release Agreement which provided for AII to assume all reserves ceded by AII to Maiden Reinsurance with respect to its proportional 40% share of the ultimate net loss under the AmTrust Quota Share related to the commuted business including: (a) all losses incurred in Accident Year 2017 and Accident Year 2018 under California workers' compensation policies and as defined in the AmTrust Quota Share ("Commuted California Business"); and (b) all losses incurred in Accident Year 2018 under New York workers' compensation policies ("Commuted New York Business"), and together with the Commuted California Business ("Commuted Business") in exchange for the release and full discharge of Maiden Reinsurance's obligations to AII with respect to the Commuted Business. The Commuted Business excludes any business classified by AII as Specialty Program or Specialty Risk business.

~~Maiden Reinsurance paid $312,786 ("Commutation Payment"), which is the sum~~

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of the net ceded reserves in the amount of $330,682 with respect to the Commuted Business as of December 31, 2018 less payments in the amount of $17,896 made by Maiden Reinsurance with respect to the Commuted Business from January 1, 2019 through July 31, 2019. The Commutation Payment was settled on August 12, 2019U.S. dollars, except share and ~~Maiden Reinsurance paid AII approximately $6,335 in interest related to the Commutation Payment premium, calculated at the rate of 3.30%~~ per ~~annum from January 1, 2019 through August 12, 2019.~~share data)

10. Related Party Transactions (continued)

AII and Maiden Reinsurance also agreed that as of July 31, 2019, the AmTrust Quota Share was deemed amended as applicable so that the Commuted Business is no longer included as part of Covered Business under the AmTrust Quota Share.

On January 30, 2019, in connection with the termination of the reinsurance agreement described above, the Company and AmTrust entered into a second amendment to the Master Agreement between the parties, originally entered into on July 3, 2007, to remove the provisions requiring AmTrust to reinsure business with the Company. Please refer to "Note 10. Related Party Transactions" in the Annual Report on Form 10-K for the year ended December 31, 2022 for further details.

European Hospital Liability Quota Share

Effective April 1, 2011, Maiden Reinsurance entered into the European Hospital Liability Quota Share with AEL and AIU DAC. Pursuant to the terms of the European Hospital Liability Quota Share, Maiden Reinsurance assumed 40% of the premiums and losses related to policies classified as European Hospital Liability, including associated liability coverages and policies covering physician defense costs, written or renewed on or after April 1, 2011. The European Hospital Liability Quota Share also covers policies written or renewed on or before March 31, 2011, but only with respect to losses that occur, accrue or arise on or after April 1, 2011. The maximum limit of liability attaching shall be €5,000 (€10,000 effective January 1, 2012) or currency equivalent (on a 100% basis) per original claim for any one original policy. Maiden Reinsurance paid a ceding commission of 5% on contracts assumed under the European Hospital Liability Quota Share.

Effective July 1, 2016, the European Hospital Liability Quota Share was amended such that Maiden Reinsurance assumes from AEL 32.5% of the premiums and losses of all policies written or renewed on or after July 1, 2016 until June 30, 2017 and 20% of all policies written or renewed on or after July 1, 2017. Thereafter, on January 30, 2019, Maiden Reinsurance, AEL and AIU DAC agreed to terminate the European Hospital Liability Quota Share on a run-off basis effective as of January 1, 2019.

Effective July 1, 2022, Maiden Reinsurance and AIU DAC entered into an agreement ("Commutation Agreement") which provided for AIU DAC to assume all reserves ceded by AIU DAC to Maiden Reinsurance with respect to AIU DAC’s French Medical Malpractice exposures for underwriting years 2012 through 2018 reinsured by Maiden Reinsurance under the European Hospital Liability Quota Share. In accordance with the Commutation Agreement, Maiden Reinsurance paid $31,291 (€29,401) to AIU DAC, which is the sum of net ceded reserves of $27,625 (€25,956) and an agreed exit cost of $3,666 (€3,444). As a result of the Commutation Agreement, Maiden Reinsurance reduced its exposure to AmTrust's Hospital Liability business, ~~however, it continues to have~~but still has exposure to Italian medical malpractice liabilities under the European Hospital Liability Quota Share.

The table below shows the effect of both of these quota share arrangements with AmTrust on the Company's Condensed Consolidated Income Statements for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Gross and net premiums written	Gross and net premiums written	$	(805)	$	1,137	$	(18,520)	$	(3,082)	Gross and net premiums written	$	223	$	(2,809)	$	(5,790)	$	(17,715)
Net premiums earned	Net premiums earned	5,319		7,509		3,804		19,383		Net premiums earned	3,835		3,318		5,366		(1,515)
Net loss and LAE	Net loss and LAE	(15,461)		(9,960)		(19,072)		(4,330)		Net loss and LAE	(7,521)		(4,534)		(14,703)		(3,611)
Commission and other acquisition expenses	Commission and other acquisition expenses	(2,004)		(2,852)		(2,127)		(7,486)		Commission and other acquisition expenses	(1,431)		(1,366)		(2,010)		(123)

Collateral provided to AmTrust

a) AmTrust Quota Share

To provide AmTrust's U.S. insurance subsidiaries with credit for reinsurance on their statutory financial statements, AII, as the direct reinsurer of AmTrust's insurance subsidiaries, established trust accounts ("Trust Accounts") for their benefit. Maiden Reinsurance has provided appropriate collateral to secure its proportional share under the AmTrust Quota Share of AII's

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~10. Related Party Transactions (continued)~~

obligations to the AmTrust subsidiaries to whom AII is required to provide collateral which can include any of the following:

(a) assets loaned by Maiden Reinsurance to AII for deposit into the Trust Accounts, pursuant to a loan agreement between those ~~parties,~~ parties;

(b) assets transferred by Maiden Reinsurance for deposit into the Trust ~~Accounts,~~Accounts; or

Maiden Reinsurance may provide any or a combination of these forms of collateral, provided that the aggregate value thereof equals Maiden Reinsurance's proportionate share of its obligations under the AmTrust Quota Share. The collateral requirements under the AmTrust Quota Share with AII was satisfied as follows:

•by lending funds of $167,975 at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 pursuant to a loan agreement entered into between those parties. Advances under the loan are secured by promissory ~~notes. This loan~~notes and was assigned by AII to AmTrust effective December 31, 2014 and is carried at cost. Interest is payable at a rate equivalent to the Federal Funds Effective Rate ("Fed Funds") plus 200 basis points per annum. Interest income on the loan was ~~$1,771~~$2,927 and ~~$3,808~~$5,625 for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively ~~(2021~~(2022 - ~~$885~~$1,158 and ~~$2,611,~~$2,037, respectively) and the effective yield was ~~4.2%~~7.0% and ~~3.0%~~6.7% for the respective periods ~~(2021~~(2022 - ~~2.1%~~2.8% and ~~2.1%~~2.4%).

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

10. Related Party Transactions (continued)

•on January 30, 2019, in connection with the termination of the reinsurance agreements described above, the Company and AmTrust amended the Loan Agreement between Maiden Reinsurance, AmTrust and AII, originally entered into on November 16, 2007, by extending the maturity date to January 1, 2025 and specifies that due to the termination of the AmTrust Quota Share, no further loans or advances may be made pursuant to the Loan Agreement;

•effective December 1, 2008, the Company entered into a Reinsurer Trust Assets Collateral agreement to provide to AII sufficient collateral to secure its proportional share of AII's obligations to the U.S. AmTrust subsidiaries. The amount of the collateral at ~~September~~June 30, ~~2022~~2023 was ~~$104,453~~$13,869 (December 31, ~~2021~~2022 - ~~$246,874)~~$42,305) and the accrued interest was ~~$589~~$62 (December 31, ~~2021~~2022 - ~~$1,171)~~$224). Please refer to "Note 4. (e) Investments" for additional information;

•on January 11, 2019, the Company transferred $575,000 to AmTrust as a portion of the existing Trust Accounts used for collateral on the AmTrust Quota Share ~~were~~was converted to a funds withheld arrangement. The ~~Company transferred $575,000 to AmTrust as a~~ funds withheld receivable ~~which has~~earns an annual interest rate of 3.5% for ~~2022 of 2.1%,~~2023, which is subject to annual ~~adjustment. The annual interest rate was 1.80%~~adjustment (2.1% for ~~2021.~~2022). At ~~September~~June 30, ~~2022,~~2023, the funds withheld balance was ~~$490,603~~$286,900 (December 31, ~~2021~~2022 - ~~$575,000)~~$416,835) and ~~the~~ accrued interest was ~~$2,597~~$3,061 (December 31, ~~2021~~2022 - ~~$2,609)~~$2,359). The interest income on the funds withheld receivable was ~~$2,597~~$3,061 and ~~$8,585~~$6,342 for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively ~~(2021~~(2022 - ~~$2,609~~$3,436 and ~~$7,741,~~$5,988, respectively).

Pursuant to the terms of the LPT/ADC Agreement, Maiden Reinsurance, Cavello and AmTrust and certain of its affiliated companies entered into a Master Collateral Agreement (“MCA”) to define and enable the operation of collateral provided under the AmTrust Quota Share. Under the MCA, Cavello provided letters of credit on behalf of Maiden Reinsurance to AmTrust in an amount representing Cavello’s obligations under the LPT/ADC Agreement. Because these letters of credit replaced other collateral previously provided directly by Maiden Reinsurance to AmTrust, the MCA coordinates the collateral protection that will be provided to AmTrust to ensure that no gaps in collateral funding occur by operation of the LPT/ADC Agreement and related MCA. As a result of entering into both the LPT/ADC Agreement and the MCA, certain post-termination endorsements (“PTEs”) to the AmTrust Quota Share between AII and Maiden Reinsurance were required.

Effective July 31, 2019, the PTEs: i) enable the operation of both the LPT/ADC Agreement and MCA by making provision for certain forms of collateral, including letters of credit provided by Cavello on Maiden Reinsurance’s behalf, and further defines the permitted use and return of collateral; and ii) increase the required funding percentage for Maiden Reinsurance under the collateral arrangements between the parties to 105% of its obligations, subject to a minimum excess funding requirement of $54,000, as may be mutually amended by the parties from time to time. Under certain defined conditions, Maiden Reinsurance may be required to increase this funding percentage to 110%.

Effective March 16, 2020, Maiden Reinsurance discontinued as a Bermuda company and completed its re-domestication to the State of Vermont. Bermuda is a Solvency II equivalent jurisdiction and the State of Vermont is not such a jurisdiction; therefore, the collateral provided under the respective agreements with AmTrust subsidiaries was strengthened to reflect the impact of the re-domestication concurrent with the date of Maiden Reinsurance’s re-domestication to Vermont. Maiden Reinsurance and AmTrust agreed to: 1) amend the AmTrust Quota Share pursuant to Post Termination Endorsement No. 2 effective March 16, 2020; and 2) amend the European Hospital Liability Quota Share pursuant to Post Termination Endorsement No. 1 effective March 16, 2020.

Pursuant to the terms of Post Termination Endorsement No. 2 to the AmTrust Quota Share, Maiden Reinsurance strengthened the collateral protection provided by Maiden Reinsurance to AII by increasing the required funding percentage for Maiden Reinsurance under the collateral arrangements between the parties to 110% of its obligations, subject to a minimum excess funding requirement of $54,000, as may be mutually amended by the parties from time to time. Post Termination Endorsement No. 2 also sets forth conditions by which the funding percentage will be reduced and the sequence of how collateral will be utilized as obligations, as defined under the AmTrust Quota Share, are satisfied. Pursuant to the terms of Post Termination Endorsement No. 2, the funding percentage was reduced to 107.5% during the first quarter of 2023.

Pursuant to the terms of Post Termination Endorsement No. 1 to the European Hospital Liability Quota Share, Maiden Reinsurance strengthened the collateral protection provided by Maiden Reinsurance to AEL and AIU DAC by increasing the required funding percentage for Maiden Reinsurance under the collateral arrangements between the parties to the greater of 120% of the Exposure (as defined therein) and the amount of security required to offset the increase in the Solvency Capital Requirement (“SCR”) that results from the changes in the SCR which arise out of Maiden Reinsurance's re-domestication as compared to the SCR calculation if Maiden Reinsurance had remained domesticated in a Solvency II equivalent jurisdiction with a solvency ratio above 100% and provided collateral equivalent to 100% of the Exposure.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~10. Related Party Transactions (continued)~~

b) European Hospital Liability Quota Share

Collateral has been provided to both AEL and AIU DAC under the European Hospital Liability Quota Share. For AEL, the amount of the collateral held in reinsurance trust accounts at ~~September~~June 30, ~~2022~~2023 was ~~$197,737~~$157,863 (December 31, ~~2021~~2022 - ~~$244,488)~~$188,473) and the accrued interest was ~~$710~~$1,163 (December 31, ~~2021~~2022 - ~~$1,273)~~$966). ~~For AIU DAC, the Company utilized funds withheld to satisfy its collateral requirements which was used to settle the Commutation Agreement on September 12, 2022.~~

Therefore, at September 30, 2022, the amount of funds withheld was $0 (December 31, 2021 - $26,460) and the accrued interest was $0 (December 31, 2021 - $141). AIU DAC paid Maiden Reinsurance a fixed annual interest rate of 0.5% on the average daily funds withheld balance. The interest income on the funds withheld receivable was $3 and $59 for the three and nine months ended September 30, 2022, respectively (2021 - $37 and $111, respectively).

~~Brokerage Agreement~~

Effective July 1, 2007, the Company had a reinsurance brokerage agreement with AII Reinsurance Broker Ltd. ("AIIB"), a wholly owned subsidiary of AmTrust. Pursuant to the brokerage agreement, AIIB provided brokerage services relating to the AmTrust Quota Share and the European Hospital Liability Quota Share for a fee equal to 1.25% of the premium assumed. AIIB was not the Company's exclusive broker. The brokerage agreement was terminated as of March 15, 2019.

Maiden Reinsurance had $67 and $48 of reinsurance brokerage expense for the three and nine months ended September 30, 2022 (2021 - $94 and $242, respectively) and deferred reinsurance brokerage of $868 at September 30, 2022 (December 31, 2021 - $1,147) as a result of this agreement.

Asset Management Agreement

Effective July 1, 2007, the Company entered into an asset management agreement with AII Insurance Management Limited ("AIIM"), a wholly owned subsidiary of AmTrust, pursuant to which AIIM agreed to provide investment management services to the Company. Effective January 1, 2018, AIIM provides investment management services for a quarterly fee of 0.02125% of the average value of the account. The agreement may be terminated upon 30 days written notice by either party.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

10. Related Party Transactions (continued)

The Company recorded ~~$99~~$72 and ~~$329~~$145 of investment management fees for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively ~~(2021~~(2022 - ~~$196~~$104 and ~~$690,~~$230, respectively) under this agreement.

On September 9, 2020, Maiden Reinsurance, AmTrust and AIIM entered into a novation agreement, effective July 1, 2020, which provided for the novation of the asset management agreement, dated January 1, 2018 between Maiden Reinsurance and AIIM, and the release by Maiden Reinsurance of AIIM's obligations under the asset management agreement. The novation mandates that AmTrust is to be bound by the terms of the asset management agreement in place of AIIM and AmTrust agrees to perform any and all past, present and future obligations of AIIM under the asset management agreement.

On November 13, 2020, Maiden LF, Maiden GF, AmTrust and AIIM entered into a novation agreement, effective July 1, 2020, which provided for the novation of the asset management agreement, dated January 1, 2018 between Maiden LF, Maiden GF and AIIM, and the release by Maiden LF and Maiden GF of AIIM's obligations under the asset management agreement. The novation mandates that AmTrust is to be bound by the terms of the asset management agreement in place of AIIM and AmTrust agrees to perform any and all past, present and future obligations of AIIM under the asset management agreement.

~~683 Capital Partners, LP (“683 Partners”)~~

At September 30, 2022, 683 Partners and its affiliates own or control approximately 5.0% of the outstanding common shares of the Company. 683 Partners and its affiliates are not related parties as defined in ASC 850: ~~Related Party Disclosures~~.

~~Limited Partnership Agreement with 683 Capital Management, LLC ("683 Capital")~~

In July 2020, the Company and 683 Capital entered into a limited partnership agreement (“683 LP Agreement”) whereby 683 Capital will separately manage certain funds of Maiden Reinsurance at its discretion, subject to guidelines established by the parties. Under the 683 LP Agreement, Maiden Reinsurance will pay 683 Capital a management fee and subject to certain metrics agreed to by the parties, an incentive fee upon attainment of those metrics. Maiden Reinsurance may periodically and in its discretion increase the amount invested under the 683 LP Agreement, and subject to certain conditions, reduce the amount invested under the 683 LP Agreement. Hedge fund investments of $15,447 were managed by 683 Capital under this agreement at September 30, 2022 (December 31, 2021 - $32,929) which reflected investment results through that date along with a reduction in the amount invested under the 683 LP Agreement during the nine months ended September 30, 2022.

11. Commitments, Contingencies and Guarantees

There are no material changes from the commitments, contingencies and concentrations previously disclosed in the Company’s Form 10-K for the year ended December 31, ~~2021.~~2022.

a)Concentrations of Credit Risk

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company’s assets where significant concentrations of credit risk may exist include investments, cash and cash equivalents, loan to related party, reinsurance balances receivable, reinsurance recoverable on paid and unpaid losses and funds withheld receivable. Please refer to "Note 8. Reinsurance" for additional information regarding the Company's credit risk exposure on its reinsurance counterparties including the impact of the LPT/ADC Agreement effective January 1, 2019. The Company requires its reinsurers to have adequate financial strength.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~11. Commitments, Contingencies and Guarantees (continued)~~

The Company evaluates the financial condition of its reinsurers and monitors its concentration of credit risk on an ongoing basis. Provisions are made for amounts that are considered potentially uncollectible. Letters of credit are provided by its reinsurers for material amounts recoverable as discussed in "Note 8. Reinsurance".

The Company manages the concentration of credit risk in its investment portfolio through issuer and sector exposure limitations. The Company believes it bears minimal credit risk in its cash on deposit. The Company also monitors the credit risk related to the loan to related party, reinsurance balances receivable and funds withheld receivable, within which the largest balances are due from AmTrust. AmTrust has a financial strength/credit rating of A- (Excellent) from A.M. Best at ~~September~~June 30, ~~2022.~~2023. To mitigate credit risk, the Company generally has a contractual right of offset thereby allowing claims to be settled net of any premiums or loan receivable. The Company believes these balances as at ~~September~~June 30, ~~2022~~2023 will be fully collectible.

Please refer to "Note 2. Significant Accounting Polices" for additional information on the Company's credit loss allowances as at June 30, 2023 regarding other investments, reinsurance recoverable on unpaid losses, reinsurance balances receivable and funds withheld receivable that were recorded under Topic 326 which was adopted effective January 1, 2023.

b)Investment Commitments and Related Financial Guarantees

The ~~Company's~~Company had total unfunded commitments on ~~other~~alternative investments ~~is $76,437~~of $103,721 at ~~September~~June 30, ~~2022~~2023 (December 31, ~~2021~~2022 - ~~$68,262). The Company's unfunded~~$112,989) which included commitments ~~on equity method~~for other investments, ~~was $25,069 at September 30, 2022 (December 31, 2021 - $25,950). The Company's unfunded commitments on~~ private equity securities ~~at September 30, 2022 was $17,663 (December 31, 2021 - $27,415).~~and equity method investments. The ~~Company's~~table below shows the total unfunded commitments ~~on other investments~~by type of investment as at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021 were as follows:~~2022:


		September 30, 2022				December 31, 2021					June 30, 2023				December 31, 2022
		Fair Value		% of Total		Fair Value		% of Total			Fair Value		% of Total		Fair Value		% of Total
Private equity funds	Private equity funds	$	56,767	74.3	%	$	46,149	67.6	%	Private equity funds	$	51,808	49.9	%	$	54,996	48.7	%
Private credit funds	Private credit funds	14,981		19.6	%	4,897		7.2	%	Private credit funds	9,423		9.1	%	13,906		12.3	%
Investments in direct lending entities		3,304		4.3	%	13,216		19.4	%
Other privately held investments		1,385		1.8	%	4,000		5.8	%

Privately held equity investments										Privately held equity investments	705		0.7	%	705		0.6	%
Total unfunded commitments on other investments	Total unfunded commitments on other investments	$	76,437	100.0	%	$	68,262	100.0	%	Total unfunded commitments on other investments	$	61,936	59.7	%	$	69,607	61.6	%

Total unfunded commitments on equity securities										Total unfunded commitments on equity securities	$	16,509	15.9	%	$	16,509	14.6	%

Total unfunded commitments on equity method investments										Total unfunded commitments on equity method investments	$	25,276	24.4	%	$	26,873	23.8	%

Total unfunded commitments on alternative investments										Total unfunded commitments on alternative investments	$	103,721	100.0	%	$	112,989	100.0	%

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

11. Commitments, Contingencies and Guarantees (continued)

Any loss for which the Company could be liable would be contingent on the default of a loan by the real estate joint venture entity for which the Company provided a financial guarantee to a lender. While the Company has committed to aggregate limits as to the amount of guarantees it will provide as part of its limited partnerships, guarantees are only provided on an individual transaction basis and are subject to the terms and conditions of each transaction mutually agreed by the parties involved. The Company is not bound to such guarantees without its express authorization.

As discussed above, at ~~September~~June 30, ~~2022,~~2023, guarantees of ~~$41,302~~$43,135 (December 31, ~~2021~~2022 - ~~$33,305)~~$42,141) were provided to lenders by the Company on behalf of real estate joint ventures, however, the likelihood of the Company incurring any losses pertaining to project level financing guarantees was determined to be remote. Therefore, no liability has been accrued under ASC 450-20.

c)Operating Lease Commitments

The Company leases office spaces ~~housing, office~~and equipment ~~and company vehicles~~ under various operating leases expiring in various years through ~~2024.~~2025. The Company's leases are currently classified as operating leases and none of them have non-lease components. For operating leases that have a lease term of more than twelve months, and whose lease payments are above a certain threshold, the Company recognizes a lease liability and a right-of-use asset in the Condensed Consolidated Balance Sheets at the present value of the remaining lease payments until expiration.

As the lease contracts generally do not provide an implicit discount rate, the Company used the weighted-average discount rate of 10%, representing its secured incremental borrowing rate, in calculating the present value of the lease liability. At June 30, 2023, the Company's future lease obligations of $329 (December 31, 2022 - $300) were calculated based on the present value of future annual rental commitments excluding taxes, insurance and other operating costs for non-cancellable operating leases discounted using its secured incremental borrowing rate. This amount ~~of $328 is recorded~~has been recognized on the Consolidated Balance Sheet as a lease liability within accrued expenses and other liabilities with an equivalent amount for the right-of-use asset presented as part of other assets ~~at September 30, 2022 (December 31, 2021 - $473)~~.

The Company has made an accounting policy election not to include renewal, termination, or purchase options that are not reasonably certain of exercise when determining the term of the borrowing. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.The Company's weighted-average remaining lease term is approximately ~~2.1~~1.6 years at ~~September~~June 30, ~~2022.~~ 2023.

Under Topic 842, Leases, the Company continues to recognize the related leasing expense on a straight-line basis over the lease term on the Consolidated Statements of Income. The Company's total lease expense was $135 and $255 for three and six months ended June 30, 2023, respectively (2022 - $82 and $159, respectively ) recognized within general and administrative expenses consistent with the prior accounting treatment under Topic 840.

d)Legal Proceedings

Except as noted below, the Company is not a party to any material legal proceedings. From time to time, the Company is subject to routine legal proceedings, including arbitration, arising in the ordinary course of business. These legal proceedings generally relate to claims asserted by or against the Company in the ordinary course of insurance or reinsurance operations. Based on the Company's opinion, the eventual outcome of these legal proceedings is not expected to have a material adverse effect on its financial condition or results of operations.

In April 2009, the Company learned that Bentzion S. Turin, the former Chief Operating Officer, General Counsel and Secretary of Maiden Holdings and Maiden Reinsurance, sent a letter to the U.S. Department of Labor claiming that his employment with the Company was terminated in retaliation for corporate whistle-blowing in violation of the whistle-blower protection provisions of the Sarbanes-Oxley Act of 2002.

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

~~11. Commitments, Contingencies and Guarantees (continued)~~

Mr. Turin alleged that he was terminated for raising concerns regarding corporate governance with respect to the negotiation of the terms of the Trust Preferred Securities Offering. He seeks reinstatement as Chief Operating Officer, General Counsel and Secretary of Maiden Holdings and Maiden Reinsurance, back pay and legal fees incurred. On December 31, 2009, the U.S. Secretary of Labor found no reasonable cause for Mr. Turin’s claim and dismissed the complaint in its entirety. Mr. Turin objected to the Secretary's findings and requested a hearing before an administrative law judge in the U.S. Department of Labor. The Company moved to dismiss Mr. Turin's complaint, and its motion was granted by the Administrative Law Judge on June 30, 2011. On July 13, 2011, Mr. Turin filed a petition for review of the Administrative Law Judge's decision with the Administrative Review Board in the U.S. Department of Labor. On March 29, 2013, the Administrative Review Board reversed the dismissal of the complaint on procedural grounds, and remanded the case to the administrative law judge. The administrative hearing began in September 2014 and concluded in November 2018. On September 2, 2021, Administrative Law Judge Theresa C. Timlin of the U.S. Department of Labor issued a decision and order which denied Mr. Turin’s complaint in full. On September 16, 2021, Mr. Turin filed a petition for review of the Administrative Law Judge's decision with the Administrative Review Board in the U.S. Department of Labor. ~~The Company believes that it had good~~On June 29, 2023, the Administrative Review Board issued a decision and ~~sufficient reasons for terminating Mr. Turin's employment~~order which summarily affirmed the September 2, 2021 decision and ~~that~~order of the ~~claim is without merit. The Company will continue to vigorously defend itself against this claim.~~Administrative Law Judge.

MAIDEN HOLDINGS, LTD.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(in thousands of U.S. dollars, except share and per share data)

11. Commitments, Contingencies and Guarantees (continued)

A putative class action complaint was filed against Maiden Holdings, Arturo M. Raschbaum, Karen L. Schmitt, and John M. Marshaleck in the United States District Court for the District of New Jersey on February 11, 2019. On February 19, 2020, the Court appointed lead plaintiffs, and on May 1, 2020, lead plaintiffs filed an amended class action complaint (the “Amended Complaint”).The Amended Complaint asserts violations of Section 10(b) of the Exchange Act and Rule 10b-5 (and Section 20(a) for control person liability) arising in large part from allegations that Maiden failed to take adequate loss reserves in connection with reinsurance provided to AmTrust. Plaintiffs further claim that certain of Maiden Holdings’ representations concerning its business, underwriting and financial statements were rendered false by the allegedly inadequate loss reserves, that these misrepresentations inflated the price of Maiden Holdings' common stock, and that when the truth about the misrepresentations was revealed, the Company’s stock price fell, causing Plaintiffs to incur losses. On September 11, 2020, a motion to dismiss was filed on behalf of all Defendants. On August 6, 2021, the Court issued an order denying, in part, Defendants’ motion to dismiss, ordering Plaintiffs to file a shorter amended complaint no later than August 20, 2021, and permitting discovery to proceed on a limited basis. On February 7, 2023, the District Court denied Plaintiffs’ motion for reconsideration of the District Court’s decision denying Plaintiffs’ objection to the Magistrate Judge’s December 2021 ruling on discovery. The Company expects to file a dispositive motion in the near future. We believe the claims are without merit and we intend to vigorously defend ourselves. It is possible that additional lawsuits will be filed against the Company, its subsidiaries and its respective officers due to the diminution in value of our securities as a result of our operating results and financial condition. It is currently uncertain as to the effect of such litigation on our business, operating results and financial condition.

12. Earnings per Common Share

The following is a summary of the elements used in calculating basic and diluted earnings per common share:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Numerator:	Numerator:									Numerator:

Net (loss) income	Net (loss) income	$	(8,160)	$	(3,140)	$	(9,047)	$	14,258	Net (loss) income	$	(2,933)	$	1,062	$	(14,261)	$	(887)

Gain from repurchase of preference shares - Series A, C and D		—		6,004		28,233		87,168
Gain from repurchase of preference shares										Gain from repurchase of preference shares	—		24,690		—		28,233
Amount allocated to participating common shareholders(1)	Amount allocated to participating common shareholders(1)	—		(17)		(109)		(1,017)		Amount allocated to participating common shareholders(1)	—		(137)		—		(154)

Net (loss) income allocated to Maiden common shareholders	Net (loss) income allocated to Maiden common shareholders	$	(8,160)	$	2,847	$	19,077	$	100,409	Net (loss) income allocated to Maiden common shareholders	$	(2,933)	$	25,615	$	(14,261)	$	27,192
Denominator:	Denominator:									Denominator:
Weighted average number of common shares – basic	Weighted average number of common shares – basic	87,161,499		86,433,780		86,935,823		85,937,012		Weighted average number of common shares – basic	101,754,218		87,092,045		101,653,848		86,821,114
Potentially dilutive securities:	Potentially dilutive securities:									Potentially dilutive securities:
Share options and restricted share units(2)	Share options and restricted share units(2)	—		4,452		1,729		4,406		Share options and restricted share units(2)	—		1,867		—		2,711
Adjusted weighted average number of common shares – diluted(2)	Adjusted weighted average number of common shares – diluted(2)	87,161,499		86,438,232		86,937,552		85,941,418		Adjusted weighted average number of common shares – diluted(2)	101,754,218		87,093,912		101,653,848		86,823,825
Basic and diluted (loss) earnings per share attributable to common shareholders	Basic and diluted (loss) earnings per share attributable to common shareholders	$	(0.09)	$	0.03	$	0.22	$	1.17	Basic and diluted (loss) earnings per share attributable to common shareholders	$	(0.03)	$	0.29	$	(0.14)	$	0.31

(1)This represents the share in net income using the two-class method for holders of non-vested restricted shares issued to the Company's employees under the 2019 Omnibus Incentive Plan.

(2)Please refer to "Note 6. Shareholders' Equity" and "Note 14. Share Compensation and Pension Plans" in the Notes to Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 for the terms and conditions of securities that could potentially be dilutive in the future. There were no potentially dilutive securities for the three and six months ended ~~September~~June 30, ~~2022~~2023 (2022 - 1,867 and ~~1,729 potentially dilutive securities for the nine months ended September 30, 2022 (2021 - 4,452 and 4,406,~~2,711, respectively).

~~MAIDEN HOLDINGS, LTD.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)~~

~~(in thousands of U.S. dollars, except share and per share data)~~

13. Income Taxes

The Company recognized an income tax benefit of ~~$91~~$194 and ~~income tax expense of $451~~$222 for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to an income tax benefit of ~~$155~~$713 and ~~$363~~income tax expense of $542 for the same respective periods in ~~2021.~~2022. The effective tax rate on the Company's net loss differs from the statutory rate of zero percent under Bermuda law due to tax on foreign operations, primarily the U.S. and Sweden.

A valuation allowance has been established against the net U.S. deferred tax assets which are primarily attributable to net operating losses and discounting of loss reserves for tax purposes. At this time, the Company believes it is necessary to establish a full valuation allowance against the U.S. net deferred tax assets ~~due to insufficient positive~~as more evidence is needed regarding the utilization of these tax benefits in the future.

~~14. Subsequent Events~~

~~Exchange of Preference Shares for Common Shares~~

~~On November 9, 2022, the Company announced its intention to exchange all of the Company’s outstanding 8.250% Non-Cumulative Preference Shares Series A (the “Series A Preference Shares”), 7.125% Non-Cumulative Preference Shares Series C (the “Series C Preference Shares”) and 6.700% Non-Cumulative Preference Shares Series D (the “Series D Preference Shares” and, together with the Series A Preference Shares and the Series C Preference Shares, the “Preference Shares”) for shares of Maiden’s common shares, $0.01 par value per share (the “Common Shares”), subject to the terms of the certificate of designations for each of the Preference Shares, as amended (the "Exchange~~"). The Exchange requires that the terms of each of the Preference Shares be varied and any such variation will require the affirmative vote of holders of two-thirds of the issued shares of each series of the Preference Shares. Maiden Reinsurance, which currently owns more than 73% of each series of the Preference Shares, has indicated it will consent to the variations for each of the series of Preference Shares in order to effectuate the Exchange. The Company’s board of directors (the “~~Board”) established a special committee consisting solely of disinterested and independent directors (the “Special Committee~~”) for the purpose of evaluating and, if appropriate, negotiating and approving potential amendments to the certificates of designations for each series of Preference Shares in order to effectuate the Exchange. Advised by its own financial and legal advisors, the Special Committee unanimously approved an exchange ratio of three Common Shares per Preference Share of each series for record holders of the Preference Shares. The Board has also approved the amendments to the certificates of designations for each series of Preference Shares, and the Exchange. Under the proposed terms of the Exchange, holders of Preference Shares at the time of the Exchange will receive Common Shares having a fair value that meets the “Minimum Price” as determined in accordance with the rules of NASDAQ and as will be described in an information statement that Maiden will file with the Securities and Exchange Commission (the “~~SEC”) and will distribute to preference shareholders (the “Information Statement~~”). Specifically, holders of Preference Shares of each series will receive, for each Preference Share held, three Common Shares, with the value of each Preference Share so exchanged being equal to three ~~times~~ the price that is the lower of: (i) the closing price of the Common Shares (as reflected on Nasdaq.com) immediately preceding the date of the Exchange; and (ii) the average closing price of the Common Shares (as reflected on Nasdaq.com) for the five trading days immediately preceding the date of the Exchange. As a result of the Exchange, the Preference Shares will no longer trade on the New York Stock Exchange, and no Preference Shares will be issued or outstanding. All rights of the former holders related to ownership of the Preference Shares will terminate.

Upon completion of the Exchange, it is expected that Maiden Reinsurance will own approximately 29% of the Common Shares as of the date of the Exchange as described above, which Common Shares will be eliminated for accounting and financial reporting purposes on the Company’s consolidated financial statements.~~Maiden Reinsurance's voting power, with respect to its Common Shares will be capped at 9.5% under the terms of the bye-laws of the Company.~~

The Exchange and the ownership of the Common Shares by Maiden Reinsurance is being made in compliance with Maiden Reinsurance's investment policy which has been approved by the Vermont Department of Financial Regulation.

As a result of the Exchange, Maiden estimates that its book value per Common Share will increase by approximately $0.82 per Common Share, subject to the determination of the final value of the Preference Shares and the exchange price of the Common Shares.~~Maiden expects to complete the transaction on or before December 31, 2022 and will notify holders of the exchange date when determined.~~

3536

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and related notes included elsewhere in this Quarterly Report on Form 10-Q (this "Form 10-Q" or this "Report"). References in this Form 10-Q to the terms "we", "us", "our", "the Company", "Maiden" or other similar terms mean the consolidated operations of Maiden Holdings, Ltd. and its subsidiaries, unless the context requires otherwise. References in this Form 10-Q to the term "Maiden Holdings" means Maiden Holdings, Ltd. only. Certain reclassifications have been made for ~~2021~~2022 to conform to the ~~2022~~2023 presentation and have no impact on consolidated net income and total equity previously reported.

Note on Forward-Looking Statements

This Quarterly Report on Form 10-Q includes projections concerning financial information and statements concerning future economic performance and events, plans and objectives relating to management, operations, products and services, and assumptions underlying these projections and statements. These projections and statements are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 and are not historical facts but instead represent only our belief regarding future events, many of which, by their nature, are inherently uncertain and outside our control. These projections and statements may address, among other things, our strategy for growth, product development, financial results and reserves. Our actual results and financial condition may differ, possibly materially, from these projections and statements and therefore you should not place undue reliance on them.

Factors that could cause our actual results and financial condition to differ, possibly materially, from those in the specific projections and statements are discussed throughout this Management's Discussion and Analysis of Financial Condition and Results of Operations and in "Risk Factors" in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 that was filed with the U.S. Securities and Exchange Commission ("SEC") on March ~~14, 2022,~~15, 2023, however, these factors should not be construed as exhaustive. Forward-looking statements speak only as of the date they are made and we undertake no obligation to update or revise any forward-looking statement that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.

3637

Overview

Maiden Holdings is a Bermuda-based holding company. We create shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. We also provide a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies that enable our clients to meet their capital and risk management objectives. We expect our legacy solutions business to contribute to our active asset and capital management strategies.

We are not currently underwriting reinsurance business on new prospective risks but are actively underwriting risks on a retroactive basis through Genesis Legacy Solutions ("GLS"). We also have various historic reinsurance programs underwritten by Maiden Reinsurance Ltd. ("Maiden Reinsurance") which are in run-off, including the liabilities associated with AmTrust Financial Services, Inc. ("AmTrust") which we terminated in 2019 as discussed in "Note 10. Related Party Agreements" of the Notes to Condensed Consolidated Financial Statements in Part I Item 1. "Financial Information". In addition, we have a Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") with Cavello Bay Reinsurance Limited ("Cavello") and a commutation agreement that further reduces our exposure to and limits the potential volatility related to our AmTrust liabilities in run-off, as discussed in "Note 8. Reinsurance" of the Notes to Condensed Consolidated Financial Statements in Part I Item 1. "Financial Information".

Short-term income protection business is written on a primary basis by our wholly owned subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF") in the Scandinavian and Northern European markets. Insurance support services are provided to Maiden LF and Maiden GF through our wholly owned subsidiary, Maiden Global Holdings, Ltd. ("Maiden Global") which is also a licensed intermediary in the United Kingdom. Maiden Global had previously operated internationally by providing branded auto and credit life insurance products through insurer partners, particularly those in Europe and other global markets. These products also produced reinsurance programs which were underwritten by our wholly owned subsidiary Maiden ~~Reinsurance Ltd. ("~~Reinsurance. During 2023, we are evaluating the strategic value of Maiden ~~Reinsurance").~~

LF and Maiden GF in relation to their ongoing growth and profitability prospects, regulatory capital requirements and ability to create shareholder value in excess of our target return on capital levels. We are not currently underwriting reinsurance business on new prospective risks but are actively underwriting risks on a retroactive basis through Genesis Legacy Solutions ("GLS"). We also have various historic reinsurance programs underwritten by Maiden Reinsurance which are in run-off, includingexpect to continue this evaluation during the ~~liabilities associated with AmTrust Financial Services, Inc. ("AmTrust") which we terminated in 2019 as discussed in "Note 10. Related Party Agreements~~"second half of ~~the Notes to Condensed Consolidated Financial Statements in Part I Item 1.~~ ~~"Financial Information"~~. In addition, we have a Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") with Cavello Bay Reinsurance Limited ("Cavello") and a commutation agreement that further reduces our exposure to and limits the potential volatility related to these AmTrust liabilities in run-off, as discussed in "~~Note 8. Reinsurance" of the Notes to Condensed Consolidated Financial Statements in Part I Item 1.~~ ~~"Financial Information"~~.2023.

Our business currently consists of two reportable segments: Diversified Reinsurance and AmTrust Reinsurance. Our Diversified Reinsurance segment consists of a portfolio of predominantly property and casualty reinsurance business focusing on regional and specialty property and casualty insurance companies located primarily in Europe. This segment also includes transactions entered into by GLS which was formed in November 2020. Our AmTrust Reinsurance segment includes all business ceded to Maiden Reinsurance by AmTrust, primarily the quota share reinsurance agreement (“AmTrust Quota Share”) between Maiden Reinsurance and AmTrust’s wholly owned subsidiary, AmTrust International Insurance, Ltd. (“AII”) and the European hospital liability quota share reinsurance contract ("European Hospital Liability Quota Share") with AmTrust’s wholly owned subsidiaries, AmTrust Europe Limited ("AEL") and AmTrust International Underwriters DAC ("AIU DAC"), both of which are in run-off effective as of January 1, 2019.

Please refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations" section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 that was filed on March 15, 2023 for further information on recent developments within the Company.

We believe Maiden Holdings North America, Ltd.'s ("Maiden NA") investments, including its ownership of Maiden Reinsurance and its active asset management strategy, will create opportunities to utilize net operating loss carry-forwards ("NOL") of $262.1 millionas of September 30, 2022. These NOL carryforwards, in combination with additional net deferred tax assets ("DTA") primarily related to our insurance liabilities result in a net U.S. DTA (before valuation allowance) of $120.8 million or $1.39 per common share at September 30, 2022.

These net DTA are not presently recognized on the Company's consolidated balance sheet as a full valuation allowance is carried against them. At this time, while positive evidence in support of reducing the valuation allowance is accumulating, the Company believes it is necessary to maintain its full valuation allowance against the net U.S. DTA due to insufficient accumulation of evidence at this time regarding the utilization of these losses. As our profitability continues to improve, we will continuously evaluate the amount of the valuation allowance held against the net U.S. DTA.

~~For further details, please see~~ ~~"Note 13. Income Taxes"~~ ~~included under Item 8~~ ~~"Financial Statements and Supplementary Data"~~ in our Annual Report on Form 10-K for the year ended December 31, 2021. Taken together, we believe these measures should generate additional income for Maiden NA in a tax-efficient manner, while sharing in the improvement in profitability anticipated in Maiden Reinsurance as a result of the measures enacted as described above.

Business Strategy

We continued to deploy our revised operating strategy during ~~2022~~2023 which leverages the significant assets and capital we retain. In addition to restoring operating profitability, our strategic focus centers on creating the greatest risk-adjusted shareholder returns in order to increase book value for our common shareholders, both near and long-term. We also believe that these areas of strategic focus will enhance our profitability through increased returns, which should also increase the likelihood of fully utilizing the significant net operating loss ("NOL") carryforwards as described further below which would create additional common shareholder value.

This strategy presently has three principal areas of focus:

•Asset management - investing in assets and asset classes in a prudent but expansive manner in order to maximize investment returns and is principally enabled by limiting the amount of insurance risk we assume in relation to the assets we hold and maintaining required regulatory capital at very strong levels to manage our aggregate risk profile;

•Legacy underwriting - judiciously building a portfolio of legacy run-off acquisitions and retroactive reinsurance transactions which we believe will produce attractive underwriting returns; and

•Capital management - effectively managing the capital we hold on our balance sheet and when appropriate, repurchasing securities or returning capital to enhance common shareholder returns.

As our insurance liabilities run-off and these strategies potentially develop along timelines longer than initially anticipated, we may allocate capital to other insurance activities that produce more consistent levels of revenue and profit as we seek to create longer-term shareholder value.

~~The returns expected to be produced by each pillar~~For example, we have not engaged or pursued active reinsurance underwriting of new prospective risks as our strategy are evaluated in relation to our cost of debt capital, which carries a weighted average effective interest rate of 7.6%. To the extent our experience or belief indicates we cannot exceed the cost of debt capital over a reasonable long-term investment horizon, we expect to refrain from activities in those areas. As an example, our present assessment of the reinsurance marketplace along with our current operating profile ~~continues to be~~has been that the risk-adjusted returns that may be produced via ~~active reinsurance~~such underwriting ~~of new prospective risks~~ are likely to be lower over the long-term than our cost of capital. However, as interest rates have increased and moved towards historically observed levels, risk-adjusted returns for active reinsurance underwriting of new

prospective risks may become more attractive and while we have no immediate plans to resume such underwriting, we continue to evaluate if such a strategy would produce suitable value for shareholders.

Further, we continue to also evaluate our ongoing activities in insurance distribution. To date, our insurance distribution investments have achieved an internal rate of return of 28.3% and a multiple of capital of 1.45x on those investments.

As part of our ongoing evaluation of both the insurance and reinsurance marketplace and the ability of both the distribution and the reinsurance markets to increase our current income, we increasingly believe expansion of those strategies may be appropriate. We are exploring distribution opportunities which are non-risk bearing and capital efficient and given ongoing changes in reinsurance markets, can be potentially complemented by limited and selective deployment of reinsurance capacity to supplement those activities and enhance returns to shareholders.

The measures implemented in recent years have allowed us to more flexibly allocate capital to those activities most likely to produce the greatest returns for shareholders, and we are actively engaged in evaluating and deploying funds in all pillars of the strategies as discussed herein. ~~We also believe~~

The returns expected to be produced by each pillar of our strategy are primarily evaluated in relation to our cost of debt capital, which carries a weighted average effective interest rate of 7.6%. To the extent our experience or belief indicates we cannot exceed the cost of debt capital, we expect to refrain from activities in those areas.

Our ability to execute our asset and capital management initiatives is dependent on maintaining adequate levels of unrestricted liquidity and cash flows. Further, there can be no assurance that ~~these areas of strategic focus~~our insurance liabilities will ~~enhance our profitability through increased returns,~~run-off at levels that will permit further capital management activities, which we ~~believe also increase~~continually review as part of our strategy. Please refer to the ~~likelihood of fully utilizing the significant NOL carryforwards described above which would create additional common shareholder value.~~ "Liquidity and Capital Resources" section for further information on our asset and capital management activities.

Asset Management

As part of our expanded asset management activities, as noted we have evaluated and continue to consider investing in various initiatives in the insurance industry across a variety of segments which we believe will produce appropriate risk-adjusted returns while maintaining the option to consider underwriting activities in the future. We believe these expanded activities will produce a broad range of positive impacts on our financial condition, including current income, longer-term gains and in certain instances, fee income.

In recent years, we have invested approximately ~~$263.6~~$268.6 million into alternative investments which include equity securities, other investments and equity method investments in a wide variety of asset classes and we believe these activities will exceed that benchmark cost of capital with adjustments as necessary if those returns do not emerge.

Recent development and trends in financial markets, particularly the rapid rise in interest rates and heightened risk of economic recession, indicate that it may take longer than expected to achieve those returns and we expect that to factor into future capital allocation decisions. In particular, as interest rates have risen to more historically observed levels, we have focused on investing in assets that produce higher levels of current income as opposed to longer-term gains, in order to increase returns to shareholders and increase the opportunity to recognize our deferred tax assets discussed below.

Legacy Underwriting

In November 2020, we formed GLS which specializes in providing a full range of legacy services to small insurance entities, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies that enable our clients to meet their capital and risk management objectives. We acquire legacy liabilities and (re)insurance reserves from companies and provide retroactive reinsurance coverage for portfolios of (re)insurance business, primarily via loss portfolio transfer contracts (“LPT”). Additionally, we provide reinsurance contracts to other (re)insurers to mitigate some of their risk of future adverse development ~~(adverse~~(an adverse development cover, or “ADC”) on insurance risks relating to prior accident years.

We believe the formation of GLS is highly complementary to our overall longer-term strategy and will produce risk-adjusted returns in excess of our debt cost of capital. In addition, while we anticipate profitable growth from the GLS portfolio as it develops, we expect our required capital to continue to decline as insurance risk incurred by GLS will be more than offset by the run-off of insurance liabilities from our prior reinsurance strategies. GLS, along with other recent insurance industry investments, enables us to leverage our knowledge base while not re-entering active underwriting of new prospective risks and maintaining an efficient operating profile. We believe GLS not only enhances our profitability through both fee income and effective claims management services, but it will also increase our asset base through the addition of blocks of reserves or companies that can be successfully wound down.

Effective October 1, 2021, GLS completed its first loss portfolio transfer transaction which ~~includes~~included an ADC cover. GLS and its subsidiaries have completed additional transactions in 2022 and as of September 30, 2022, GLS and its subsidiaries have insurance related liabilities totaling $29.5 million which included total reserves of $16.3 million, derivative liability on retroactive reinsurance of $9.0 million, and deferred gains on retroactive reinsurance of $4.1 million. GLS continues to write additional retroactive reinsurance transactions consistent with its business plan. In addition to producing long-term returns that may exceed the target cost of capital, we expect the business produced through GLS should further enhance our ability to pursue the asset and capital management pillars of our business strategy. The nature of GLS business plan is that it may take a sustained period of growth in insurance liabilities to produce the targeted returns. In addition, early stage initiatives such as GLS may take a period of time to reach profitability. Finally, the nature of legacy transactions which GLS seeks to execute may be inconsistent as to their timing and not predictable as regards how many transactions may be completed in any fiscal period. As of June 30, 2023, GLS and its subsidiaries hold insurance related liabilities of $27.8 million including total reserves of $21.5 million, an underwriting-related derivative liability of $4.0 million, and net deferred gains on retroactive reinsurance of $2.3 million.

Capital Management

Our capital management strategy is significantly informed by the required capital needed to operate our business in a prudent manner and our ongoing analysis of our loss development trends. ~~Recent trends continue to increase~~Trends in recent years have increased our confidence in our recorded ultimate losses for our insurance liabilities in run-off, however a prudent assessment dictates that the run-off portfolio still requires additional maturity to fully ~~emerge.~~emerge, as evidenced by the adverse loss development we have experienced in 2022 and 2023. While there is no ~~guarantee~~assurance that ~~these recent~~prior positive long-term loss development trends will ~~persist,~~resume, as our ~~confidence has increased it has enabled us to pursue continued capital management initiatives, primarily~~insurance liabilities further mature we remain confident that we can continue the prudent and disciplined repurchase of both our ~~preference~~common shares and senior notes which are authorized for repurchase, which we believe ~~provide~~provided the greatest risk-adjusted returns to our common shareholders. Our current assessment is that losses have continued to stabilize sufficiently to continue the capital management initiatives we initiated in 2020, although we have approached these strategies in a deliberate fashion.

On March 3, 2021 and May 6, 2021, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines, of up to $100.0 million and ~~$50.0 million, respectively,~~ ~~of the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated. The authorizations are collectively referred to as the~~ ~~"2021 Preference Share Repurchase Program". The Company has a remaining authorization of $3.9 million for preference share repurchases at September 30, 2022.~~

On November 9, 2022, subject to the terms and conditions of the preference shares including the affirmative vote of two-thirds of our preference shareholders, we announced our plans to exchange all outstanding preference shares for our common shares. As part of this transaction, we estimate that our book value per common share will increase by approximately $0.82 in the fourth quarter of 2022 subject to the determination of the final value of the preference shares and the exchange price of the common shares. Please refer to "Notes to ~~Condensed~~ Consolidated Financial Statements - Note ~~14. Subsequent Events"~~ 6 — Shareholders' Equity"under Item 8 "Financial Statements and Supplementary Data" ~~in Part I Item 1.~~ ~~"Financial Information"~~of the Annual Report on Form 10-K for the year ended December 31, 2022 for further ~~information.~~information on the common shares issued as part of the exchange for preference shares held by Maiden Reinsurance and other preference shareholders in 2022 ("Exchange").

Completion of the Exchange represented a significant milestone in our capital management plan and we continue to evaluate other capital management options that may be available to us, including repurchase of the Company's common shares and senior notes from time to time at market prices or as may be privately negotiated as approved by our Board in its respective authorizations. The Company expects to deploy its capital management strategy on a long-term and disciplined basis, balanced along with its other strategic initiatives.

Please refer to ""Notes to Condensed Consolidated Financial Statements -(unaudited) Note 6. Shareholders' ~~Equity"~~ ~~under Item 8~~ Equity and Note 7. Long-Term Debt"~~Financial Statements and Supplementary Data"~~ included under ~~in Part I~~ Item 1. ~~"Financial Information"~~"Financial Statements" of this Quarterly Report on Form 10-Q for further information on the recent repurchases ~~and further detail on our preference shares.~~

~~Our ability to execute our asset and capital management initiatives is dependent on maintaining adequate levels~~made by Maiden Reinsurance during the second quarter of ~~unrestricted liquidity and cash flows. Further,~~2023. However, there can be no assurance that we will continue to pursue such capital management initiatives, or that they will provide appropriate risk-adjusted returns.

Maiden Holdings North America ("Maiden NA")

We believe Maiden NA’s investments, including its ownership of Maiden Reinsurance and its active asset management strategy, will create opportunities to utilize NOL carryforwards of$295.9 million at June 30, 2023. The NOL carryforwards combined with additional net deferred tax assets ("DTA") primarily related to our insurance liabilities result in net U.S. DTA (before valuation allowance) of $119.3 million or $1.17 per common share at June 30, 2023.

Net U.S. DTA of $119.3 million is not presently recognized on the Company's condensed consolidated balance sheets as a full valuation allowance is carried against it. At this time, while positive evidence in support of reducing the valuation allowance is growing, the Company believes it is necessary to maintain a full valuation allowance against the net U.S. DTA as more evidence is needed regarding the utilization of these losses. As circumstances further develop, we will ~~run-off at levels that will permit~~continuously evaluate the amount of the valuation allowance held against the net U.S. DTA.

For further ~~capital management activities, which we continually review as part of our strategy. Please refer to the~~ details please see "Note 13 — Income Taxes"~~Liquidity~~ included under Item 8 "Financial Statements and ~~Capital Resources"~~Supplementary Data ~~section~~" of the Annual Report on Form 10–K for ~~further information on our asset and capital management activities,~~the year ended December 31, 2022. Taken together, we believe these measures should generate additional income for Maiden NA in ~~particular our various preference share repurchase measures.~~a tax-efficient manner, while sharing in the improvement in profitability anticipated in Maiden Reinsurance as a result of the measures enacted as described above.

Three and ~~Nine~~Six Months Ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 Financial Highlights


For the Three Months Ended September 30,		2022			2021			Change
For the Three Months Ended June 30,										For the Three Months Ended June 30,	2023			2022			Change
Summary Consolidated Statement of Income Data (unaudited):	Summary Consolidated Statement of Income Data (unaudited):	($ in thousands except per share data)								Summary Consolidated Statement of Income Data (unaudited):	($ in thousands except per share data)

Net loss		$	(8,160)		$	(3,140)		$	(5,020)
Net (loss) income										Net (loss) income	$	(2,933)		$	1,062		$	(3,995)
Gain from repurchase of preference shares	Gain from repurchase of preference shares	—			6,004			(6,004)		Gain from repurchase of preference shares	—			24,690			(24,690)
Net (loss) income attributable to Maiden common shareholders	Net (loss) income attributable to Maiden common shareholders	(8,160)			2,864			(11,024)		Net (loss) income attributable to Maiden common shareholders	(2,933)			25,752			(28,685)
Basic and diluted earnings per common share:
Basic and diluted (loss) earnings per common share:										Basic and diluted (loss) earnings per common share:
Net (loss) income attributable to common shareholders(2)	Net (loss) income attributable to common shareholders(2)	(0.09)			0.03			(0.12)		Net (loss) income attributable to common shareholders(2)	(0.03)			0.29			(0.32)
Gain from repurchase of preference securities per common share	Gain from repurchase of preference securities per common share	—			0.07			(0.07)		Gain from repurchase of preference securities per common share	—			0.28			(0.28)
Gross premiums written	Gross premiums written	5,380			6,821			(1,441)		Gross premiums written	6,875			3,339			3,536
Net premiums earned	Net premiums earned	12,251			15,030			(2,779)		Net premiums earned	11,039			10,443			596
Underwriting loss(3)	Underwriting loss(3)	(12,627)			(3,649)			(8,978)		Underwriting loss(3)	(9,262)			(5,130)			(4,132)
Net investment results(13)	Net investment results(13)	4,692			5,730			(1,038)		Net investment results(13)	16,466			6,737			9,729

Non-GAAP measures:	Non-GAAP measures:									Non-GAAP measures:
Non-GAAP operating loss(1)		(21,060)			(3,114)			(17,946)
Non-GAAP basic and diluted operating loss per common share(1)		(0.24)			(0.04)			(0.20)
Non-GAAP operating earnings(1)										Non-GAAP operating earnings(1)	4,467			16,633			(12,166)
Non-GAAP basic and diluted operating earnings per common share(1)										Non-GAAP basic and diluted operating earnings per common share(1)	0.04			0.19			(0.15)
Annualized non-GAAP operating return on average common shareholders' equity(1)	Annualized non-GAAP operating return on average common shareholders' equity(1)	(32.6)		%	(4.5)		%	(28.1)		Annualized non-GAAP operating return on average common shareholders' equity(1)	5.6		%	25.2		%	(19.6)

For the Nine Months Ended September 30,		2022			2021			Change
For the Six Months Ended June 30,										For the Six Months Ended June 30,	2023			2022			Change
Summary Consolidated Statement of Income Data (unaudited):	Summary Consolidated Statement of Income Data (unaudited):	($ in thousands except per share data)								Summary Consolidated Statement of Income Data (unaudited):	($ in thousands except per share data)

Net (loss) income		$	(9,047)		$	14,258		$	(23,305)
Net loss										Net loss	$	(14,261)		$	(887)		$	(13,374)
Gain from repurchase of preference shares	Gain from repurchase of preference shares	28,233			87,168			(58,935)		Gain from repurchase of preference shares	—			28,233			(28,233)
Net income attributable to Maiden common shareholders		19,186			101,426			(82,240)
Basic and diluted earnings per common share:
Net income attributable to Maiden common shareholders(2)		0.22			1.17			(0.95)
Net (loss) income attributable to Maiden common shareholders										Net (loss) income attributable to Maiden common shareholders	(14,261)			27,346			(41,607)
Basic and diluted (loss) earnings per common share:										Basic and diluted (loss) earnings per common share:
Net (loss) income attributable to Maiden common shareholders(2)										Net (loss) income attributable to Maiden common shareholders(2)	(0.14)			0.31			(0.45)
Gain from repurchase of preference shares per common share	Gain from repurchase of preference shares per common share	0.32			1.01			(0.69)		Gain from repurchase of preference shares per common share	—			0.33			(0.33)
Gross premiums written	Gross premiums written	(1,451)			7,865			(9,316)		Gross premiums written	7,711			(6,831)			14,542
Net premiums earned	Net premiums earned	23,816			40,106			(16,290)		Net premiums earned	20,041			11,565			8,476
Underwriting (loss) income(3)		(19,412)			6,377			(25,789)
Underwriting loss(3)										Underwriting loss(3)	(17,515)			(6,785)			(10,730)
Net investment results(13)	Net investment results(13)	21,576			37,521			(15,945)		Net investment results(13)	26,965			16,884			10,081

Non-GAAP measures:	Non-GAAP measures:									Non-GAAP measures:
Non-GAAP operating (loss) earnings(1)	Non-GAAP operating (loss) earnings(1)	(11,362)			58,135			(69,497)		Non-GAAP operating (loss) earnings(1)	(3,426)			9,698			(13,124)
Non-GAAP basic and diluted operating (loss) earnings per common share(1)		(0.13)			0.67			(0.80)
Non-GAAP basic and diluted (loss) operating earnings per common share(1)										Non-GAAP basic and diluted (loss) operating earnings per common share(1)	(0.03)			0.11			(0.14)

Annualized non-GAAP operating return on average common shareholders' equity(1)	Annualized non-GAAP operating return on average common shareholders' equity(1)	(5.9)		%	32.3		%	(38.2)		Annualized non-GAAP operating return on average common shareholders' equity(1)	(2.1)		%	7.2		%	(9.3)

3941


		September 30, 2022			December 31, 2021			Change			June 30, 2023			December 31, 2022			Change
Consolidated Financial Condition	Consolidated Financial Condition	($ in thousands except per share data)								Consolidated Financial Condition	($ in thousands except per share data)
Total investments and cash and cash equivalents(4)	Total investments and cash and cash equivalents(4)	$	708,040		$	888,699		$	(180,659)	Total investments and cash and cash equivalents(4)	$	583,402		$	633,684		$	(50,282)
Total assets	Total assets	1,989,614			2,322,610			(332,996)		Total assets	1,664,913			1,846,866			(181,953)
Reserve for loss and LAE	Reserve for loss and LAE	1,146,084			1,489,373			(343,289)		Reserve for loss and LAE	1,001,261			1,131,408			(130,147)
Senior notes - principal amount	Senior notes - principal amount	262,500			262,500			—		Senior notes - principal amount	262,361			262,500			(139)
Common shareholders' equity		207,721			225,047			(17,326)

Shareholders' equity	Shareholders' equity	327,393			384,257			(56,864)		Shareholders' equity	269,290			284,579			(15,289)
Total capital resources(5)	Total capital resources(5)	589,893			646,757			(56,864)		Total capital resources(5)	531,651			547,079			(15,428)
Ratio of debt to total capital resources(10)	Ratio of debt to total capital resources(10)	44.5		%	40.6		%	3.9		Ratio of debt to total capital resources(10)	49.3		%	48.0		%	1.3
Book Value calculations:	Book Value calculations:									Book Value calculations:
Book value per common share(6)	Book value per common share(6)	$	2.38		$	2.60		$	(0.22)	Book value per common share(6)	$	2.65		$	2.80		$	(0.15)
Accumulated dividends per common share(12)	Accumulated dividends per common share(12)	4.27			4.27			—		Accumulated dividends per common share(12)	4.27			4.27			—
Book value per common share plus accumulated dividends	Book value per common share plus accumulated dividends	$	6.65		$	6.87		$	(0.22)	Book value per common share plus accumulated dividends	$	6.92		$	7.07		$	(0.15)
Change in book value per common share plus accumulated dividends	Change in book value per common share plus accumulated dividends	(3.2)		%						Change in book value per common share plus accumulated dividends	(2.1)		%
Diluted book value per common share(7)	Diluted book value per common share(7)	$	2.37		$	2.59		$	(0.22)	Diluted book value per common share(7)	$	2.62		$	2.79		$	(0.17)

Non-GAAP measures:	Non-GAAP measures:									Non-GAAP measures:
Adjusted book value per common share(8)	Adjusted book value per common share(8)	$	2.79		$	3.18		$	(0.39)	Adjusted book value per common share(8)	$	3.22		$	3.25		$	(0.03)
Adjusted shareholders' equity(9)	Adjusted shareholders' equity(9)	362,531			434,200			(71,669)		Adjusted shareholders' equity(9)	326,998			329,987			(2,989)
Adjusted total capital resources(9)	Adjusted total capital resources(9)	625,031			696,700			(71,669)		Adjusted total capital resources(9)	589,359			592,487			(3,128)
Ratio of debt to adjusted total capital resources(11)	Ratio of debt to adjusted total capital resources(11)	42.0		%	37.7		%	4.3		Ratio of debt to adjusted total capital resources(11)	44.5		%	44.3		%	0.2

(1)Non-GAAP operating earnings (loss), non-GAAP operating earnings (loss) per common share, and annualized non-GAAP operating return on average common shareholders' equity are non-GAAP financial measures. See "Key Financial Measures" for additional information.

(2)Please refer to "Notes to Condensed Consolidated Financial Statements (unaudited) Note 12. Earnings per Common Share" for the calculation of basic and diluted income ~~or loss~~(loss) per common share.

(3)Underwriting income or loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities. See "Key Financial Measures" for additional information.

(4)Total investments and cash and cash equivalents includes both restricted and unrestricted.

(5)Total capital resources is the sum of the Company's principal amount of debt and shareholders' equity. See "Key Financial Measures" for additional information.

(6)Book value per common share is calculated using ~~common~~ shareholders’ equity ~~(shareholders' equity excluding the aggregate liquidation value of our preference shares)~~ divided by the number of common shares outstanding. See "Key Financial Measures" for additional information.

(7)Diluted book value per common share is calculated by dividing ~~common~~ shareholders' equity, adjusted for assumed proceeds from the exercise of dilutive options, by the number of outstanding common shares plus dilutive options and restricted shares (assuming exercise of all dilutive share based awards). See "Key Financial Measures" for additional information.

(8)Adjusted book value per common share is a non-GAAP measure that is calculated using ~~common~~ shareholders' equity, adjusted by adding ~~the following items~~ to shareholders' ~~equity: 1)~~equity the unamortized deferred gain on retroactive reinsurance arising from the LPT/ADC Agreement; and 2) an adjustment which reflects the equity method accounting related to the fair value of certain hedged liabilities within an equity method investment in a limited partnership investment held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities cannot currently be recognized at fair value,Agreement, divided by the number of common shares outstanding. See "Key Financial Measures" for additional information.

(9)Adjusted shareholders' equity and adjusted total capital resources are calculated by adding ~~the following items~~ to shareholders' ~~equity: 1)~~equity the unamortized deferred gain on retroactive reinsurance arising from the LPT/ADC Agreement; and 2) an adjustment which reflects the equity method accounting related to the fair value of certain hedged liabilities within an equity method investment held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities cannot currently be recognized at fair value. The deferred gain arises from the LPT/ADC Agreement with Cavello relating to losses from the AmTrust Quota Share agreement. Under U.S. GAAP, the deferred gain shall be amortized over the estimated remaining settlement period. See "Key Financial Measures" for additional information.

(10)Ratio of debt to total capital resources is calculated using the total principal amount of debt divided by the sum of total capital resources.

(11)Ratio of debt to adjusted total capital resources is calculated using the total principal amount of debt divided by the sum of adjusted total capital resources.

(12)Accumulated dividends per common share includes the cumulative sum of dividends declared and paid in the past on the Company's issued common shares since inception.

(13)Net investment results include the sum of net investment income, net realized and unrealized gains (losses), and interest in income (loss) of equity method investments.

4042

Key Financial Measures

In addition to our key financial measures presented in accordance with GAAP in the Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Income and Comprehensive Income, management uses certain non-GAAP financial measures to evaluate the Company's financial performance and the overall growth in value generated for the Company’s common shareholders. Management believes that these measures, which may be defined differently by other companies, explain the Company’s results to investors in a manner that allows for a more complete understanding of the underlying trends in the Company’s business. The non-GAAP measures should not be viewed as a substitute for those determined in accordance with U.S. GAAP. The calculation of these key financial measures including the reconciliation of non-GAAP measures to the nearest GAAP measure and relevant discussions are found within Item 2 - "Management's Discussion and Analysis of Financial Condition and Results of Operations". These non-GAAP financial measures are:

Non-GAAP operating earnings (loss) and non-GAAP diluted operating earnings (loss) per common share: Management believes that the use of non-GAAP operating earnings and non-GAAP diluted operating earnings per common share enables investors and other users of the Company’s financial information to analyze its performance in a manner similar to how management analyzes performance. Management also believes that these measures generally follow industry practice therefore allowing the users of financial information to compare the Company’s performance with its industry peer group, and that the equity analysts and certain rating agencies which follow the Company, and the insurance industry as a whole, generally exclude these items from their analyses for the same reasons. Non-GAAP operating earnings should not be viewed as a substitute for U.S. GAAP net income.

Non-GAAP operating earnings (loss) is an internal performance measure used by management as these measures focus on the underlying fundamentals of the Company's operations by excluding, on a recurring basis: (1) net realized investment gains ~~or losses on investment;~~(losses); (2) foreign exchange and other gains ~~or losses;~~(losses); (3) the portion of favorable or unfavorable prior year reserve development for which we have ceded the risk under the LPT/ADC ~~Agreement;~~Agreement and related changes in amortization of the deferred gain liability; and (4) interest in income (loss) of equity method investments. We ~~have~~ excluded net realized investment gains ~~on investment,~~(losses), interest in income (loss) of equity method investments and foreign exchange and other gains (losses) as we believe these are influenced by market opportunities and other factors. We do not believe that ceded risks under the LPT/ADC Agreement are representative of our ongoing and future business which are different to retroactive reinsurance risks written by GLS that are representative of our ongoing and future business. We believe all of these amounts are substantially independent of our business and any potential future underwriting process, ~~and~~ therefore including them would distort the analysis of underlying trends in our operations.

Underwriting income (loss) is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities. For purposes of these non-GAAP operating measures, the fee-generating business which is included in our Diversified Reinsurance segment, is considered part of the underwriting operations of the Company. Management believes that this measure is important in evaluating the underwriting performance of the Company and its segments. This measure is also a useful tool to measure the profitability of the Company separately from the investment results and is also a widely used performance indicator in the insurance industry. A reconciliation of the Company's underwriting results can be found in the Condensed Consolidated Financial Statements in the "Notes to Condensed Consolidated Financial Statements (unaudited) Note 3. Segment Information" included under Item 1. "Financial Statements" of this Quarterly Report on Form 10-Q.

The Company no longer presents certain non-GAAP measures such as combined ratio and its related components in this Quarterly Report on Form 10-Q for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, as it believes that as the run-off of our reinsurance portfolios progresses, such ratios are increasingly not meaningful and of less value to readers as they evaluate the financial results of the Company, particularly compared to historical data.

While an important metric of success, underwriting income (loss) does not reflect all components of profitability, as it does not recognize the impact of investment income earned on premiums between the time premiums are received and the time loss payments are ultimately paid to clients. Because we do not manage our cash and investments by segment, investment income and interest expense are not allocated to the reportable segments. Certain general and administrative expenses are generally allocated to segments based on actual costs incurred.

Non-GAAP Operating Return on Average Adjusted ~~Common~~Shareholders' Equity ("Non-GAAP Operating ROACE"): Management uses non-GAAP operating return on average adjusted ~~common~~ shareholders' equity as a measure of profitability that focuses on the return to common shareholders. It is calculated using non-GAAP operating earnings (loss) available to common shareholders (as defined above) divided by average adjusted ~~common~~ shareholders' equity.

Book Value per Common Share and Diluted Book Value per Common Share: Book value per common share and diluted book value per common share are non-GAAP measures. Management uses growth in both of these metrics as a prime measure of the value we are generating for our common shareholders, because management believes that growth in each metric ultimately results in growth in the Company’s common share price. These metrics are impacted by the Company’s net income and external factors, such as interest rates, which can drive changes in unrealized gains or losses on our fixed income investment portfolio, as well as common ~~or preference~~ share repurchases.

Ratio of Debt to Total Capital Resources: Management uses this non-GAAP measure to monitor the financial leverage of the Company. This measure is calculated using the total principal amount of debt divided by the sum of total capital resources.

Non-GAAP underwriting income (loss) and Non-GAAP Net Loss and LAE: Management has further adjusted underwriting income (loss), as defined above, as well as reported net loss and LAE by excluding the portion of favorable or unfavorable prior year reserve development for which we have ceded the risk under retroactive reinsurance agreements such as the LPT/ADC Agreement. ~~These~~The losses are estimated to be fully recoverable from Cavello and management believes adjusting for this development shows the ultimate economic benefit of the LPT/ADC Agreement on our underwriting results. ~~We believe~~

4143

We believe reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations.

Adjusted Total Shareholders' Equity, Adjusted Total Capital Resources, Ratio of Debt to Adjusted Total Capital Resources and Adjusted Book Value per Common Share: Management has adjusted GAAP shareholders' equity by adding ~~the following items~~ to shareholders' ~~equity: 1)~~equity the unamortized deferred gain on ceded retroactive reinsurance under the LPT/ADC Agreement; and 2) an adjustment which reflects the equity method accounting related to the fair value of certain hedged liabilities within an equity method investment held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities cannot currently be recognized at fair value ("LP Investment Adjustment").

Agreement. The unamortized deferred gain on ceded retroactive reinsurance under the LPT/ADC Agreement includes the aggregate impact of: 1) cumulative increases to losses incurred prior to December 31, 2018 for which we have ceded the risk under the LPT/ADC Agreement; and 2) changes in estimated ultimate losses for certain workers' compensation reserves previously commuted by the Company to AmTrust which are subject to specific terms and conditions pursuant to the LPT/ADC Agreement.

As a result, by virtue of this adjustment, management has also adjusted Total Capital Resources and computed the Ratio of Debt to Adjusted Capital Resources and Adjusted Book Value per Common Share. The deferred gain liability on retroactive reinsurance under the LPT/ADC Agreement represents loss reserves estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement. We believe reflecting the economic benefit of this non-recurring retroactive reinsurance agreement is helpful to understand future trends in our operations, which will improve the Company's shareholders' equity over the settlement or contract periods, respectively.

Alternative investments is the total of the Company's holdings of equity securities, other investments and equity method investments as reported on the Company's Condensed Consolidated Balance Sheets.

Certain Operating Measures

Refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations" section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, filed with the SEC on March ~~14, 2022,~~15, 2023, for a general discussion on "Certain Operating Measures" utilized by the Company.

Critical Accounting Policies and Estimates

The Company's critical accounting policies and estimates are discussed in "Management's Discussion and Analysis of Financial Condition and Results of Operations" section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, filed with the SEC on March ~~14, 2022.~~ 15, 2023.

The critical accounting policies and estimates should be read in conjunction with "Part I, Item 1 - Notes to Condensed Consolidated Financial Statements (unaudited) Note 2. Significant Accounting Policies" included in this Form 10-Q and "Notes to Consolidated Financial Statements Note 2. Significant Accounting Policies" included within the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, filed with the SEC on March ~~14, 2022.~~15, 2023. There have been no material changes in the application of our critical accounting estimates subsequent to that report.

4244

Results of Operations

The following table sets forth our selected unaudited Condensed Consolidated Statement of Income data for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022		2021		2022		2021		($ in thousands)	2023		2022		2023		2022
Gross premiums written	Gross premiums written	$	5,380	$	6,821	$	(1,451)	$	7,865	Gross premiums written	$	6,875	$	3,339	$	7,711	$	(6,831)
Net premiums written	Net premiums written	$	5,222	$	6,953	$	(1,915)	$	7,518	Net premiums written	$	6,875	$	3,186	$	7,635	$	(7,137)
Net premiums earned	Net premiums earned	$	12,251	$	15,030	$	23,816	$	40,106	Net premiums earned	$	11,039	$	10,443	$	20,041	$	11,565
Other insurance revenue		368		138		888		946
Other insurance revenue, net										Other insurance revenue, net	78		469		19		520
Net loss and LAE	Net loss and LAE	(17,426)		(10,514)		(22,017)		(7,546)		Net loss and LAE	(11,532)		(6,874)		(21,347)		(4,591)
Commission and other acquisition expenses	Commission and other acquisition expenses	(5,398)		(6,313)		(12,811)		(19,154)		Commission and other acquisition expenses	(4,945)		(4,885)		(9,180)		(7,413)
General and administrative expenses(1)	General and administrative expenses(1)	(2,422)		(1,990)		(9,288)		(7,975)		General and administrative expenses(1)	(3,902)		(4,283)		(7,048)		(6,866)
Underwriting (loss) income (2)		(12,627)		(3,649)		(19,412)		6,377
Underwriting loss (2)										Underwriting loss (2)	(9,262)		(5,130)		(17,515)		(6,785)
Other general and administrative expenses(1)	Other general and administrative expenses(1)	(4,069)		(4,660)		(15,383)		(21,578)		Other general and administrative expenses(1)	(2,937)		(3,011)		(9,899)		(11,314)
Net investment income	Net investment income	6,637		7,477		20,871		24,596		Net investment income	10,518		7,667		20,063		14,234
Net realized and unrealized investment (losses) gains		(1,572)		(937)		2,848		8,013
Net realized and unrealized investment gains										Net realized and unrealized investment gains	1,145		2,111		2,150		4,420

Foreign exchange and other gains		8,586		4,116		19,121		6,070
Foreign exchange and other (losses) gains										Foreign exchange and other (losses) gains	(2,621)		6,586		(5,437)		10,535
Interest and amortization expenses	Interest and amortization expenses	(4,833)		(4,832)		(14,498)		(14,495)		Interest and amortization expenses	(4,773)		(4,833)		(8,597)		(9,665)
Income tax benefit (expense)	Income tax benefit (expense)	91		155		(451)		363		Income tax benefit (expense)	194		713		222		(542)
Interest in (loss) income of equity method investments		(373)		(810)		(2,143)		4,912
Interest in income (loss) of equity method investments										Interest in income (loss) of equity method investments	4,803		(3,041)		4,752		(1,770)

Net (loss) income	Net (loss) income	(8,160)		(3,140)		(9,047)		14,258		Net (loss) income	(2,933)		1,062		(14,261)		(887)
Gain from repurchase of preference shares	Gain from repurchase of preference shares	—		6,004		28,233		87,168		Gain from repurchase of preference shares	—		24,690		—		28,233
Net (loss) income available to Maiden common shareholders		$	(8,160)	$	2,864	$	19,186	$	101,426
Net (loss) income (attributable) available to Maiden common shareholders										Net (loss) income (attributable) available to Maiden common shareholders	$	(2,933)	$	25,752	$	(14,261)	$	27,346

(1)Underwriting related general and administrative expenses is a non-GAAP measure. Please refer to "General and Administrative Expenses" below for additional information related to these corporate expenses and the reconciliation to those presented in our unaudited Condensed Consolidated Statements of Income.

(2)Underwriting ~~income (loss)~~loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities.

(3)The Company no longer presents certain non-GAAP measures such as combined ratio and its related components in its results of operation, as it believes that as the run-off of its reinsurance portfolios progresses, such ratios are increasingly not meaningful and of less value to readers as they evaluate our financial results.

Net (Loss) Income

Net loss attributable to Maiden common shareholders for the three months ended June 30, 2023 was $2.9 million compared to net income available to Maiden common shareholders of $25.8 million for the same respective period in 2022. Net income available to Maiden common shareholders for the three months ended ~~September~~June 30, 2022 ~~was $8.2~~included $24.7 million ~~compared to net income~~ of ~~$2.9 million for~~gains from the ~~same period in 2021. The net income for the three months ended September 30, 2021 included a gain from~~ repurchase of our preference ~~shares of $6.0 million. We did not repurchase any preference shares in the three months ended September 30, 2022; excluding~~shares.

Excluding the gain on the repurchase of our preference shares ~~for the same period~~ in ~~2021, net loss~~2022, there was ~~$3.1 million for the third quarter of 2021 compared to~~ a net loss of ~~$8.2~~$2.9 million for the ~~third~~second quarter of ~~2022. The decrease in results during~~2023 compared to net income of $1.1 million for the ~~third~~second quarter of 2022, ~~compared~~primarily due to the ~~third quarter of 2021 was primarily due to:~~following:

•a higher underwriting loss of ~~$12.6~~$9.3 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to underwriting loss of ~~$3.6~~$5.1 million in the same period in ~~2021~~2022 largely due to:

◦adverse prior year loss development of ~~$0.8~~$4.5 million in the ~~third~~second quarter of ~~2022~~2023 compared to ~~favorable~~adverse prior year loss development of ~~$5.4~~$1.0 million during the same period in ~~2021;~~2022; and

◦on a current accident year basis, underwriting loss of ~~$11.8~~$4.8 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to an underwriting loss of ~~$9.0~~$4.2 million for the same period in ~~2021.~~2022.

•~~total income from investment activities was $4.7~~foreign exchange and other losses were $2.6 million for the three months ended ~~September~~June 30, ~~2022~~2023, compared to ~~$5.7~~foreign exchange and other gains of $6.6 million for the same period in ~~2021~~2022.

The decrease in our quarterly results were partly offset by the following favorable factors:

•increased total income from investment activities to $16.5 million for the three months ended June 30, 2023 compared to $6.7 million for the same period in 2022 which was comprised of:

◦net investment income ~~decreased~~increased to ~~$6.6~~$10.5 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to ~~$7.5~~$7.7 million for the same period in ~~2021;~~2022;

◦realized and unrealized investment ~~losses~~gains were ~~$1.6~~$1.1 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to ~~losses~~gains of ~~$0.9~~$2.1 million for the same period in ~~2021;~~2022; and

◦interest in ~~loss~~income of equity method investments was ~~$0.4~~$4.8 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to a loss of ~~$0.8~~$3.0 million for the same period in ~~2021.~~2022.

~~The decrease in our results as discussed above was partially offset by the following:~~

•corporate general and administrative expenses decreased to ~~$4.1~~$2.9 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to ~~$4.7~~$3.0 million for the same period in ~~2021; and~~

•~~foreign exchange and other gains increased to $8.6 million for the three months ended September 30, 2022, compared to foreign exchange and other gains of $4.1 million for the same period in 2021.~~2022.

Net ~~income available~~loss attributable to Maiden common shareholders for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$19.2~~$14.3 million compared to net income available to Maiden common shareholders of ~~$101.4~~$27.3 million for the same period in ~~2021.~~2022. The net ~~decrease in results~~income for the ~~nine~~six months ended ~~September~~June 30, 2022 ~~compared to the same period in 2021 was primarily due to lower~~included $28.2 million of gains ~~in 2022~~ from the repurchase of our preference ~~shares which were $28.2 million for the nine months ended September 30, 2022 compared to $87.2 million for the same period in 2021.~~shares.

Excluding the gain on the repurchase of our ~~Preference Shares,~~preference shares in 2022, our net loss for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$9.0~~$14.3 million compared to a net ~~income~~loss of ~~$14.3~~$0.9 million for the same period in ~~2021.~~2022. The ~~most significant items affecting our financial performance during~~net decrease in results for the ~~nine~~six months ended ~~September~~June 30, 2023 compared to 2022 ~~on a comparative basis to 2021 included:~~was primarily due to:

•a higher underwriting loss of ~~$19.4~~$17.5 million infor the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to an underwriting ~~income~~loss of ~~$6.4~~$6.8 million infor the same period in ~~2021~~2022 largely due to:

•~~favorable~~adverse prior year loss development of ~~$5.5~~$8.2 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to favorable prior year development of ~~$23.7~~$6.3 million ~~during~~for the same period in ~~2021~~2022 primarily related to the quota share reinsurance agreements in the AmTrust Reinsurance segment;

•on a current accident year basis, an underwriting loss of ~~$24.9~~$9.4 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to an underwriting loss of ~~$17.3~~$13.1 million for the same period in ~~2021~~2022 primarily due to results within the AmTrust Reinsurance segment as discussed ~~below and further within the segment analysis; and~~below:

•significantly higher than expected negative premium adjustments in the AmTrust Reinsurance segment related to adjustments for estimated surcharges on Workers' Compensation policies and inuring AmTrust reinsurance for certain programs in Specialty Risk and Extended Warranty cessions (collectively the "AmTrust Cession Adjustments" which are discussed in greater detail in the AmTrust Reinsurance segment), net of commission and loss adjustments, contributed an underwriting loss of $5.1 million to our reported results for the ~~nine~~six months ended ~~September~~June 30, 2022.

•~~total income from investment activities were $21.6~~foreign exchange and other losses of $5.4 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to ~~$37.5~~foreign exchange and other gains of $10.5 million for the same period in ~~2021~~2022.

The decrease in our year-to-date results were partly offset by the following favorable factors:

•increased total income from investment activities of $27.0 million for the six months ended June 30, 2023 compared to $16.9 million for the same period in 2022 which was comprised of:

•net investment income ~~decreased~~increased to ~~$20.9~~$20.1 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to ~~$24.6~~$14.2 million for the same period in ~~2021, primarily due to the decline in average fixed income assets of 29.0%;~~2022;

•realized and unrealized investment gains ~~decreased to $2.8~~were $2.2 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to realized and unrealized gains of ~~$8.0~~$4.4 million for the same period in ~~2021;~~2022; and

•~~interest in loss of equity method investments of $2.1 million for the nine months ended September 30, 2022 compared to an~~ interest in income of equity method investments was $4.8 million for the six months ended June 30, 2023 compared to a loss of ~~$4.9~~$1.8 million for the same period in ~~2021.~~

~~The decrease in our results as discussed above was partially offset by the following:~~

2022.

•corporate general and administrative expenses decreased to ~~$15.4~~$9.9 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to ~~$21.6~~$11.3 million for the same period in ~~2021; and~~2022.

•~~foreign exchange and other gains increased to $19.1 million for the nine months ended September 30, 2022 compared to foreign exchange and other gains of $6.1 million for the same period in 2021.~~

Net Premiums Written

The tables below compare net premiums written by our reportable segments, reconciled to the total consolidated net premiums written for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


For the Three Months Ended September 30,		2022		2021		Change in
For the Three Months Ended June 30,													For the Three Months Ended June 30,	2023			2022	Change in
($ in thousands)	($ in thousands)	Total			Total			$			($ in thousands)	Total				Total		$
Diversified Reinsurance	Diversified Reinsurance	$	6,027			$	5,816		$	211			Diversified Reinsurance	$	6,652			$	5,995	$	657
AmTrust Reinsurance	AmTrust Reinsurance	(805)				1,137			(1,942)				AmTrust Reinsurance	223				(2,809)		3,032

Total	Total	$	5,222			$	6,953		$	(1,731)			Total	$	6,875			$	3,186	$	3,689

For the Nine Months Ended September 30,		2022		2021		Change in
For the Six Months Ended June 30,													For the Six Months Ended June 30,	2023			2022	Change in
($ in thousands)	($ in thousands)	Total			Total			$			($ in thousands)	Total				Total		$
Diversified Reinsurance	Diversified Reinsurance	$	16,605			$	10,600		$	6,005			Diversified Reinsurance	$	13,425			$	10,578	$	2,847
AmTrust Reinsurance	AmTrust Reinsurance	(18,520)				(3,082)			(15,438)				AmTrust Reinsurance	(5,790)				(17,715)		11,925

Total	Total	$	(1,915)			$	7,518		$	(9,433)			Total	$	7,635			$	(7,137)	$	14,772

Net premiums written for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022 decreased~~2023 increased to ~~$5.2~~$6.9 million and ~~$(1.9)~~$7.6 million, respectively, compared to net premiums written of ~~$7.0~~$3.2 million and ~~$7.5~~$(7.1) million for the same respective periods in ~~2021:~~2022:

•Premiums written in the Diversified Reinsurance segment increased by ~~$0.2~~$0.7 million and ~~$6.0~~$2.8 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021. The growth for the third quarter of~~ 2022 ~~was largely~~ due to growth in direct premiums for Credit Life programs written by Maiden LF and Maiden GF which increased compared to the third quarter of 2021. The growth for the nine months ended September 30, 2022 was due to the prior year return of unearned premiums after the non-renewal of the German Auto Programs reinsurance contract in our IIS business on January 1, 2021, and direct premiums written by Maiden LF and Maiden GF which increased compared to 2021.GF.

•~~Negative~~Premiums written ~~premiums~~ in the AmTrust Reinsurance segment ~~are primarily related~~increased by $3.0 million and $11.9 million for the three and six months ended June 30, 2023 compared to ~~$15.8 million of~~the same respective periods in 2022 largely due to significant negative written premiums for the AmTrust Cession Adjustments ~~for~~during the ~~nine~~three and six months ended ~~September~~June 30, 2022.

Please refer to the analysis below of our Diversified Reinsurance and AmTrust Reinsurance segments for further details.

Net Premiums Earned

Net premiums earned ~~decreased~~increased by ~~$2.8~~$0.6 million ~~or 18.5%~~ and ~~$16.3~~$8.5 million ~~or 40.6%~~ for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021.~~2022.

The tables below ~~compare~~compares net premiums earned by our reportable segments, reconciled to the total consolidated net premiums earned, for the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022:


For the Three Months Ended June 30,	2023		2022		Change in
($ in thousands)	Total		Total			$
Diversified Reinsurance	$	7,204	$	7,125		$	79
AmTrust Quota Share Reinsurance	3,835		3,318			517


Total	$	11,039	$	10,443		$	596

For the Six Months Ended June 30,	2023		2022		Change in
($ in thousands)	Total		Total			$
Diversified Reinsurance	$	14,675	$	13,080		$	1,595
AmTrust Quota Share Reinsurance	5,366		(1,515)			6,881


Total	$	20,041	$	11,565		$	8,476

Net premiums earned in the Diversified Reinsurance segment for the three and six months ended June 30, 2023 increased by $0.1 million or 1.1% and $1.6 million or 12.2% compared to the same respective periods in 2022 mainly due to growth in Credit Life programs written by Maiden LF and ~~2021:~~

For the Three Months Ended September 30, 2022 2021 Change in
($ in thousands) Total Total $ %
Diversified Reinsurance $ 6,932 $ 7,521 $ (589) (7.8) %
AmTrust Quota Share Reinsurance 5,319 7,509 (2,190) (29.2) %
Total $ 12,251 $ 15,030 $ (2,779) (18.5) %
For the Nine Months Ended September 30, 2022 2021 Change in
($ in thousands) Total Total $ %
Diversified Reinsurance $ 20,012 $ 20,723 $ (711) (3.4) %
AmTrust Quota Share Reinsurance 3,804 19,383 (15,579) (80.4) %
Total $ 23,816 $ 40,106 $ (16,290) (40.6) %
Maiden GF. Please refer to the analysis of our Diversified Reinsurance segment for further discussion.

Net premiums earned in the AmTrust Reinsurance segment for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022 decreased~~2023 increased by ~~$2.2~~$0.5 million and ~~$15.6~~$6.9 million compared to the same respective periods in ~~2021~~2022 primarily due to significant negative earned premium adjustments made in the ~~AmTrust Cession Adjustment~~first quarter of s.2022. Please refer to the analysis of our AmTrust Reinsurance segment for further discussion.

Net premiums earned in the Diversified Reinsurance segment for the three and nine months ended September 30, 2022 decreased by $0.6 million or 7.8% and $0.7 million or 3.4% compared to the same periods in 2021, respectively. Please refer to the analysis of our Diversified Reinsurance segment for further discussion.

Other Insurance Revenue

All of our Other Insurance Revenue is produced by our Diversified Reinsurance segment. Please refer to the analysis below of our Diversified Reinsurance segment for further discussion.

Net Investment Income

~~Total net~~Net investment income ~~decreased~~increased by ~~$0.8~~$2.9 million or ~~11.2%~~37.2% and ~~decreased by $3.7~~$5.8 million or ~~15.1%~~41.0% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021. The decline~~2022. Annualized average book yields increased to 4.2% and 4.0% for the three and six months ended June 30, 2023, respectively, compared to 2.0% and 1.9% for the same respective periods in 2022 due to the following factors:

• 33.9% of our fixed income investments as of June 30, 2023 are floating rate investments which enabled us to take advantage of a higher interest rate environment by reinvesting at higher yields more quickly;

• higher crediting interest rate on our funds withheld balance with AmTrust which increased to 3.5% in 2023 from 2.1% in 2022, on an average ending balances of $319.2 million and $351.8 million during the three and six months ended June 30, 2023, respectively; and

•higher weighted average interest rate on our loan to related party of $168.0 million which increased to 7.0% and 6.7% during the three and six months ended June 30, 2023, respectively, compared to 2.8% and 2.4% for the same respective periods in 2022.

Average aggregate fixed income assets ~~of 26.0% and 29.0% for the three and nine months ended September~~at June 30, 2023 decreased by 36.8% compared to June 30, 2022 ~~respectively, was driven by~~due to the continued run-off of reinsurance liabilities previously written on prospective risks, resulting in ~~significant~~ negative operating cash flows as we run-off our existing reinsurance liabilities.

Net investment income was helped by an increase in annualized average book yields to 2.2% and 2.0% for the three and nine months ended September 30, 2022, respectively, compared to 1.9% and 1.9% for the three and nine months ended September 30, 2021, respectively. The Company's shorter duration on its fixed income portfolio as well as floating rate investments held enabled it to take advantage of the higher interest rate environment by reinvesting at higher yields more quickly.

The following table details our average aggregate fixed income assets (at cost) and annualized investment book yield for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


		For the Three Months Ended September 30,						For the Nine Months Ended September 30,							For the Three Months Ended June 30,						For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022			2021			2022			2021			($ in thousands)	2023			2022			2023			2022
Average aggregate fixed income assets, at cost (1)	Average aggregate fixed income assets, at cost (1)	$	1,264,251		$	1,708,297		$	1,327,597		$	1,870,686		Average aggregate fixed income assets, at cost (1)	$	855,506		$	1,353,007		$	894,686		$	1,402,471
Annualized investment book yield	Annualized investment book yield	2.2		%	1.9		%	2.0		%	1.9		%	Annualized investment book yield	4.2		%	2.0		%	4.0		%	1.9		%

(1)Fixed income assets include available-for-sale ("AFS") securities, cash and restricted cash, funds ~~held~~withheld receivable, and loan to related party. These amounts are an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.

Net Realized and Unrealized Investment Gains ~~(Losses)~~

Net realized and unrealized investment ~~losses~~gains of ~~$1.6~~$1.1 million and ~~gains of $2.8~~$2.2 million were recognized for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to net realized and unrealized investment ~~losses~~gains of ~~$0.9~~$2.1 million and ~~net realized and unrealized investment gains of $8.0~~$4.4 million for the same respective periods in ~~2021. Realized gains for the nine months ended September 30, 2022 and 2021 primarily reflect sales of corporate bonds for the settlement of claim payments to AmTrust.~~

~~Net~~2022. Total net realized and unrealized investment gains for the ~~nine~~three and six months ended ~~September~~June 30, 2023 and 2022 ~~included the recognition of $3.7 million in unrealized gains related to an increase~~are summarized in the ~~valuation of an~~table below by investment ~~in an insurtech start-up company. Net realized~~category:


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2023		2022		2023		2022







Net realized gains (losses):					($ in thousands)
Fixed income assets(1)	$	(786)	$	(47)	$	(786)	$	1,096
Other investments, including equity securities	10		—		186		79
Total net realized (losses) gains	(776)		(47)		(600)		1,175

Net unrealized gains:
Other investments, including equity securities	1,921		2,158		2,750		3,245
Total net unrealized gains	1,921		2,158		2,750		3,245

Total net realized and unrealized investment gains	$	1,145	$	2,111	$	2,150	$	4,420

(1) Fixed income assets includes AFS securities as well as cash, restricted cash, funds withheld receivable, and unrealized investment losses and gains for the three and nine months ended September 30, 2021 included the recognition of $3.0 million in unrealized losses and $0.9 million in unrealized gains, respectively,loan to related ~~to an investment in an insurtech start-up company that was acquired by a special purpose acquisition company.~~party.

Interest in Income (Loss) ~~Income~~ of Equity Method Investments

The Company ~~had~~recognized interest in income of equity method investments of $4.8 million and $4.8 million for the three and six months ended June 30, 2023, respectively, compared to an interest in the loss of equity method investments of ~~$0.4~~$3.0 million and ~~$2.1 million for the three and nine months ended September 30, 2022, respectively, compared to interest in loss of equity method investments of $0.8 million and an interest in income of $4.9~~$1.8 million for the same respective periods in ~~2021.~~2022. Equity method investments consist of ~~hedge fund investments of $15.4 million,~~ real estate investments of ~~$44.9~~$42.6 million and other investments of ~~$19.8~~$30.6 million as of ~~September~~June 30, ~~2022. The following table details our interest~~2023. Interest in ~~the loss or~~ income ~~from~~(loss) of equity method investments for the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022 ~~and 2021:~~is detailed by investment category in the following table:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022		2021		2022		2021		($ in thousands)	2023		2022		2023		2022

Hedge fund investments	Hedge fund investments	$	(1,437)	$	(1,838)	$	(4,981)	$	1,786	Hedge fund investments	$	(84)	$	(3,476)	$	83	$	(3,544)
Real estate investments	Real estate investments	(24)		—		(6)		—		Real estate investments	(185)		18		(403)		18
Other investments	Other investments	1,088		1,028		2,844		3,126		Other investments	5,072		417		5,072		1,756
Interest in (loss) income from equity method investments		$	(373)	$	(810)	$	(2,143)	$	4,912
Interest in income (loss) of equity method investments										Interest in income (loss) of equity method investments	$	4,803	$	(3,041)	$	4,752	$	(1,770)

Net Loss and LAE

Net loss and LAE increased by ~~$6.9~~$4.7 million ~~and $14.5 million during~~for the ~~three and nine months ended September 30, 2022, respectively,~~second quarter of 2023 compared to the same ~~respective periods~~period in ~~2021~~2022 largely due to adverse prior year loss development in both reporting segments. Net losses were impacted by net adverse prior year loss development of $4.5 million for the second quarter of 2023 compared to net adverse prior year loss development of $1.0 million for the same period in 2022.

Net loss and LAE increased by $16.8 million for the ~~AmTrust Reinsurance Segment (excluding~~six months ended June 30, 2023 compared to the ~~favorable impact~~same period in 2022 largely due to adverse prior year loss development in both reporting segments. Net losses were impacted by net adverse prior year loss development of ~~AmTrust Cession Adjustments)~~$8.2 million for the six months ended June 30, 2023 compared to favorable prior year reserve development of $6.3 million for the same period in ~~2021.~~ 2022.

The cessation of active reinsurance underwriting on prospective risks included the termination of the AmTrust Quota Share and European Hospital Liability Quota Share effective January 1, 2019.

Net loss and LAE for the third quarter of 2022 was impacted by net adverse prior year loss development of $0.8 million compared to net favorable prior year loss development of $5.4 million for the same period in 2021. Net loss and LAE for nine months ended September 30, 2022 was impacted by net favorable prior year loss development of $5.5 million compared to net favorable prior year loss development of $23.7 million during the same period in 2021. This The segment net loss development is discussed in greater detail in the individual segment discussion and analysis and is primarily associated with run-off of unearned premium for terminated reinsurance contracts in the AmTrust Reinsurance and Diversified Reinsurance segments.

4648

Commission and Other Acquisition Expenses

Commission and other acquisition expenses ~~decreased~~increased by ~~$0.9~~$0.1 million or ~~14.5%~~1.2% and ~~$6.3~~increased by $1.8 million or ~~33.1%~~23.8% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021 largely due to negative~~2022 driven by lower earned ~~premiums~~premium adjustments in the AmTrust Reinsurance segment ~~which reduced~~in 2023 compared to 2022. This resulted in a corresponding increase in commission costs ~~due to the AmTrust Cession Adjustments.~~and brokerage fees. Please see further discussion in the individual segment analysis below.

General and Administrative Expenses

General and administrative expenses include both segment and corporate expenses segregated for analytical purposes as a component of underwriting income. Total general and administrative expenses decreased by ~~$0.2~~$0.5 million, or ~~2.4%~~6.2% and decreased by $1.2 million or 6.8% for the three and six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same ~~period~~respective periods in ~~2021. Total general and administrative expenses decreased by $4.9 million, or 16.5% for the nine months ended September 30,~~ 2022 ~~compared to the same period in 2021~~ primarily due to lower ~~payroll and equity-based~~stock-based incentive ~~staff~~ compensation costs and ~~lower regulatory and professional fees~~corporate insurance expenses incurred.

General and administrative expenses for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 were comprised of:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022		2021		2022		2021		($ in thousands)	2023		2022		2023		2022
General and administrative expenses – segments	General and administrative expenses – segments	$	2,422	$	1,990	$	9,288	$	7,975	General and administrative expenses – segments	$	3,902	$	4,283	$	7,048	$	6,866
General and administrative expenses – corporate	General and administrative expenses – corporate	4,069		4,660		15,383		21,578		General and administrative expenses – corporate	2,937		3,011		9,899		11,314
Total general and administrative expenses	Total general and administrative expenses	$	6,491	$	6,650	$	24,671	$	29,553	Total general and administrative expenses	$	6,839	$	7,294	$	16,947	$	18,180

Interest and Amortization Expenses

~~The~~Total interest and amortization expenses related to ~~the~~ outstanding senior notes issued by Maiden Holdings in 2016 and Maiden NA in 2013 ("Senior Notes") were $4.8 million and ~~$14.5~~$8.6 million for the three and ~~nine~~six months ended ~~September~~June 30, 2023, respectively, compared to $4.8 million and $9.7 million for the same respective periods in 2022. This included interest expense incurred on the Senior Notes for the three and six months ended June 30, 2023 and 2022 of $4.8 million and ~~2021,~~$9.6 million, respectively.

The issuance costs related to the Senior Notes were capitalized and are amortized over their effective life using the effective interest method of amortization. Due to a change in the amortization method for the 2013 Senior Notes at June 30, 2023, amortization expenses were $0.0 million and $(0.9) million for the three and six months ended June 30, 2023, respectively, compared to amortization expenses of $0.1 million and $0.1 million for the same respective periods in 2022.

During the three and six months ended June 30, 2023, the Company realized a gain of $39.9 thousand due to the partial repurchase of the 2013 Senior Notes which was offset against total interest and amortization expenses discussed above.

Please refer to "Notes to Condensed Consolidated Financial Statements (unaudited) Note 7. Long Term Debt" for further details on the Senior Notes. The weighted average effective interest rate for the Senior Notes was 7.6% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively.

Foreign Exchange and Other (Losses) Gains

Net foreign exchange and other ~~gains amounted to $8.6~~losses of $2.6 million and ~~$19.1~~losses of $5.4 million were realized during the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to net foreign exchange and other gains of ~~$4.1~~$6.6 million and ~~$6.1~~gains of $10.5 million for the same respective periods in ~~2021.~~2022.

At ~~September~~June 30, ~~2022,~~2023, net foreign exchange ~~gains~~losses were primarily driven by exposures to euro, British pound and other non-USD denominated net loss reserves and insurance related liabilities in excess of foreign currency assets. Our non-USD denominated liabilities at ~~September~~June 30, ~~2022~~2023 included net loss reserves of ~~$281.7~~$313.5 million. ~~There was no new business written in non-USD currencies during the three and nine months ended September 30, 2022.~~ Our foreign currency asset exposures at ~~September~~June 30, ~~2022~~2023 included ~~$185.3~~$172.1 million of fixed maturity securities managed by our investment managers who have the discretion to hold foreign currency exposures as part of their total return strategy as well as ~~$24.9~~$22.6 million of equity method real estate investments denominated in Canadian dollars.

Net foreign exchange ~~gains~~losses of ~~$8.6~~$2.6 million and ~~$20.5~~$4.7 million for the three and ~~nine~~six months ended ~~September~~June 30, 2023, respectively, were attributable to the weakening of the U.S. dollar on the re-measurement of net loss reserves and insurance related liabilities denominated in British pound and euro.

Net foreign exchange gains of $7.9 million and $11.9 million during the three and six months ended June 30, 2022, respectively, were attributable to the strengthening of the U.S. dollar on the re-measurement of net loss reserves and insurance related liabilities denominated in British pound and euro. Net foreign exchange gains of $4.1 million and $6.3 million during the three and nine months ended September 30, 2021 were attributable to the strengthening of the U.S. dollar on the re-measurement of net loss reserves and insurance related liabilities denominated in British pound and euro.

4749

Underwriting Results by Reportable Segment

Diversified Reinsurance Segment

The underwriting results for our Diversified Reinsurance segment for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 were as follows:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022		2021		2022		2021		($ in thousands)	2023		2022		2023		2022
Gross premiums written	Gross premiums written	$	6,185	$	5,684	$	17,069	$	10,947	Gross premiums written	$	6,652	$	6,148	$	13,501	$	10,884
Net premiums written	Net premiums written	$	6,027	$	5,816	$	16,605	$	10,600	Net premiums written	$	6,652	$	5,995	$	13,425	$	10,578
Net premiums earned	Net premiums earned	$	6,932	$	7,521	$	20,012	$	20,723	Net premiums earned	$	7,204	$	7,125	$	14,675	$	13,080
Other insurance revenue		368		138		888		946
Other insurance revenue, net										Other insurance revenue, net	78		469		19		520
Net loss and LAE	Net loss and LAE	(1,965)		(554)		(2,945)		(3,216)		Net loss and LAE	(3,828)		(2,340)		(6,984)		(980)
Commission and other acquisition expenses	Commission and other acquisition expenses	(3,394)		(3,461)		(10,684)		(11,668)		Commission and other acquisition expenses	(3,514)		(3,519)		(7,170)		(7,290)
General and administrative expenses	General and administrative expenses	(1,901)		(1,583)		(7,007)		(6,190)		General and administrative expenses	(3,058)		(3,008)		(5,647)		(5,106)
Underwriting income		$	40	$	2,061	$	264	$	595
Underwriting (loss) income										Underwriting (loss) income	$	(3,118)	$	(1,273)	$	(5,107)	$	224

Underwriting results in the Diversified Reinsurance segment decreased for the three and six months ended June 30, 2023 compared to the same respective periods in 2022. This was primarily due to an underwriting loss from International and GLS operations for the three and six months ended June 30, 2023 as detailed in the table below.

Underwriting (loss) income by business unit is detailed in the table below for the Diversified Reinsurance segment for the three and six months ended June 30, 2023 and 2022, respectively:


	For the Three Months Ended June 30,		For the Six Months Ended June 30,
($ in thousands)	2023	2022	2023		2022
International	(1,845)	(305)	$	(2,025)	$	448
GLS	(1,147)	98	(2,211)		(42)

Other run-off lines	(126)	(1,066)	(871)		(182)
Underwriting (loss) income	(3,118)	(1,273)	$	(5,107)	$	224

Premiums — The growth in written and earned premium was the result of new Credit Life programs written by Maiden LF and Maiden GF in the three and six months ended June 30, 2023.

Gross premiums written increased by $0.5 million or 8.2% and ~~$6.1~~increased by $2.6 million or 24.0% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021. Gross~~2022.

Net premiums written for the nine months ended September 30, 2022 increased primarily due to the prior year return of unearned premiums written in a German Auto quota share reinsurance contract in our IIS business which went into run-off on January 1, 2021. Direct premiums written by Maiden LF and Maiden GF increased by ~~$0.8~~$0.7 million or ~~14.9%~~11.0% and ~~$1.2~~increased by $2.8 million or ~~7.4%~~26.9% during the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, compared to the same respective periods in 2022.

Net premiums earned increased by $0.1 million or 1.1% and increased by $1.6 million or 12.2% during the three and six months ended June 30, 2023, respectively, compared to the same respective periods in ~~2021.~~

Net premiums written increased by $0.2 million and $6.0 million during the three and nine months ended September 30, 2022, respectively, compared to the same respective periods in 2021. Net premiums written for the nine months ended September 30, 2022 increased primarily due to the prior year return of unearned premiums written in our German Auto quota share reinsurance contract which went into run-off on January 1, 2021.

Net premiums earned decreased by $0.6 million or 7.8% and $0.7 million or 3.4% during the three and nine months ended September 30, 2022, respectively, compared to the same respective periods in 2021.2022.

Other Insurance Revenue, Net — Other insurance revenue, ~~increased by $0.2 million and decreased by $0.1 million for the three and nine months ended September 30, 2022, respectively, compared to the same respective periods in 2021. Other insurance revenue~~net includes fee related income earned from our GLS business, fair value changes in underwriting-related derivatives related to certain coverages on retroactive reinsurance contracts written by GLS, and fee income derived from our IIS business not directly associated with premium revenue assumed by the Company as specified in the table below. ~~The decline of~~

Total other insurance revenue, ~~from International business~~net decreased by $0.4 million and $0.5 million for the three and ~~nine~~six months ended ~~September~~June 30, 2023, respectively, compared to the same respective periods in 2022 ~~was~~primarily due to ~~the loss of fee income from an auto customer program that went into run-off~~fair value changes in non-hedged underwriting-related derivatives on ~~July 31, 2021.~~ GLS contracts.

The table below shows other insurance revenue by source for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:

For the Three Months Ended September 30, 2022 2021 Change
($ in thousands)
International $ 24 $ 61 $ (37)
Changes in fair value of non-hedged derivatives on retroactive reinsurance 306 — 306
Other service fee income 38 77 (39)
Total Diversified Reinsurance $ 368 $ 138 $ 230
For the Nine Months Ended September 30, 2022 2021 Change
($ in thousands)
International $ 44 $ 714 $ (670)
Changes in fair value of non-hedged derivatives on retroactive reinsurance 699 — 699
Other service fee income 145 232 (87)
Total Diversified Reinsurance $ 888 $ 946 $ (58)


For the Three Months Ended June 30,	2023		2022		Change
	($ in thousands)
International	$	—	$	10	$	(10)
Changes in fair value of non-hedged underwriting-related derivatives	(18)		393		(411)
Other service fee income	96		66		30
Total other insurance revenue, net	$	78	$	469	$	(391)

For the Six Months Ended June 30,	2023		2022		Change
	($ in thousands)
International	$	97	$	20	$	77
Changes in fair value of non-hedged underwriting-related derivatives	(230)		393		(623)
Other service fee income	152		107		45
Total other insurance revenue, net	$	19	$	520	$	(501)

Net Loss and LAE — Net loss and LAE increased by ~~$1.4~~$1.5 million and ~~decreased~~increased by ~~$0.3~~$6.0 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021~~2022 primarily due to ~~lower~~new premium growth in Credit Life programs written by Maiden LF and Maiden GF as well as ~~favorable~~adverse prior year development ~~on German Auto programs and adverse development~~experienced in ~~European Capital Solutions~~the current year periods.

The net loss and LAE was impacted by net ~~favorable~~adverse prior year loss development of ~~$0.6~~$1.3 million and ~~$2.0~~$2.1 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023, respectively, compared to ~~favorable~~adverse prior year development of ~~$1.7~~$0.8 million and ~~$2.6~~favorable development of $1.4 million for the same respective periods in ~~2021.~~ 2022.

The net ~~favorable~~adverse loss development for the three and ~~nine~~six months ended ~~September~~June 30, 2023 was primarily from a German auto program in run-off from our International unit along with development from other runoff business lines and included the recognition of expected credit losses on reinsurance recoverable on unpaid losses.

The prior year loss development in 2022 was ~~driven by~~due to favorable reserve development in German Auto Programs and GLS partly offset by adverse development in European Capital ~~Solutions. The favorable loss development for~~Solutions that occurred in the ~~same respective periods in 2021 was experienced in German Auto Programs, European Capital Solutions and other run-off business.~~second quarter of 2022.

Commission and Other Acquisition Expenses — Commission and other acquisition expenses remained flat and decreased by $0.1 million or ~~1.9% and $1.0 million or 8.4%~~1.6% for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021. The lower commission expense was largely related to an auto customer program that went into run-off on July 31, 2021.~~2022.

General and Administrative Expenses — General and administrative expenses increased by ~~$0.3~~$0.1 million or ~~20.1%~~1.7% and increased by $0.5 million or 10.6% for the three and six months ended ~~September~~June 30, ~~2022 and increased by $0.8 million or 13.2% for the nine months ended September 30, 2022,~~2023, respectively, compared to the same respective periods in ~~2021.~~2022.

AmTrust Reinsurance Segment

The AmTrust Reinsurance segment reported an underwriting loss of ~~$12.7~~$6.1 million and ~~$19.7~~$12.4 million during the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to an underwriting loss of ~~$5.7~~$3.9 million and ~~underwriting income of $5.8~~$7.0 million for the same respective periods in ~~2021.~~2022.

The ~~AmTrust Cession Adjustments contributed an~~decrease in underwriting results for the three and six months ended June 30, 2023 was primarily due to adverse prior year loss development of ~~$5.1~~$3.2 million ~~to the reported results~~and $6.1 million during the ~~nine~~three and six months ended ~~September~~June 30, ~~2022; excluding these adjustments,~~2023, respectively, compared to net prior year loss development of adverse $0.1 million and favorable $4.9 million for the ~~AmTrust Reinsurance segment had an underwriting loss of $14.6 million on the run-off of unearned premium for terminated AmTrust reinsurance contracts.~~ same respective periods in 2022.

The underwriting results for the AmTrust Reinsurance segment for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 were as follows:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022		2021		2022		2021		($ in thousands)	2023		2022		2023		2022
Gross premiums written	Gross premiums written	$	(805)	$	1,137	$	(18,520)	$	(3,082)	Gross premiums written	$	223	$	(2,809)	$	(5,790)	$	(17,715)
Net premiums written	Net premiums written	$	(805)	$	1,137	$	(18,520)	$	(3,082)	Net premiums written	$	223	$	(2,809)	$	(5,790)	$	(17,715)
Net premiums earned	Net premiums earned	$	5,319	$	7,509	$	3,804	$	19,383	Net premiums earned	$	3,835	$	3,318	$	5,366	$	(1,515)
Net loss and LAE	Net loss and LAE	(15,461)		(9,960)		(19,072)		(4,330)		Net loss and LAE	(7,704)		(4,534)		(14,363)		(3,611)
Commission and other acquisition expenses	Commission and other acquisition expenses	(2,004)		(2,852)		(2,127)		(7,486)		Commission and other acquisition expenses	(1,431)		(1,366)		(2,010)		(123)
General and administrative expenses	General and administrative expenses	(521)		(407)		(2,281)		(1,785)		General and administrative expenses	(844)		(1,275)		(1,401)		(1,760)
Underwriting (loss) income		$	(12,667)	$	(5,710)	$	(19,676)	$	5,782
Underwriting loss										Underwriting loss	$	(6,144)	$	(3,857)	$	(12,408)	$	(7,009)

Premiums — The tables below show net premiums written by category for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively:


For the Three Months Ended September 30,		2022		2021		Change in
For the Three Months Ended June 30,													For the Three Months Ended June 30,	2023			2022	Change in
($ in thousands)	($ in thousands)	Total			Total			$			($ in thousands)	Total				Total		$
Net Premiums Written	Net Premiums Written												Net Premiums Written
Small Commercial Business	Small Commercial Business	$	(636)			$	(1,309)		$	673			Small Commercial Business	$	(75)			$	(2,649)	$	2,574
Specialty Program	Specialty Program	(43)				22			(65)				Specialty Program	1				(62)		63
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	(126)				2,424			(2,550)				Specialty Risk and Extended Warranty	297				(98)		395
Total AmTrust Reinsurance	Total AmTrust Reinsurance	$	(805)			$	1,137		$	(1,942)			Total AmTrust Reinsurance	$	223			$	(2,809)	$	3,032

For the Nine Months Ended September 30,		2022		2021		Change in
For the Six Months Ended June 30,													For the Six Months Ended June 30,	2023			2022	Change in
($ in thousands)	($ in thousands)	Total			Total			$			($ in thousands)	Total				Total		$
Net Premiums Written	Net Premiums Written												Net Premiums Written
Small Commercial Business	Small Commercial Business	$	(15,007)			$	(5,381)		$	(9,626)			Small Commercial Business	$	(158)			$	(14,371)	$	14,213
Specialty Program	Specialty Program	732				(7)			739				Specialty Program	157				775		(618)
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	(4,245)				2,306			(6,551)				Specialty Risk and Extended Warranty	(5,789)				(4,119)		(1,670)
Total AmTrust Reinsurance	Total AmTrust Reinsurance	$	(18,520)			$	(3,082)		$	(15,438)			Total AmTrust Reinsurance	$	(5,790)			$	(17,715)	$	11,925

Furthermore, the termination of the AmTrust Quota Share and the European Hospital Liability Quota Share as of January 1, 2019 resulted in no new business written under these contracts since 2018.

The negative gross and net premiums written for the ~~nine~~six months ended ~~September~~June 30, 2023 reflect cession adjustments of $6.1 million due to the cancellation of cases in a certain program within Specialty Risk and Extended Warranty.

The negative gross and net premiums written for the six months ended June 30, 2022 reflect the AmTrust Cession Adjustments which consist of higher than expected adjustments related to the following items:

•$11.0 million of premium reductions on Workers Compensation policy surcharges in Small Commercial Business subsequent to the termination of the AmTrust Quota Share; and

•$4.8 million of premium reductions to AmTrust's inuring reinsurance for certain programs in Specialty Risk and Extended Warranty which reduced the amount of premium ceded to Maiden.

There were also negative gross and net premiums written for the three and nine months ended September 30, 2021 reflecting premium adjustments on Small Commercial Business policies in the AmTrust Quota Share. Furthermore, the termination of the AmTrust Quota Share and the European Hospital Liability Quota Share as of January 1, 2019 resulted in no new business written under these contracts since 2018.

Net premiums earned ~~decreased~~increased by ~~$2.2~~$0.5 million and ~~$15.6~~$6.9 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021~~2022 primarily ~~due~~driven by lower negative premium adjustments during the first half of 2023 compared to ~~the~~significantly higher AmTrust Cession Adjustments ~~as discussed above and~~made in the first half of 2022, largely due to termination of the AmTrust Quota Share and European Hospital Liability Quota Share as of January 1, 2019. Excluding AmTrust Cession Adjustments of $15.8 million, net premiums earned were $19.6 million for the nine months ended September 30, 2022 compared to $19.4 million for the same period in 2021. There were negative premiums earned ~~for the three and nine months ended September 30, 2022 and 2021~~ in Small Commercial Business ~~due to premium adjustments on such policies in the AmTrust Quota Share.~~policies.

The tables below provide detail on net premiums earned ~~for~~in the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


For the Three Months Ended September 30,		2022		2021		Change in
For the Three Months Ended June 30,								For the Three Months Ended June 30,	2023		2022		Change in
($ in thousands)	($ in thousands)	Total		Total		$		($ in thousands)	Total		Total		$
Net Premiums Earned	Net Premiums Earned							Net Premiums Earned
Small Commercial Business	Small Commercial Business	$	(636)	$	(1,227)	$	591	Small Commercial Business	$	(75)	$	(2,649)	$	2,574
Specialty Program	Specialty Program	(43)		28		(71)		Specialty Program	1		(62)		63
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	5,998		8,708		(2,710)		Specialty Risk and Extended Warranty	3,909		6,029		(2,120)
Total AmTrust Reinsurance	Total AmTrust Reinsurance	$	5,319	$	7,509	$	(2,190)	Total AmTrust Reinsurance	$	3,835	$	3,318	$	517

For the Nine Months Ended September 30,		2022		2021		Change in
For the Six Months Ended June 30,								For the Six Months Ended June 30,	2023		2022		Change in
($ in thousands)	($ in thousands)	Total		Total		$		($ in thousands)	Total		Total		$
Net Premiums Earned	Net Premiums Earned							Net Premiums Earned
Small Commercial Business	Small Commercial Business	$	(14,995)	$	(5,073)	$	(9,922)	Small Commercial Business	$	(158)	$	(14,359)	$	14,201
Specialty Program	Specialty Program	733		12		721		Specialty Program	157		776		(619)
Specialty Risk and Extended Warranty	Specialty Risk and Extended Warranty	18,066		24,444		(6,378)		Specialty Risk and Extended Warranty	5,367		12,068		(6,701)
Total AmTrust Reinsurance	Total AmTrust Reinsurance	$	3,804	$	19,383	$	(15,579)	Total AmTrust Reinsurance	$	5,366	$	(1,515)	$	6,881

Net Loss and LAE — Net loss and LAE increased by ~~$5.5~~$3.2 million and ~~$14.7~~$10.8 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021 primarily due to net~~2022 driven by higher adverse prior year loss development ~~(excluding~~in the ~~favorable impact of AmTrust Cession Adjustments) in 2022 compared to favorable development in 2021 as discussed below.~~

current year periods. Net adverse prior year loss development was ~~$1.4~~$3.2 million and $6.1 million during the three and six months ended ~~September~~June 30, ~~2022,~~2023, respectively compared to net adverse development of $0.1 million and favorable development of $4.9 million for the same respective periods in 2022.

Net adverse prior year loss development ~~of $3.7 million~~ for the ~~same period~~three and six months ended June 30, 2023 was primarily due to General Liability and Commercial Auto Liability partly offset by continued favorable development in ~~2021.~~Workers Compensation. Net adverse prior year loss development for the three months ended ~~September~~June 30, 2022 was driven by ~~unfavorable movements~~modest deterioration in ~~European Hospital~~General Liability due to higher than expected loss emergence in Italian Hospital Liability policies as well as the agreed exit cost of $3.7 million (€3.4 million) for the commutation of French Hospital Liability policies as described in ~~"Note 10. Related Party Transactions";~~and Commercial Auto partly offset by continued favorable ~~runoff of~~development on Workers ~~Compensation business. Net~~Compensation. The net favorable prior year loss development for the ~~three~~six months ended ~~September 30, 2021 was driven by favorable development in Workers Compensation and Commercial Auto Liability.~~

~~Net favorable prior year loss development was $3.5 million during the nine months ended September~~June 30, 2022 compared to net favorable prior year loss development of $21.1 million for the same period in 2021. Net favorable prior year loss development of $3.5 million during the nine months ended September 30, 2022 included $5.3 million of favorable loss reserve adjustments related to the AmTrust Cession Adjustments. Excluding these adjustments, there was ~~adverse development of $1.8 million for the nine months ended September 30, 2022 driven by unfavorable movements in European Hospital Liability~~ due to higher than expected loss emergence in Italian Hospital Liability policies as well as the agreed exit cost of $3.7 million (€3.4 million) for the commutation of French Hospital Liability policies as described in ~~"Note 10. Related Party Transactions".~~ ~~This was partly offset by~~ favorable runoff of Workers Compensation ~~business. Prior year favorable loss development in 2021 was due to Workers Compensation~~business and ~~Commercial Auto Liability partly offset by adverse development in Hospital Liability.~~AmTrust Cession Adjustments for Specialty Risk and Extended Warranty.

Commission and Other Acquisition Expenses — Commission and other acquisition expenses ~~decreased~~increased by ~~$0.8~~$0.1 million and ~~$5.4~~$1.9 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021 due~~2022. This was driven by lower negative earned premium adjustments in the first half of 2023 compared to ~~the~~significantly higher AmTrust Cession Adjustments made in the first half of 2022, largely due to negative premiums earned in Small Commercial Business policies which resulted in ~~negative earned premiums~~a corresponding decrease in commission costs and ~~a reduction to~~ brokerage fees. Excluding AmTrust Cession Adjustments of $5.4 million, commission and other acquisition expenses were $7.5 million for the nine months ended September 30, 2022 compared to $7.5 million for the same period in 2021.

General and Administrative Expenses — General and administrative expenses ~~increased~~decreased by ~~$0.1~~$0.4 million ~~or 28.0% and $0.5 million or 27.8%~~ for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to the same respective periods in ~~2021 primarily due to higher letter of credit fees associated with the LPT/ADC Agreement.~~2022.

5053

Liquidity and Capital Resources

Liquidity

Maiden Holdings is a holding company and transacts no business of its own. We therefore rely on cash flows in the form of dividends, advances, loans and other permitted distributions from our subsidiary companies to pay expenses and make dividend payments on our common ~~and preference~~ shares. The jurisdictions in which our operating subsidiaries are licensed to write business impose regulations requiring companies to maintain or meet statutory solvency and liquidity requirements and also place restrictions on the declaration and payment of dividends and other distributions.

As of ~~September~~June 30, ~~2022,~~2023, the Company had investable assets of ~~$1.4~~$1.06 billion compared to ~~$1.7~~$1.24 billion as of December 31, ~~2021.~~2022. Investable assets are the combined total of our investments, cash and cash equivalents (including restricted cash), loan to a related party and funds withheld receivable. The decrease in our investable assets is ~~primarily~~due to the ~~result of our~~ cessation of active reinsurance underwriting of new prospective risks ~~in 2018 and 2019~~ which ~~subsequently resulted~~results in negative operating cash flows toas we settle claim payments from the run-off of ~~the liabilities from that~~our reinsurance portfolio ~~in 2022.~~liabilities.

The regulatory and liquidity requirements of the Company's operating segments are discussed in "Management's Discussion and Analysis of Financial Condition and Results of Operations" section included under Item 7 of our Annual Report on Form 10- K for the year ended December 31, ~~2021,~~2022, that was filed with the SEC on March ~~14, 2022.~~15, 2023.

~~As previously indicated,~~ Maiden Reinsurance re-domesticated from Bermuda to Vermont on March 16, 2020. We continue to be actively engaged with the Vermont Department of Financial Regulation ("Vermont DFR") regarding ~~the formulation of~~ Maiden Reinsurance's longer term business plan, including its investment policy, changes to which require prior regulatory approval as stipulated by Vermont law or the Vermont DFR for any active underwriting, capital management or other strategic initiatives. Maiden Reinsurance has received all necessary approvals required to date by the Vermont DFR, including its activities via GLS and its investment policy which includes: 1) the expansion of approved asset classes for investment reflecting not only Maiden Reinsurance’s solvency position but the material reduction in required capital necessary to operate its ~~business as discussed further in Item 7 -~~ ~~Management's Discussion and Analysis of Financial Condition and Results of Operations – Liquidity & Capital Resources – Cash and Investments~~;business; and 2) the purchase of affiliated securities as demonstrated in ~~the recent~~previous preference share tender ~~offers.~~offers and the recently completed Exchange. The Investment Policy, as approved and as amended, maintains our established investment management and governance practices.

~~During the second quarter of~~In 2022 and 2023, the Vermont DFR approved an annual dividend program to be paid by Maiden Reinsurance to Maiden NA, with notification to the Vermont DFR as dividends are paid. Subsequent to that approval, Maiden Reinsurance has paid ~~$12.5~~$31.3 million in dividends to Maiden NA ~~during the nine months ended September 30, 2022.~~with $6.3 million paid to Maiden NA on a quarterly basis since approval was granted.

We may experience continued volatility in our results of operations which could negatively impact our financial condition and create a reduction in the amount of available distribution or dividend capacity from our regulated reinsurance subsidiaries, which would also reduce liquidity. Further, we and our insurance subsidiaries may need additional capital to maintain compliance with regulatory capital requirements and/or be required to post additional collateral under existing reinsurance arrangements, which could reduce our liquidity.

Operating, investing and financing cash flows

Our sources of funds historically have consisted of premium receipts net of commissions and brokerage, investment income, net proceeds from capital raising activities, and proceeds from sales, maturities, pay downs and redemption of investments. Cash is currently used primarily to pay loss and LAE, ceded reinsurance premium, general and administrative expenses, and interest expense, with the remainder in excess of our operating requirements made available to our investment managers for investment in accordance with our investment policy as well as for capital management such as repurchasing our shares.

Our business has undergone significant changes since 2018. ~~We have entered into~~As previously noted, we engaged in a series of transactions that have materially reduced our balance sheet risk and transformed our operations. As a result of these transactions, we are not presently engaged in any active underwriting of new prospective ~~risks~~reinsurance business thus our net premiums written will continue to be materially lower and investment income will become a significantly larger portion of our total revenues. We are writing new retroactive risks through GLS, however this will be smaller in relation to the run-off of our prior reinsurance business. Despite the initial inflow of new business from GLS, the run-off of our prior reinsurance business has continued to cause significant negative operating cash flows as we run off the AmTrust Reinsurance segment reserves as shown in the cash flows table ~~further~~ below.

While the development of the GLS platform over time should further enhance our ability to pursue the asset and capital management pillars of our business strategy, we ~~still~~continue to expect ~~the~~a trend of negative overall cash flows to continue to reduce our asset base going forward through the remainder of ~~2022~~2023 and beyond.

We expect to use funds from cash and investment portfolios, collected premiums on reinsurance contracts in force or being run-off, investment income and proceeds from investment sales and redemptions to meet our expected claims payments and operational expenses. Claim payments will be principally from the run-off of existing reserves for loss and LAE. A significant portion of those liabilities are collateralized and claim payments will be funded by using this collateral which should provide sufficient funding to fulfill those obligations.

The Company’s management believes ~~its~~our current sources of liquidity are adequate to meet ~~its~~ cash requirements for the next twelve months as we generally expect negative operating cash flows to be sufficiently offset by positive investing cash flows. While we continue to expect our cash flows to be sufficient to meet our cash requirements and to operate our business, our ability to execute our asset and capital management initiatives are dependent on maintaining adequate levels of unrestricted liquidity and cash flows. Our expanded asset management strategy can be impacted by both investment specific and broader financial market conditions and may not produce the expected liquidity and cash flows these investments are designed to achieve, or the timing thereof may also be impacted by those factors.

5154

At ~~September~~June 30, ~~2022 and December 31, 2021,~~2023, unrestricted cash, ~~and~~ cash equivalents and ~~unrestricted~~ fixed maturity investments were ~~$72.0~~$82.2 million compared to $64.3 million held at December 31, 2022, an increase of $17.9 million during the six months ended June 30, 2023. This was driven by $11.0 million of net proceeds from sales and ~~$81.1 million, respectively. The decrease~~redemption of ~~$9.1 million in unrestricted cash and fixed maturity~~alternative investments ~~during 2022 was primarily the result of:~~

• ~~$10.0 million utilized for the 2021 Preference Share Repurchase Program,~~

• ~~$40.0 million utilized for net purchases of other~~including equity method investments and ~~equity securities, and~~

• ~~$14.3~~$30.0 million of collateral released by AmTrust, partly offset by $9.6 million for interest payments on the Senior Notes ~~partly offset by:~~

• ~~$45.0 million of collateral released by AmTrust,~~ and

•~~$5.8~~ $0.6 million for ~~net proceeds from equity method investments.~~common share repurchases under the Company's authorized repurchase plan.

Please see the related discussion on investing and financing cash flows below. The table below summarizes our operating, investing and financing cash flows for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


For the Nine Months Ended September 30,		2022		2021
For the Six Months Ended June 30,						For the Six Months Ended June 30,	2023		2022
		($ in thousands)					($ in thousands)
Operating activities	Operating activities	$	(99,833)	$	(299,750)	Operating activities	$	(63,662)	$	(88,756)
Investing activities	Investing activities	119,379		344,206		Investing activities	45,183		96,333
Financing activities	Financing activities	(10,983)		(128,988)		Financing activities	(916)		(10,983)
Effect of exchange rate changes on foreign currency cash	Effect of exchange rate changes on foreign currency cash	(2,152)		(333)		Effect of exchange rate changes on foreign currency cash	233		(1,213)
Total increase (decrease) in cash, restricted cash and cash equivalents		$	6,411	$	(84,865)
Total decrease in cash, restricted cash and cash equivalents						Total decrease in cash, restricted cash and cash equivalents	$	(19,162)	$	(4,619)

Cash Flows used in Operating Activities

Cash flows used in operating activities for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 were ~~$99.8~~$63.7 million compared to cash flows used in operating activities of ~~$299.8~~$88.8 million for the ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, a decrease of ~~$199.9~~$25.1 million due to settlement of claim payments to AmTrust using the funds withheld receivable in the current year period whereas cash was primarily used in the prior year period.

Cash Flows provided by Investing Activities

Cash flows provided by investing activities consist primarily of proceeds from the sales and maturities of investments net of payments for investments acquired. Net cash provided by investing activities was $45.2 million for the six months ended June 30, 2023 compared to $96.3 million for the same period in 2022.

Cash flows provided by investing activities included net proceeds of $11.0 million from alternative investments including equity method investments during the ~~settlement~~six months ended June 30, 2023 compared to net purchases of ~~balances due to AmTrust through reduction of funds held receivable rather than cash. The operating cash flows used in operations~~$19.1 million for the ~~nine~~same respective period in 2022.

For the six months ended ~~September~~June 30, 2023, the proceeds from the sales, maturities and calls exceeded the purchases of fixed maturity securities by $34.2 million compared to net proceeds of $115.5 million for the same respective period in 2022 ~~and 2021 were primarily~~as the ~~result~~size of the fixed income portfolio continues to decrease as claims payments are made for the runoff of existing reserves for terminated AmTrust Quota Share and the European Hospital Liability Quota Share ~~contracts as well as return of premiums due to AmTrust Cession Adjustments.~~

~~Cash Flows provided by Investing Activities~~

Cash flows from investing activities consist primarily of proceeds from the sales and maturities of investments and payments for investments acquired. Net cash provided by investing activities was $119.4 million for the nine months ended September 30, 2022 compared to $344.2 million for the same period in 2021 due to proceeds from the sale of fixed maturity investments which were made primarily to settle claim payments during the nine months ended September 30, 2022 and 2021 as well as repurchase preference shares during the nine months ended September 30, 2022 and 2021.

For the nine months ended September 30, 2022, the proceeds from the sales, maturities and calls exceeded the purchases of fixed maturity securities by $153.6 million compared to net proceeds of $418.5 million for fixed maturity securities in the same period in 2021. There was also net proceeds of equity method investments of $5.8 million partly offset by $40.0 million utilized for net purchases of other investments and equity securities during the nine months ended September 30, 2022.contracts.

Cash Flows used in Financing Activities

Cash flows used in financing activities were ~~$11.0~~$0.9 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to ~~$129.0~~$11.0 million during the ~~nine~~same respective period in 2022. During the six months ended ~~in 2021 due to~~June 30, 2023, the ~~repurchase~~Company repurchased 299,630 common shares at an average price per share of $2.07 under the Company's ~~preference shares.~~authorized common share repurchase plan for a total cost of $0.6 million. During the ~~nine~~six months ended ~~September~~June 30, 2022, the Company ~~paid $10.0 million for the repurchase of~~repurchased 1,581,509 preference shares at an average price per share of $6.31 for an aggregate total consideration of $10.0 million pursuant to the 2021 Preference Share Repurchase ~~Program compared to 9,075,673 preference shares repurchased by the Company during the same period in 2021 for an aggregate total consideration of $132.2 million.~~Program.

No dividends on common ~~or preference~~ shares were paid during the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021.~~2022. Our Board of Directors have not declared any common ~~or preference~~ share dividends since the third quarter of 2018.

Restrictions, Collateral and Specific Requirements

The Company's restrictions, collateral and specific requirements are discussed in "Management's Discussion and Analysis of Financial Condition and Results of Operations" section included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, that was filed with the SEC on March ~~14, 2022.~~15, 2023.

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, restricted cash and cash equivalents and fixed maturity investments used as collateral were ~~$372.5~~$232.6 million and ~~$582.1~~$296.8 million, respectively. This collateral represents ~~83.8%~~73.9% and ~~87.8%~~82.2% of the fair value of total fixed maturity investments, cash, restricted cash and equivalents at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively.

Cash and Investments

~~The~~Historically, the investment of our funds ~~has~~had generally been designed to ensure safety of principal while generating current income. Accordingly, the majority of our funds ~~have~~had been invested in liquid, investment-grade fixed income securities which are all designated as AFS at ~~September~~June 30, ~~2022.~~2023.

As our insurance liabilities continue to run-off and the required capital to operate our business for regulatory purposes decreases, we have modified Maiden Reinsurance’s investment policy which has been approved by the Vermont DFR. Under this modified investment policy, we have expanded the range of asset classes we invest in to enhance the income and total returns our investment portfolio produces. We categorize these investments as alternative investments which include "Other Investments", "Equity Securities", and "Equity Method Investments" on our Condensed Consolidated Balance Sheets. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, our cash and investments consisted of:


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
		($ in thousands)					($ in thousands)
Fixed maturities, available-for-sale, at fair value	Fixed maturities, available-for-sale, at fair value	$	371,973	$	597,145	Fixed maturities, available-for-sale, at fair value	$	287,324	$	314,527
Equity securities, at fair value	Equity securities, at fair value	42,600		24,003		Equity securities, at fair value	45,251		43,621
Equity method investments	Equity method investments	80,165		83,742		Equity method investments	73,216		80,159
Other investments	Other investments	140,804		117,722		Other investments	150,149		148,753
Total investments	Total investments	635,542		822,612		Total investments	555,940		587,060
Cash and cash equivalents	Cash and cash equivalents	24,376		26,668		Cash and cash equivalents	17,242		30,986
Restricted cash and cash equivalents	Restricted cash and cash equivalents	48,122		39,419		Restricted cash and cash equivalents	10,220		15,638
Total Investments and Cash and Cash Equivalents	Total Investments and Cash and Cash Equivalents	$	708,040	$	888,699	Total Investments and Cash and Cash Equivalents	$	583,402	$	633,684

In addition to the discussion on Cash and Cash Equivalents and Fixed Maturities that follows herein, please see the "Notes to Condensed Consolidated Financial Statements (unaudited) Note 4. Investments" included under Part I Item 1 "Financial Information" of this Form 10-Q for further discussion on our AFS fixed income securities.

As our insurance liabilities continue to run-off and the required capital to operate our business for regulatory purposes decreases, we have modified Maiden Reinsurance’s investment policy (which has been approved by the Vermont DFR as noted) and have expanded the range of asset classes we invest in to enhance the income and total returns our investment portfolio produces. We categorize these investments as alternative investments which include "~~Other Investments~~", ~~"Equity Securities", and~~ ~~"Equity Method Investments"~~ ~~as captioned on our condensed consolidated balance sheets.~~

Under this revised investment policy, we have increased the amount of alternative investments ~~during 2022 and 2021,~~held, and we expect to continue to increase the amounts invested therein. Under our investment policy, alternative investments could include, but are not limited to, privately held investments, private equities, private credit lending funds, fixed-income funds, hedge funds, equity funds, real estate (including joint ventures and limited partnerships) and other non-fixed-income investments.

For further details on our alternative investments, in addition to the discussion of the investments herein, please see "Notes to Condensed Consolidated Financial Statements (unaudited) Note 4(b). Other Investments, Equity Securities and Equity Method Investments" included under Part I Item 1 "Financial Information" of this Form 10-Q.

Our investment performance is subject to a variety of risks, including risks related to general economic conditions, market volatility, interest rate fluctuations, foreign exchange risk, liquidity risk and credit and default risk. Interest rates are highly sensitive to many factors, including governmental monetary policies, domestic and international economic and political conditions and other factors beyond our control. An increase in interest rates could result in significant losses, realized or unrealized, in the value of our investment portfolio. A portion of our portfolio consists of alternative investments that subject us to restrictions on redemption, which may limit our ability to withdraw funds for some period of time after the initial investment. The values of, and returns on, such investments may also be more volatile.

We believe our other investments, equity securities and equity method investments portfolio provides diversification against our fixed-income investments and an opportunity for improved risk-adjusted return, however, the returns of these investments may be more volatile and we may experience significant unrealized gains or losses in any particular quarter or year. While we believe the returns produced by these investments will exceed our cost of capital, in particular our cost of debt capital, it is too soon to determine if the actual returns will achieve this objective and it may be an extended period of time before that determination can be made.

We may utilize and pay fees to various companies to provide investment advisory and/or management services related to these investments. These fees, which would be predominantly based upon the amount of assets under management, would be included in net investment income. In addition, costs associated with evaluating, analyzing and monitoring these investments may require additional expenditures than traditional marketable securities. ~~During 2022, our investment expenses associated with our alternative investments have decreased compared to 2021.~~

The substantial majority of our current and future investments are held by Maiden Reinsurance, whose investment policy was approved by the Vermont DFR. ~~We may utilize a portion of Maiden Reinsurance's unrestricted assets~~Prior to ~~purchase affiliated securities and, during~~ the ~~nine months ended September 30, 2022, we utilized $10.0 million in conjunction with~~Exchange, the ~~2021 Preference Share Repurchase Program. As of September 30, 2022, Maiden Reinsurance~~Company cumulatively invested ~~$175.8~~$176.4 million in ~~the~~ preference shares of Maiden ~~Holdings.~~Holdings which have since been extinguished and exchanged for 41,439,348 common shares of the Company pursuant to the Exchange. As a result of the Exchange, there are no preference shares outstanding. The market value of our common shares held by Maiden Reinsurance due to the Exchange was $86.9 million at June 30, 2023.

Cash & Cash Equivalents

At ~~September~~June 30, ~~2022,~~2023, we consider the levels of cash and cash equivalents held to be within our targeted ranges. During periods when interest rates experience greater volatility, we have periodically maintained more cash and cash equivalents to better assess current market conditions and opportunities within our defined risk appetite, and may do so in future periods.

Fixed Maturity Investments

The average yield and average duration of our fixed maturities, by asset class, and our cash and cash equivalents (restricted and unrestricted) are as follows at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively:


September 30, 2022		Original or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Average yield(1)		Average duration(2)
June 30, 2023													June 30, 2023	Original or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Average yield(1)		Average duration(2)
		($ in thousands)												($ in thousands)
U.S. treasury bonds	U.S. treasury bonds	$	58,464	$	—	$	(241)	$	58,223	0.5	%	0.2	U.S. treasury bonds	$	62,802	$	3	$	(121)	$	62,684	4.6	%	0.3
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	73,874		—		(7,682)		66,192		2.9	%	4.4	U.S. agency bonds – mortgage-backed	37,175		—		(4,321)		32,854		3.2	%	5.5
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	7,199		—		(397)		6,802		4.2	%	3.1	Collateralized mortgage-backed securities	7,199		—		(406)		6,793		6.5	%	4.2
Non-U.S. government bonds	Non-U.S. government bonds	12,586		—		(1,605)		10,981		0.3	%	3.1	Non-U.S. government bonds	14,834		—		(786)		14,048		0.7	%	2.0
Collateralized loan obligations	Collateralized loan obligations	175,047		—		(30,514)		144,533		2.3	%	0.3	Collateralized loan obligations	98,260		—		(3,100)		95,160		4.6	%	0.2
Corporate bonds	Corporate bonds	105,144		—		(19,902)		85,242		1.5	%	2.4	Corporate bonds	80,183		—		(4,398)		75,785		1.5	%	2.0

Total fixed maturities	Total fixed maturities	432,314		—		(60,341)		371,973		1.9	%	1.6	Total fixed maturities	300,453		3		(13,132)		287,324		3.5	%	1.6
Cash and cash equivalents	Cash and cash equivalents	72,498		—		—		72,498		0.6	%	0.0	Cash and cash equivalents	27,462		—		—		27,462		0.6	%	0.0
Total	Total	$	504,812	$	—	$	(60,341)	$	444,471	1.7	%	1.4	Total	$	327,915	$	3	$	(13,132)	$	314,786	3.2	%	1.4


December 31, 2021		Original or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Average yield(1)		Average duration(2)
December 31, 2022													December 31, 2022	Original or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value		Average yield(1)		Average duration(2)
		($ in thousands)												($ in thousands)
U.S. treasury bonds	U.S. treasury bonds	$	59,989	$	—	$	(110)	$	59,879	0.2	%	0.9	U.S. treasury bonds	$	55,647	$	1	$	(116)	$	55,532	4.0	%	0.7
U.S. agency bonds – mortgage-backed	U.S. agency bonds – mortgage-backed	96,554		2,429		(193)		98,790		2.7	%	2.1	U.S. agency bonds – mortgage-backed	38,767		—		(4,402)		34,365		2.7	%	4.7
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	14,972		565		—		15,537		3.2	%	3.1	Collateralized mortgage-backed securities	7,199		—		(432)		6,767		5.3	%	2.7
Non-U.S. government bonds	Non-U.S. government bonds	3,163		113		—		3,276		0.3	%	7.3	Non-U.S. government bonds	12,643		—		(825)		11,818		0.3	%	2.8
Collateralized loan obligations	Collateralized loan obligations	183,974		140		(5,093)		179,021		1.3	%	0.3	Collateralized loan obligations	119,120		—		(5,028)		114,092		3.1	%	0.3
Corporate bonds	Corporate bonds	236,692		10,094		(6,144)		240,642		2.5	%	2.7	Corporate bonds	97,063		—		(5,110)		91,953		1.5	%	2.1

Total fixed maturities	Total fixed maturities	595,344		13,341		(11,540)		597,145		1.9	%	1.7	Total fixed maturities	330,439		1		(15,913)		314,527		2.7	%	1.5
Cash and cash equivalents	Cash and cash equivalents	66,087		—		—		66,087		—	%	0.0	Cash and cash equivalents	46,624		—		—		46,624		1.2	%	0.0
Total	Total	$	661,431	$	13,341	$	(11,540)	$	663,232	1.7	%	1.5	Total	$	377,063	$	1	$	(15,913)	$	361,151	2.5	%	1.3

(1) Average yield is calculated by dividing annualized investment income for each sub-component of fixed maturity securities and cash and cash equivalents (including amortization of premium or discount) by amortized cost.

(2) Average duration in years.

During the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the yield on the 10-year U.S. Treasury bond ~~increased~~decreased by ~~231~~7 basis points to ~~3.83%~~3.81%. The 10-year U.S. Treasury rate is the key risk-free determinant in the fair value of many of the fixed maturity securities in our portfolio. The U.S. Treasury yield curve experienced a ~~material upward~~slight shift during the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, reflecting concerns of the U.S. Federal Reserve about ~~ongoing~~reduced but continuing elevated inflation ~~emanating from~~levels and the ~~combination of: 1) the~~ongoing strength of the U.S. economy as the economic effects of the COVID-19 pandemic continue to abate; 2) geopolitical instability in Eastern Europe which threatened additional inflation and global economic stability; 3) the levels of fiscal stimulus administered by the U.S. federal government to support the economy; and 4) the anticipated monetary policy responses required to temper these factors.despite significant interest rate increases implemented since 2022. Central banks globally ~~have responded~~continue to respond in similar fashion and ~~continue to~~ suggest additional interest rate increases may ~~occur.~~occur; however, the significant majority of rate increases by central banks have largely impacted the short end of the yield curve and the limited movement in 10-year U.S. Treasury yields is consistent with that experience.

The ~~movement~~change in the market values of our fixed maturity portfolio during the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 generated net unrealized ~~losses~~gains of ~~$62.1~~$2.8 million which ~~reduced~~increased our book value per common share by ~~$0.71~~$0.03 during ~~that~~the period. Current outlooks for global monetary policy indicate that ~~substantial~~ quantitative tightening by central banks in the U.S. and globally ~~appears~~are likely to ~~continue for at least~~moderate in the near ~~term.~~term, although expectations remain that central banks will maintain a bias toward further tightening for the foreseeable future. Our investment portfolios, in particular our fixed maturity portfolio, may be adversely impacted by unfavorable market conditions caused by these measures, which could cause continued volatility in our results of operations and negatively impact our financial condition.

Interest rate risk is the price sensitivity of a security to changes in interest rates. Credit spread risk is the price sensitivity of a security to changes in credit spreads. As noted, the fair value of our fixed maturity investments will fluctuate with changes in interest rates and credit spreads. We attempt to maintain adequate liquidity in our fixed maturity investments portfolio with a strategy designed to emphasize the preservation of our invested assets and provide sufficient liquidity for the prompt payment of claims and contract liabilities. Because we collateralize a significant portion of our insurance liabilities, unanticipated or large increases in interest rates could require us to utilize significant amounts of unrestricted cash and fixed maturity securities to provide additional collateral, which could impact our asset and capital management strategy described herein.

We also monitor the duration and structure of our investment portfolio as discussed below. As of ~~September~~June 30, ~~2022,~~2023, the aggregate hypothetical change in fair value from an immediate 100 basis points increase in interest rates, assuming credit

spreads remain constant, in our fixed maturity investments portfolio would decrease the fair value of that portfolio by ~~$11.8~~$7.3 million. Actual shifts in interest rates may not change by the same magnitude across the maturity spectrum or on an individual security and, as a result, the impact on the fair value of our fixed maturity securities may be materially different from the resulting change in value described above.

To limit our exposure to unexpected interest rate increases which would reduce the value of our fixed income securities and reduce our shareholders' equity, we attempt to maintain the duration of our fixed maturity investment portfolio combined with our cash and cash equivalents, both restricted and unrestricted, within a reasonable range of the duration of our loss reserves. At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, these respective durations in years were as follows:


		September 30, 2022	December 31, 2021		June 30, 2023	December 31, 2022
Fixed maturities and cash and cash equivalents	Fixed maturities and cash and cash equivalents	1.4	1.5	Fixed maturities and cash and cash equivalents	1.4	1.3
Reserve for loss and LAE - gross of LPT/ADC Agreement reserves	Reserve for loss and LAE - gross of LPT/ADC Agreement reserves	5.1	4.4	Reserve for loss and LAE - gross of LPT/ADC Agreement reserves	5.3	5.3
Reserve for loss and LAE - net of LPT/ADC Agreement reserves	Reserve for loss and LAE - net of LPT/ADC Agreement reserves	0.8	1.4	Reserve for loss and LAE - net of LPT/ADC Agreement reserves	1.5	1.1

During the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the weighted average duration of our fixed maturity investment portfolio ~~decreased by 0.1 year~~slightly increased to 1.4 years while the duration for the gross reserve for loss and LAE ~~increased by 0.7 year to 5.1~~remained at 5.3 years. The differential in duration between these assets and liabilities may fluctuate over time and in the case of fixed maturities, historically has been affected by factors such as market conditions, changes in asset mix and prepayment speeds in the case of both our U.S. agency mortgage-backed securities ("Agency MBS") and commercial mortgage-backed securities. At September 30, 2022, the duration of our fixed maturity investment portfolio decreased compared to December 31, 2021 due to continued sales of fixed maturity investments primarily made to settle claim payments with AmTrust.

At ~~September~~June 30, ~~2022,~~2023, the duration of our loss reserves net of the LPT/ADC Agreement was ~~lower~~slightly higher than the duration of our fixed maturity investment portfolio ~~driven by~~reflecting the ~~commutation~~increased percentage of ~~certain~~ European Hospital Liability ~~policies~~liabilities which ~~were~~are long-tailed in nature and ~~were~~ not subject to the LPT/ADC ~~Agreement.~~Agreement which continue to increase in relation to total insurance liabilities as other insurance liabilities continue to run-off more quickly.

To limit our exposure to unexpected interest rate increases that could reduce the value of our fixed maturity securities and reduce our shareholders' equity, the Company holds floating rate securities whose fair values are less sensitive to interest rates. At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021, 28.2%~~2022, 33.9% and ~~23.6%~~29.6%, respectively, of our fixed income investments are comprised of floating rate securities. The floating rate investment holdings at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 were as follows:


		September 30, 2022				December 31, 2021					June 30, 2023				December 31, 2022
($ in thousands)	($ in thousands)	Fair Value		% of Total		Fair Value		% of Total		($ in thousands)	Fair Value		% of Total		Fair Value		% of Total
Floating rate securities	Floating rate securities									Floating rate securities
Collateralized loan obligations	Collateralized loan obligations	$	144,533	12.8	%	$	174,873	11.9	%	Collateralized loan obligations	$	95,160	12.0	%	$	114,092	11.8	%
Collateralized mortgage-backed securities	Collateralized mortgage-backed securities	4,794		0.4	%	3,007		0.2	%	Collateralized mortgage-backed securities	4,844		0.6	%	4,773		0.5	%
Corporate bonds		977		0.1	%	1,145		0.1	%

Total floating rate AFS fixed maturities at fair value	Total floating rate AFS fixed maturities at fair value	150,304		13.3	%	179,025		12.2	%	Total floating rate AFS fixed maturities at fair value	100,004		12.6	%	118,865		12.3	%
Loan to related party	Loan to related party	167,975		14.9	%	167,975		11.4	%	Loan to related party	167,975		21.3	%	167,975		17.3	%
Total floating rate securities	Total floating rate securities	$	318,279	28.2	%	$	347,000	23.6	%	Total floating rate securities	$	267,979	33.9	%	$	286,840	29.6	%

Total fixed income investments at fair value (1)	Total fixed income investments at fair value (1)	$	1,129,035			$	1,467,619			Total fixed income investments at fair value (1)	$	789,792			$	970,538

(1) Total fixed income investments at fair value include AFS fixed maturities, cash and restricted cash, funds withheld receivable, and loan to related party.

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, 100.0% of the Company’s U.S. agency bond holdings are mortgage-backed. ~~Additional details on the Agency MBS holdings at September 30, 2022 and December 31, 2021 were as follows:~~

September 30, 2022 December 31, 2021
($ in thousands) Fair Value % of Total Fair Value % of Total
FNMA – fixed rate $ 32,099 48.5 % $ 47,419 48.0 %
FHLMC – fixed rate 31,337 47.3 % 47,758 48.3 %
GNMA – variable rate 2,756 4.2 % 3,613 3.7 %
Total U.S. Agency MBS $ 66,192 100.0 % $ 98,790 100.0 %

Total U.S. agency MBS comprise ~~17.8%~~11.4% of our fixed maturity investment portfolio at ~~September~~June 30, ~~2022.~~2023. Given their relative size to our total investments, if faster prepayment patterns were to occur over an extended period of time, this could potentially limit the growth in our investment income in certain circumstances or reduce the total amount of investment income we earn.

~~At September~~ Additional details on our U.S. Agency MBS holdings at June 30, ~~2022~~2023 and December 31, ~~2021, 98.8%~~2022 were as follows:


	June 30, 2023				December 31, 2022
($ in thousands)	Fair Value		% of Total		Fair Value		% of Total

FNMA – fixed rate	$	17,711	53.9	%	$	18,750	54.6	%

FHLMC – fixed rate	12,638		38.5	%	13,034		37.9	%
GNMA – variable rate	2,505		7.6	%	2,581		7.5	%

Total U.S. Agency MBS	$	32,854	100.0	%	$	34,365	100.0	%

At June 30, 2023 and ~~97.8%~~December 31, 2022, 98.2% and 98.5%, respectively, of our fixed maturity investments consisted of investment grade securities. We define a security as being below investment grade if it has an S&P credit rating of BB+ or equivalent, or less. Please see "Part I, Item 1 - Notes to Condensed Consolidated Financial Statements (unaudited) Note 4. Investments" for additional information on the credit rating of our fixed income portfolio.

The security holdings by sector and financial strength rating of our corporate bond holdings at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 were as follows:


		Ratings(1)											Ratings(1)
September 30, 2022		AAA		A+, A, A-		BBB+, BBB, BBB-		BB+ or lower		Fair Value		% of Corporate bonds portfolio
June 30, 2023														June 30, 2023	AAA		A+, A, A-		BBB+, BBB, BBB-		BB+ or lower		Fair Value		% of Corporate bonds portfolio
Corporate bonds	Corporate bonds									($ in thousands)				Corporate bonds									($ in thousands)
Basic Materials	Basic Materials	—	%	5.3	%	—	%	—	%	$	4,481	5.3	%	Basic Materials	—	%	—	%	6.7	%	—	%	$	5,074	6.7	%
Communications	Communications	—	%	5.6	%	5.2	%	—	%	9,195		10.8	%	Communications	—	%	7.1	%	6.4	%	—	%	10,228		13.5	%
Consumer	Consumer	—	%	6.2	%	38.6	%	—	%	38,176		44.8	%	Consumer	—	%	15.0	%	34.1	%	—	%	37,195		49.1	%
Energy	Energy	—	%	0.9	%	7.5	%	—	%	7,189		8.4	%	Energy	—	%	1.1	%	2.3	%	—	%	2,594		3.4	%
Financial Institutions	Financial Institutions	1.7	%	20.0	%	1.5	%	5.2	%	24,245		28.4	%	Financial Institutions	2.0	%	18.1	%	0.5	%	6.7	%	20,694		27.3	%
Industrials		—	%	2.3	%	—	%	—	%	1,956		2.3	%

Total	Total	1.7	%	40.3	%	52.8	%	5.2	%	$	85,242	100.0	%	Total	2.0	%	41.3	%	50.0	%	6.7	%	$	75,785	100.0	%


		Ratings(1)											Ratings(1)
December 31, 2021		AAA		A+, A, A-		BBB+, BBB, BBB-		BB+ or lower		Fair Value		% of Corporate bonds portfolio
December 31, 2022														December 31, 2022	AAA		A+, A, A-		BBB+, BBB, BBB-		BB+ or lower		Fair Value		% of Corporate bonds portfolio
Corporate bonds	Corporate bonds									($ in thousands)				Corporate bonds									($ in thousands)
Basic Materials	Basic Materials	—	%	2.4	%	1.7	%	—	%	$	9,995	4.1	%	Basic Materials	—	%	—	%	5.3	%	—	%	$	4,912	5.3	%
Communications	Communications	—	%	2.4	%	3.2	%	—	%	13,480		5.6	%	Communications	—	%	5.7	%	5.2	%	—	%	10,004		10.9	%
Consumer	Consumer	—	%	2.4	%	31.3	%	2.8	%	87,753		36.5	%	Consumer	—	%	6.3	%	39.1	%	—	%	41,767		45.4	%
Energy	Energy	—	%	9.4	%	4.8	%	—	%	34,068		14.2	%	Energy	—	%	0.9	%	7.7	%	—	%	7,860		8.6	%
Financial Institutions	Financial Institutions	0.6	%	18.8	%	12.9	%	2.6	%	84,025		34.9	%	Financial Institutions	1.6	%	20.3	%	0.4	%	5.2	%	25,272		27.5	%
Industrials	Industrials	—	%	1.0	%	—	%	—	%	2,393		1.0	%	Industrials	—	%	2.3	%	—	%	—	%	2,138		2.3	%
Technology		—	%	3.7	%	—	%	—	%	8,928		3.7	%

Total	Total	0.6	%	40.1	%	53.9	%	5.4	%	$	240,642	100.0	%	Total	1.6	%	35.5	%	57.7	%	5.2	%	$	91,953	100.0	%

(1) Ratings as assigned by S&P, or equivalent

The table below includes the Company’s ten largest corporate holdings at fair value and as a percentage of all fixed income securities held as at ~~September~~June 30, ~~2022;~~2023; of which 100.0% are euro denominated, with ~~54.6%~~55.7% in the Consumer Sector and ~~19.3%~~26.0% in the Financial Institutions sector.


September 30, 2022		Fair Value		% of Holdings		Rating(1)
June 30, 2023							June 30, 2023	Fair Value		% of Holdings		Rating(1)
		($ in thousands)						($ in thousands)
Anheuser-Busch INBEV NV, 2.875%, Due 9/25/2024		$	9,795	2.6	%	BBB+
Anheuser-Busch INBEV SA, 2.875%, Due 9/25/2024							Anheuser-Busch INBEV SA, 2.875%, Due 9/25/2024	$	10,789	3.7	%	A-
Chubb Ina Holdings Inc., 1.55%, Due 3/15/2028	Chubb Ina Holdings Inc., 1.55%, Due 3/15/2028	5,655		1.5	%	A	Chubb Ina Holdings Inc., 1.55%, Due 3/15/2028	6,333		2.2	%	A
Kraft Heinz Foods Co., 1.5%, Due 5/24/2024	Kraft Heinz Foods Co., 1.5%, Due 5/24/2024	5,558		1.5	%	BBB-	Kraft Heinz Foods Co., 1.5%, Due 5/24/2024	6,236		2.2	%	BBB
Glencore Finance (Europe) LTD, 1.875%, Due 9/13/2023		4,827		1.3	%	BBB+
Santander Consumer Finance SA, 1.125%, Due 10/9/2023		4,806		1.3	%	A
Volkswagen International Finance NV, 1.125%, Due 10/2/2023		4,800		1.3	%	A-
America Movil SAB DE CV, 1.5%, Due 3/10/2024	America Movil SAB DE CV, 1.5%, Due 3/10/2024	4,789		1.3	%	A-	America Movil SAB DE CV, 1.5%, Due 3/10/2024	5,348		1.9	%	A-
Utah Acquisition Sub Inc., 2.25%, Due 11/22/2024	Utah Acquisition Sub Inc., 2.25%, Due 11/22/2024	4,712		1.3	%	BBB-	Utah Acquisition Sub Inc., 2.25%, Due 11/22/2024	5,283		1.8	%	BBB-
Molson Coors Beverage Co., 1.25%, Due 7/15/2024	Molson Coors Beverage Co., 1.25%, Due 7/15/2024	4,674		1.2	%	BBB-	Molson Coors Beverage Co., 1.25%, Due 7/15/2024	5,276		1.8	%	BBB-
PPG Industries Inc., 0.875%, Due 11/3/2025	PPG Industries Inc., 0.875%, Due 11/3/2025	4,481		1.2	%	A-	PPG Industries Inc., 0.875%, Due 11/3/2025	5,073		1.8	%	BBB+
FBD Insurance PLC, 5.0%, Due 10/9/2028							FBD Insurance PLC, 5.0%, Due 10/9/2028	5,073		1.8	%	NA
Kellogg Company, 1.25%, Due 3/10/2025							Kellogg Company, 1.25%, Due 3/10/2025	4,172		1.4	%	BBB
BNP Paribas SA, 1.25%, Due 3/19/2025							BNP Paribas SA, 1.25%, Due 3/19/2025	3,406		1.2	%	A-
Total	Total	$	54,097	14.5	%		Total	$	56,989	19.8	%

(1) Ratings as assigned by S&P, or equivalent

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021, respectively, we held the following non-U.S. dollar denominated securities:~~

September 30, 2022 December 31, 2021
($ in thousands) Fair Value % of Total Fair Value % of Total
Non-U.S. dollar denominated collateralized loan obligations $ 90,514 48.9 % $ 113,399 42.9 %
Non-U.S. dollar denominated corporate bonds 83,788 45.2 % 147,740 55.9 %
Non-U.S. government bonds 10,981 5.9 % 3,275 1.2 %
Total non-U.S. dollar denominated securities $ 185,283 100.0 % $ 264,414 100.0 %

~~At September 30,~~ 2022, ~~and December 31, 2021,~~ respectively, 100.0% of our non-U.S. dollar denominated securities ~~above~~ were invested in ~~euro.~~euro denominated bonds. The net decrease in non-U.S. denominated fixed maturities is largely due to ~~the relative depreciation~~sales and maturities; of euro denominated corporate bonds during the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~ 2023.

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, all of the Company's non-U.S. government issuers have a rating of AA- or higher by S&P. The Company does not employ any credit default protection against any of the fixed maturities held in non-U.S. denominated currencies at June 30, 2023 and December 31, 2022, respectively.

At June 30, 2023 and December 31, 2022, respectively, we held the following non-U.S. dollar denominated securities:


	June 30, 2023				December 31, 2022
($ in thousands)	Fair Value		% of Total		Fair Value		% of Total
Non-USD denominated collateralized loan obligations	$	83,716	48.6	%	$	102,812	50.1	%
Non-USD denominated corporate bonds	74,309		43.2	%	90,491		44.1	%
Non-U.S. government bonds	14,048		8.2	%	11,818		5.8	%
Total non-U.S. dollar denominated securities	$	172,073	100.0	%	$	205,121	100.0	%

For our non-U.S. dollar denominated corporate bonds, the following table summarizes the composition of the fair value of our fixed maturity investments at the dates indicated by ratings at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


Ratings(1)	Ratings(1)	September 30, 2022				December 31, 2021				Ratings(1)	June 30, 2023				December 31, 2022
($ in thousands)	($ in thousands)	Fair Value		% of Total		Fair Value		% of Total		($ in thousands)	Fair Value		% of Total		Fair Value		% of Total

A+, A, A-	A+, A, A-	$	34,311	40.9	%	$	56,669	38.4	%	A+, A, A-	$	31,256	42.1	%	$	32,633	36.0	%
BBB+, BBB, BBB-	BBB+, BBB, BBB-	45,066		53.8	%	78,021		52.8	%	BBB+, BBB, BBB-	37,980		51.1	%	53,094		58.7	%
BB+ or lower	BB+ or lower	4,411		5.3	%	13,050		8.8	%	BB+ or lower	5,073		6.8	%	4,764		5.3	%
Total non-U.S. dollar denominated corporate bonds	Total non-U.S. dollar denominated corporate bonds	$	83,788	100.0	%	$	147,740	100.0	%	Total non-U.S. dollar denominated corporate bonds	$	74,309	100.0	%	$	90,491	100.0	%

(1) Ratings as assigned by S&P, or equivalent

~~The Company does not employ any credit default protection against any of the fixed maturities held in non-U.S. denominated currencies at September 30, 2022 and December 31, 2021, respectively.~~

Other Investments, Equity Securities and Equity Method Investments

Our alternative investments are categorized as other investments, equity securities, and equity method investments as reported on our condensed consolidated balance sheets. These include private equity funds, private credit funds and hedge fund investments, investments in limited partnerships, as well as investments in direct lending entities and investments in technology-oriented insurance related businesses known as insurtechs. Private equity investments consist of direct investments in privately held entities, investments in private equity funds and private equity co-investments with sponsoring entities. Private credit investments consist of loans and other debt securities of privately held entities or investment sponsors. Our alternative investments as of June 30, 2023 and December 31, 2022 consisted of the following asset classes:


	June 30, 2023				December 31, 2022
($ in thousands)	Carrying Value		% of Total		Carrying Value		% of Total

Publicly traded equity investments	$	84	—	%	$	386	0.1	%
Privately held common stocks	32,214		12.0	%	32,290		11.9	%
Privately held preferred stocks	12,953		4.8	%	10,945		4.0	%
Total equity securities	$	45,251	16.8	%	$	43,621	16.0	%

Hedge fund investments	$	—	—	%	$	5,376	2.0	%
Real estate investments	42,602		15.9	%	40,944		15.0	%
Other equity method investments	30,614		11.4	%	33,839		12.4	%
Total equity method investments	$	73,216	27.3	%	$	80,159	29.4	%

Private equity funds	$	36,284	13.5	%	$	32,298	11.8	%
Private credit funds	17,620		6.6	%	26,354		9.7	%
Privately held equity investments	34,845		13.0	%	34,014		12.5	%
Investment in direct lending funds (at cost)	61,400		22.8	%	56,087		20.6	%
Total other investments	$	150,149	55.9	%	$	148,753	54.6	%

Total alternative investments	$	268,616	100.0	%	$	272,533	100.0	%

Our allocation to alternative investments increased to ~~37.2%~~46.0% of our total cash and investments as of ~~September~~June 30, ~~2022~~2023 compared to ~~25.4%~~43.0% as of December 31, ~~2021;~~2022; and increased to ~~80.5%~~99.7% of our total shareholders' equity as of ~~September~~June 30, ~~2022~~2023 compared to ~~58.7%~~95.8% as of December 31, ~~2021. Our~~2022.

In addition to the categories described above, we also evaluate our alternative investments ~~as of September 30, 2022 and December 31, 2021 consisted of~~by the following asset classes:

September 30, 2022 December 31, 2021
($ in thousands) Carrying Value % of Total Carrying Value % of Total
Real estate equity method investments $ 44,925 17.0 % $ 44,050 19.6 %
Hedge fund equity method investments 15,447 5.9 % 32,929 14.6 %
Investments in direct lending entities 52,783 20.0 % 42,976 19.1 %
Private equity funds 31,777 12.1 % 23,324 10.3 %
Private credit funds 24,129 9.2 % 20,922 9.3 %
Privately held other investments 32,115 12.2 % 30,500 13.5 %
Other equity method investments 19,793 7.5 % 6,763 3.0 %
Privately held equity securities 42,002 15.9 % 22,829 10.1 %
Publicly traded equity securities 598 0.2 % 1,174 0.5 %
Total alternative investments $ 263,569 100.0 % $ 225,467 100.0 %


	June 30, 2023				December 31, 2022
($ in thousands)	Carrying Value		% of Total		Carrying Value		% of Total
Private Equity	$	65,509	24.4	%	$	60,227	22.1	%
Private Credit	42,775		15.9	%	51,783		19.0	%
Hedge Funds	—		—	%	5,376		2.0	%
Alternatives	87,939		32.7	%	85,866		31.5	%
Venture Capital	22,937		8.6	%	21,126		7.7	%
Real Estate	49,456		18.4	%	48,155		17.7	%
Total alternative investments	$	268,616	100.0	%	$	272,533	100.0	%

For further details on these alternative investments, see "Notes to Condensed Consolidated Financial Statements: Note 4(b) Other Investments, Equity Securities and Equity Method Investments" included under Part I Item 1. "Financial Information" of this Report on Form 10-Q.

properties. In certain of these joint ventures, the Company has provided certain indemnities, guarantees and commitments to certain parties such that it may be required to make payments now or in the future. For further details on these financial guarantees, please see "Notes to Condensed Consolidated Financial Statements: Note 11 - Commitments, Contingencies and Guarantees" included under Part I Item 1. "Financial Information" of this Report on Form 10-Q.

Investment Results

The following table summarizes our investment results for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


		For the Three Months Ended September 30,						For the Nine Months Ended September 30,							For the Three Months Ended June 30,						For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022			2021			2022			2021			($ in thousands)	2023			2022			2023			2022
Net investment income:	Net investment income:													Net investment income:
Fixed income assets(1)		$	6,646		$	8,042		$	19,635		$	26,074
Fixed income investments(1)														Fixed income investments(1)	$	8,894		$	6,832		$	17,345		$	12,989
Cash and restricted cash	Cash and restricted cash	154			(5)			172			11			Cash and restricted cash	112			25			418			18
Other investments, including equities	Other investments, including equities	776			382			2,120			602			Other investments, including equities	1,701			964			2,588			1,564
Investment expenses	Investment expenses	(939)			(942)			(1,056)			(2,091)			Investment expenses	(189)			(154)			(288)			(337)
Total net investment income	Total net investment income	6,637			7,477			20,871			24,596			Total net investment income	10,518			7,667			20,063			14,234

Net realized (losses) gains:	Net realized (losses) gains:													Net realized (losses) gains:
Fixed income assets(1)	Fixed income assets(1)	96			1,791			1,192			5,794			Fixed income assets(1)	(786)			(47)			(786)			1,096
Other investments, including equities	Other investments, including equities	(1,822)			167			(1,345)			1,130			Other investments, including equities	10			—			186			79
Total net realized (losses) gains	Total net realized (losses) gains	(1,726)			1,958			(153)			6,924			Total net realized (losses) gains	(776)			(47)			(600)			1,175

Net unrealized gains (losses):
Net unrealized gains:														Net unrealized gains:
Other investments, including equities	Other investments, including equities	154			(2,895)			3,001			1,089			Other investments, including equities	1,921			2,158			2,750			3,245
Total net unrealized gains (losses)		154			(2,895)			3,001			1,089
Total net unrealized gains														Total net unrealized gains	1,921			2,158			2,750			3,245

Interest in (loss) income of equity method investments:
Interest in (loss) income of equity method investments		(373)			(810)			(2,143)			4,912
Total interest in (loss) income of equity method investments		(373)			(810)			(2,143)			4,912
Interest in income (loss) of equity method investments:														Interest in income (loss) of equity method investments:
Interest in income (loss) of equity method investments														Interest in income (loss) of equity method investments	4,803			(3,041)			4,752			(1,770)
Interest in income (loss) of equity method investments														Interest in income (loss) of equity method investments	4,803			(3,041)			4,752			(1,770)

Total investment return included in earnings (A)	Total investment return included in earnings (A)	$	4,692		$	5,730		$	21,576		$	37,521		Total investment return included in earnings (A)	$	16,466		$	6,737		$	26,965		$	16,884

Other comprehensive loss:
Unrealized losses on AFS fixed maturities and equity method investments excluding foreign exchange (B)		$	(8,613)		$	(9,066)		$	(32,279)		$	(26,453)
Other comprehensive income (loss):														Other comprehensive income (loss):
Unrealized gains (losses) on AFS fixed maturities and equity method investments excluding foreign exchange (B)														Unrealized gains (losses) on AFS fixed maturities and equity method investments excluding foreign exchange (B)	$	847		$	(12,274)		$	2,783		$	(23,666)

Total investment return = (A) + (B)	Total investment return = (A) + (B)	$	(3,921)		$	(3,336)		$	(10,703)		$	11,068		Total investment return = (A) + (B)	$	17,313		$	(5,537)		$	29,748		$	(6,782)

Annualized income from fixed income assets and cash(2)		$	27,200		$	32,148		$	26,409		$	34,780
Average aggregate fixed income assets and cash, at cost(2)		1,264,251			1,708,297			1,327,597			1,870,686
Annualized income from fixed income assets(2)														Annualized income from fixed income assets(2)	$	36,024		$	27,428		$	35,526		$	26,014
Average aggregate fixed income assets, at cost(2)														Average aggregate fixed income assets, at cost(2)	855,506			1,353,007			894,686			1,402,471
Annualized investment book yield	Annualized investment book yield	2.2		%	1.9		%	2.0		%	1.9		%	Annualized investment book yield	4.2		%	2.0		%	4.0		%	1.9		%

Average aggregate invested assets, at fair value(3)	Average aggregate invested assets, at fair value(3)	$1,468,428			$1,896,211			$1,542,845			$2,046,594			Average aggregate invested assets, at fair value(3)	$1,108,005			$1,570,324			$1,150,740			$1,618,667
Investment return included in net earnings	Investment return included in net earnings	0.3		%	0.3		%	1.4		%	1.8		%	Investment return included in net earnings	1.5		%	0.4		%	2.3		%	1.0		%
Total investment return	Total investment return	(0.3)		%	(0.2)		%	(0.7)		%	0.5		%	Total investment return	1.6		%	(0.4)		%	2.6		%	(0.4)		%

1.~~Includes~~Fixed income investments include AFS securities as well as funds withheld receivable, and loan to related party.

2.Average aggregate fixed income assets and cash include AFS ~~securities,~~portfolio, cash and restricted cash, funds withheld receivable, and loan to related party and is computed as an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.

3.Average aggregate invested assets include all investments (AFS and alternative investments), cash and restricted cash, loan to related party and funds withheld receivable and is computed as an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.

5862

The following table details total investment returns for our fixed income investments for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively:


Fixed Income Investments(1)	Fixed Income Investments(1)	For the Three Months Ended September 30,						For the Nine Months Ended September 30,						Fixed Income Investments(1)	For the Three Months Ended June 30,						For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022			2021			2022			2021			($ in thousands)	2023			2022			2023			2022
Gross investment income	Gross investment income	$	6,800		$	8,037		$	19,807		$	26,085		Gross investment income	$	9,006		$	6,857		$	17,763		$	13,007
Net realized and unrealized gains	Net realized and unrealized gains	96			1,791			1,192			5,794			Net realized and unrealized gains	(786)			(47)			(786)			1,096
Change in AOCI (3)	Change in AOCI (3)	(8,613)			(4,988)			(36,693)			(18,956)			Change in AOCI (3)	847			(12,274)			2,783			(28,080)
Gross investment returns	Gross investment returns	$	(1,717)		$	4,840		$	(15,694)		$	12,923		Gross investment returns	$	9,067		$	(5,464)		$	19,760		$	(13,977)

Average invested assets, at fair value (4)	Average invested assets, at fair value (4)	$	1,211,365		$	1,729,162		$	1,298,327		$	1,902,726		Average invested assets, at fair value (4)	$	841,954		$	1,319,841		$	880,165		$	1,380,657

Gross Investment Returns	Gross Investment Returns	(0.1)		%	0.3		%	(1.2)		%	0.7		%	Gross Investment Returns	1.1		%	(0.4)		%	2.2		%	(1.0)		%

Investment expenses		$	99		$	196		$	329		$	690
Less: Investment expenses														Less: Investment expenses	$	72		$	104		$	145		$	230
Net investment returns	Net investment returns	$	(1,816)		$	4,644		$	(16,023)		$	12,233		Net investment returns	$	8,995		$	(5,568)		$	19,615		$	(14,207)

Net Investment Returns	Net Investment Returns	(0.1)		%	0.3		%	(1.2)		%	0.6		%	Net Investment Returns	1.1		%	(0.4)		%	2.2		%	(1.0)		%

The following table details total investment returns for our alternative investments for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively:


Alternative Investments(2)	Alternative Investments(2)	For the Three Months Ended September 30,						For the Nine Months Ended September 30,						Alternative Investments(2)	For the Three Months Ended June 30,						For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022			2021			2022			2021			($ in thousands)	2023			2022			2023			2022
Gross investment income	Gross investment income	$	403		$	(428)		$	(23)		$	5,514		Gross investment income	$	6,504		$	(2,077)		$	7,340		$	(206)
Net realized and unrealized (losses) gains	Net realized and unrealized (losses) gains	(1,668)			(2,728)			1,656			2,219			Net realized and unrealized (losses) gains	1,931			2,158			2,936			3,324

Change in AOCI (3)	Change in AOCI (3)	—			(4,078)			4,414			(7,497)			Change in AOCI (3)	—			—			—			4,414
Gross investment returns	Gross investment returns	$	(1,265)		$	(7,234)		$	6,047		$	236		Gross investment returns	$	8,435		$	81		$	10,276		$	7,532

Average invested assets, at fair value (4)	Average invested assets, at fair value (4)	$	257,063		$	167,048		$	244,518		$	143,868		Average invested assets, at fair value (4)	$	266,051		$	250,483		$	270,575		$	238,011

Gross Investment Returns	Gross Investment Returns	(0.5)		%	(4.3)		%	2.5		%	0.2		%	Gross Investment Returns	3.2		%	—		%	3.8		%	3.2		%

Investment expenses		$	840		$	746		$	727		$	1,401
Less: Investment expenses														Less: Investment expenses	$	117		$	50		$	143		$	107
Net investment returns	Net investment returns	$	(2,105)		$	(7,980)		$	5,320		$	(1,165)		Net investment returns	$	8,318		$	31		$	10,133		$	7,425

Net Investment Returns	Net Investment Returns	(0.8)		%	(4.8)		%	2.2		%	(0.8)		%	Net Investment Returns	3.1		%	—		%	3.7		%	3.1		%

1.Fixed income investments includes AFS securities as well as cash, restricted cash, funds withheld receivable, and loan to related party.

2.Alternative investments includes other investments, equity securities, and equity method investments.

3.Change in accumulated other comprehensive income ("AOCI") excludes unrealized foreign exchange gains and losses.

4.Average invested assets is the average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.

The following table details total investment returns for alternative investments by asset class for the six months ended June 30, 2023:


June 30, 2023	Private Equity			Private Credit			Hedge Funds			Alternative Assets			Venture Capital			Real Estate			Total
	($ in thousands)
Gross investment income	$	1,069		$	1,608		$	83		$	4,221		$	—		$	359		$	7,340
Net realized and unrealized gains (losses)	2,181			178						(25)			959			(357)			2,936


Total Investment Return	$	3,250		$	1,786		$	83		$	4,196		$	959		$	2		$	10,276

Average Investments	$	62,868		$	47,279		$	2,688		$	86,903		$	22,032		$	48,806		$	270,575

Gross Investment Returns	5.2		%	3.8		%	3.1		%	4.8		%	4.4		%	—		%	3.8		%
Annualized Gross Returns	10.3		%	7.6		%	6.2		%	9.7		%	8.7		%	—		%	7.6		%

Total investment returns on ~~fixed income~~alternative investments were ~~adversely impacted by the increase in interest rates~~positive across all asset classes other than real estate and earned a weighted average return of 3.8% during the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023. The gross and net investment returns were higher compared to the same respective period in ~~2021.~~ 2022 largely due to the interest in income of an equity method investment of $4.2 million, primarily in the alternative asset category, that was recognized during the six months ended June 30, 2023.

The following table details total investment returns for alternative investments by asset class for the six months ended June 30, 2022:


June 30, 2022	Private Equity			Private Credit			Hedge Funds			Alternative Assets			Venture Capital			Real Estate			Total
	($ in thousands)
Gross investment income	$	219		$	786		$	(3,544)		$	1,756		$	125		$	452		$	(206)
Net realized and unrealized gains (losses)	658			(328)			—			79			2,915			—			3,324
Change in AOCI	—			—			—			4,414			—			—			4,414
Total Investment Return	$	877		$	458		$	(3,544)		$	6,249		$	3,040		$	452		$	7,532

Average Investments	$	61,816		$	33,481		$	24,907		$	50,167		$	11,918		$	55,723		$	238,011

Gross Investment Returns	1.4		%	1.4		%	(14.2)		%	12.5		%	25.5		%	0.8		%	3.2		%
Annualized Gross Returns	2.8		%	2.7		%	(28.5)		%	24.9		%	51.0		%	1.6		%	6.3		%

Total returns on alternative investments were positive ~~for~~and earned 3.2% during the ~~nine~~six months ended ~~September~~June 30, 2022 partly due to the sale of an equity method investment which produced gross returns of $5.8 million ~~which~~and contributed 2.4% to the gross investment returns during the ~~current~~prior year period. ~~On a percentage basis however, the~~

While our alternative investment ~~returns on alternative investments during the nine months ended September 30, 2022 were higher compared~~portfolio continues to 2021 due to higher average invested alternative assets in 2022. For the nine months ended September 30, 2021, gross investment returns included unrealized gains of $0.9 million from an investment in an insurtech start-up company that was acquiredbe impacted by a ~~special purpose acquisition company which contributed 0.6%~~rapidly rising interest rate and subsequent economic uncertainty, we believe our alternative investment portfolio remains well positioned to ~~the gross investment returns for the prior year period.~~achieve its targeted longer-term returns.

5964

Other Balance Sheet Changes

The following table summarizes our other material balance sheet changes at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


($ in thousands)	($ in thousands)	September 30, 2022		December 31, 2021		Change		Change %		($ in thousands)	June 30, 2023		December 31, 2022		Change		Change %
Reinsurance balances receivable, net		$	12,368	$	19,507	$	(7,139)	(36.6)	%
Reinsurance recoverable on unpaid losses		547,975		562,845		(14,870)		(2.6)	%

Deferred commission and other acquisition expenses	Deferred commission and other acquisition expenses	27,295		36,703		(9,408)		(25.6)	%	Deferred commission and other acquisition expenses	$	20,522	$	24,976	$	(4,454)	(17.8)	%
Funds withheld receivable	Funds withheld receivable	516,589		636,412		(119,823)		(18.8)	%	Funds withheld receivable	307,031		441,412		(134,381)		(30.4)	%

Reserve for loss and LAE	Reserve for loss and LAE	1,146,084		1,489,373		(343,289)		(23.0)	%	Reserve for loss and LAE	1,001,261		1,131,408		(130,147)		(11.5)	%
Unearned premiums	Unearned premiums	73,760		100,131		(26,371)		(26.3)	%	Unearned premiums	54,620		67,081		(12,461)		(18.6)	%

Deferred gain on retroactive reinsurance										Deferred gain on retroactive reinsurance	60,025		47,708		12,317		25.8	%

Accrued expenses and other liabilities	Accrued expenses and other liabilities	147,591		44,542		103,049		231.4	%	Accrued expenses and other liabilities	25,196		60,518		(35,322)		(58.4)	%

The Company's deferred commission and other acquisition expenses decreased by ~~25.6%~~17.8% and unearned premiums decreased by ~~26.3%~~18.6% primarily due to the termination of the remaining business under both quota share contracts with AmTrust which have been in run-off since January 1, 2019. ~~Reinsurance balances receivable decreased by 36.6% with the collection of premiums receivable due from the European Hospital Liability Quota Share during the second quarter of 2022.~~

Funds withheld receivable decreased by ~~18.8% primarily~~30.4% due to ~~lower funds withheld to be utilized as collateral for~~ the ~~AmTrust Reinsurance segment with the commutation of French Hospital Liability polices under the European Hospital Liability Quota Share during the third quarter of 2022 and~~ settlement of reinsurance losses payable ~~due~~ under the AmTrust Quota Share.

Accrued expenses and other liabilities ~~increased~~decreased by ~~231.4%~~58.4% primarily due to the timing of settlement of reinsurance losses payable due to AmTrust, which have been subsequently ~~settled; it~~settled, and also ~~increased~~ due to ~~the~~a decrease in underwriting-related derivative liability on ~~retroactive reinsurance of $9.0 million related to~~ GLS policies ~~that was recognized~~to $4.0 million at June 30, 2023 compared to $14.6 million at December 31, 2022 as the acceleration of ~~September 30, 2022.~~

covered payments triggered coverage in excess of the contracts risk margin. The Company's reserve for loss and LAE decreased by ~~23.0%~~11.5% primarily due to ~~the~~continued settlement of ~~prior year~~ loss ~~claims as well as favorable loss development recognized~~reserves for AmTrust Reinsurance contracts.

The ~~favorable loss development~~deferred gain on ~~reserves covered~~retroactive reinsurance increased by ~~the LPT/ADC Agreement impacted the reinsurance recoverable on unpaid losses which decreased by $14.9~~$12.3 million or ~~2.6% as at September 30, 2022~~25.8% compared to December 31, ~~2021.~~2022 driven by net adverse prior year loss development of $6.1 million for the six months ended June 30, 2023 reported in the AmTrust Reinsurance segment. The adverse development of $6.1 million was adjusted to remove the $8.6 million favorable impact resulting from non-subject exposures and the impact of currency fluctuation from non-U.S. cessions received from AmTrust and decreased by $2.8 million for movement on certain Workers Compensation losses that were commuted to AmTrust in 2019 that inure to the benefit of Cavello as opposed to the Company under the terms of the LPT/ADC Agreement.

Capital Resources

During the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, book value per common share decreased by ~~8.5%~~5.4% to ~~$2.38~~$2.65 and diluted book value per common share decreased by ~~8.5%~~6.1% to ~~$2.37,~~$2.62, compared to December 31, ~~2021.~~2022. This was largely due to athe net ~~decrease in AOCI of $39.3 million partly offset by net income available~~loss attributable to Maiden common shareholders of ~~$19.2~~$14.3 million during the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023 and an opening allowance for expected credit losses of $5.5 million in the beginning retained earnings on January 1, 2023; partly offset by a net increase in AOCI of $4.1 million during the period.

Capital resources consist of funds deployed in support of our operations. The following table shows the movement in ~~total~~our capital resources at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


											June 30, 2023		December 31, 2022		Change		Change (%)
($ in thousands)	($ in thousands)	September 30, 2022		December 31, 2021		Change		Change %		($ in thousands)
Preference shares		$	119,672	$	159,210	$	(39,538)	(24.8)	%
Common shareholders' equity		207,721		225,047		(17,326)		(7.7)	%
Total shareholders' equity		327,393		384,257		(56,864)		(14.8)	%

Common shares at par value										Common shares at par value	$	1,497	$	1,492	$	5	0.3	%
Additional paid-in capital										Additional paid-in capital	885,462		884,259		1,203		0.1	%
Accumulated other comprehensive loss										Accumulated other comprehensive loss	(37,136)		(41,234)		4,098		(9.9)	%
Accumulated deficit										Accumulated deficit	(462,637)		(442,863)		(19,774)		4.5	%
Treasury shares, at cost										Treasury shares, at cost	(117,896)		(117,075)		(821)		0.7	%

Total Maiden shareholders' equity										Total Maiden shareholders' equity	269,290		284,579		(15,289)		(5.4)	%
Senior Notes - principal amount	Senior Notes - principal amount	262,500		262,500		—		—	%	Senior Notes - principal amount	262,361		262,500		(139)		(0.1)	%
Total capital resources	Total capital resources	$	589,893	$	646,757	$	(56,864)	(8.8)	%	Total capital resources	$	531,651	$	547,079	$	(15,428)	(2.8)	%

Total capital resources decreased by ~~$56.9~~$15.4 million, or ~~8.8% at September 30, 2022~~2.8% compared to December 31, ~~2021 primarily~~2022 due to the ~~decrease in total shareholders' equity as follows:~~following items:

•net decrease of $10.0 million from the 2021 Preference Share Repurchase Program composed of declines in preference share capital of $39.5 million partly offset by: (1) a gain on repurchase of preference shares of $28.2 million for the nine months ended September 30, 2022 which increased retained earnings; and (2) a net increase in additional paid-in capital of ~~$1.3~~$1.2 million ~~relating~~mainly due to ~~proportionate share in issuance costs~~share-based compensation of ~~preference shares repurchased, which was previously recognized as a reduction in additional paid-in capital;~~$1.1 million;

•net ~~decrease~~increase in AOCI of ~~$39.3~~$4.1 million which arose due to: (1) net unrealized ~~losses~~gains on investment of ~~$57.4~~$2.8 million ~~based on the decrease in the fair value of $62.1 million for~~mainly from our fixed income investment portfolio relating to market price movements ~~due to rising interest rates during~~in the ~~nine~~six months ended ~~September~~June 30, ~~2022, offset by $4.4 million increase for equity method investments~~2023, and ~~$0.3 million increase in deferred taxes; partly offset by~~ (2) an increase in cumulative translation adjustments of ~~$18.1~~$1.3 million in the six months ended June 30, 2023 due to ~~strengthening~~the impact of the U.S. dollar depreciation on the ~~remeasurement~~re-measurement of net ~~insurance-related liabilities~~assets denominated in ~~euro during the nine months ended September 30, 2022;~~British pound and euro;

•accumulated deficit increased by $19.8 million due to a net loss ~~attributable to Maiden~~ of ~~$9.0~~$14.3 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022;~~2023 and ~~partly offset by:~~the opening allowance for expected credit losses on other investments, reinsurance recoverable, reinsurance balances receivable and funds withheld receivable of $5.5 million for the six months ended June 30, 2023 which decreased opening retained earnings; and

•~~net increase~~treasury shares increased by $0.8 million due to ~~share-based compensation~~common shares repurchased under the Company's authorized common share repurchase plan as well as repurchases for tax withholding in respect of ~~$1.5 million.~~tax obligations on the vesting of both non-performance-based and discretionary performance-based restricted shares.

Please refer to "Notes to Consolidated Financial Statements Note 6. Shareholders' Equity" included under Part II Item 8. "Financial Statements and Supplementary Data" of our Annual Report on Form 10-K for a discussion of the equity instruments issued by the Company as at December 31, ~~2021.~~2022.

Book value and diluted book value per common share at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 were as follows:


($ in thousands except share and per share data)	($ in thousands except share and per share data)	September 30, 2022		December 31, 2021		($ in thousands except share and per share data)	June 30, 2023		December 31, 2022
Ending common shareholders’ equity	Ending common shareholders’ equity	$	207,721	$	225,047	Ending common shareholders’ equity	$	269,290	$	284,579
Proceeds from assumed conversion of dilutive options	Proceeds from assumed conversion of dilutive options	5		10		Proceeds from assumed conversion of dilutive options	—		4
Numerator for diluted book value per common share calculation	Numerator for diluted book value per common share calculation	$	207,726	$	225,057	Numerator for diluted book value per common share calculation	$	269,290	$	284,583

Common shares outstanding	Common shares outstanding	87,161,499		86,467,242		Common shares outstanding	101,605,815		101,532,151
Shares issued from assumed conversion of dilutive options and restricted shares	Shares issued from assumed conversion of dilutive options and restricted shares	509,963		494,926		Shares issued from assumed conversion of dilutive options and restricted shares	1,020,027		499,963
Denominator for diluted book value per common share calculation	Denominator for diluted book value per common share calculation	87,671,462		86,962,168		Denominator for diluted book value per common share calculation	102,625,842		102,032,114

Book value per common share	Book value per common share	$	2.38	$	2.60	Book value per common share	$	2.65	$	2.80
Diluted book value per common share	Diluted book value per common share	2.37		2.59		Diluted book value per common share	2.62		2.79

Common Shares

On February 21, 2017, the Company's Board of Directors approved the repurchase of up to $100.0 million of the Company's common shares from time to time at market prices. During the ~~nine~~three and six months ended ~~September~~June 30, ~~2022, the Company did not repurchase any~~2023, Maiden Reinsurance repurchased 299,630 common shares from the open market at an average price per share of $2.07 under ~~its~~the Company's share repurchase authorization as it is precluded from repurchasing its common shares due to its failure to pay dividends on its preference shares. Until such time as dividends on preference shares are paid, the Company will not be able to repurchase or pay dividends on its common shares. At September 30, 2022, the Company had a remaining authorization of $74.2 million for share repurchases.

~~Preference Shares~~

On March 3, 2021 and May 6, 2021, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines, of up to $100.0 million and ~~$50.0 million, respectively,~~ of the Company's preference shares from time to time at market prices in open market purchases or as may be privately negotiated. The authorizations are collectively referred to as the "2021 Preference Share Repurchase Program".

The principal purpose of the 2021 Preference Share Repurchase Program is to adjust our capital structure to reflect current operations and the amount of capital required to operate Maiden Reinsurance. The Board has not declared or paid a dividend on the preference shares since 2018 and there can be no assurance that it will declare and pay dividends on the preference shares in the future. The preference shares are perpetual and there is no fixed date on which we are required to redeem or otherwise repurchase them.

~~Please refer to~~ ~~"Notes to Consolidated Financial Statements - Note 6. Shareholders' Equity"~~ ~~under Part 1 Item 1~~ ~~"Financial Information"~~ of this Quarterly Report on Form 10-Q for further information on our preference shares, including a summary of repurchases made of the Company's preference shares during the three and nine months ended September 30, 2022.plan. The Company has a remaining authorization of ~~$3.9~~$73.6 million for ~~preference~~common share ~~repurchases.~~

~~On November 9,~~repurchases at June 30, 2023. No repurchases were made during the three and six months ended June 30, 2022 ~~subject to~~under the ~~terms and conditions of the preference shares including the affirmative vote of two-thirds of our preference shareholders, we announced our plans to exchange the preference shares for our~~ common ~~shares. Please refer to~~ ~~"Notes to Condensed Consolidated Financial Statements - Note 14. Subsequent Events"~~ ~~under Item 8~~ ~~"Financial Statements and Supplementary Data"~~ ~~in Part I Item 1.~~ ~~"Financial Information"~~ ~~for further information.~~share repurchase plan.

Senior Notes

There were no changes in the Company’s Senior Notes at ~~September~~June 30, ~~2022~~2023 compared to December 31, ~~2021 and the~~2022 other than repurchases as discussed further below. The Company did not enter into any short-term borrowing arrangements during the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023. Please refer to "Notes to Condensed Consolidated Financial Statements (unaudited) Note 7. Long Term Debt" included under Part I Item 1 "Financial Information" of this Form 10-Q for a discussion of the Company’s Senior Notes. The 2013 Senior Notes issued by Maiden NA are fully and unconditionally guaranteed by Maiden Holdings. The Senior Notes are unsecured and unsubordinated obligations of the Company.

As described in "Notes to Condensed Consolidated Financial Statements (unaudited) Note 7. Long-Term Debt" included under Part I Item 1 "Financial Information" of this Form 10-Q, on May 3, 2023, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines, of up to $100.0 million of the Company's Senior Notes from time to time at market prices in open market purchases or as may be privately negotiated. During the three and six months ended June 30, 2023, Maiden Reinsurance repurchased 5,567 notes of the 2013 Senior Notes at an average price per unit of $17.10 for a total cost of $95.2 thousand. Total interest and amortization expenses for the three and six months ended June 30, 2023 were partly offset by a gain of $39.9 thousand realized on the repurchase of the 2013 Senior Notes. The Company has a remaining authorization of $99.9 million for such repurchases at June 30, 2023.

Maiden Holdings does not have any significant operations or assets other than ownership of the shares of our subsidiaries. The dividends and other permitted distributions from Maiden NA (and its subsidiaries) will be our sole source of funds to meet ongoing cash requirements, including debt service payments. Factors that may affect payments to holders of the 2013 Senior Notes include restrictions on the payments of dividends by Maiden Reinsurance to Maiden NA which provides the sole source of income for interest payments on the 2013 Senior Notes. In 2022 and 2023, the Vermont DFR approved an annual dividend program to be paid by Maiden Reinsurance to Maiden NA, with notification to the Vermont DFR as dividends are paid. Subsequent to those approvals, Maiden Reinsurance paid total dividends of $31.3 million to Maiden NA as of June 30, 2023.

The summarized financial information below has been presented on a combined basis for the issuer Maiden NA and the guarantor Maiden Holdings, excluding all other subsidiaries. Intercompany balances and transactions between Maiden NA and Maiden Holdings, whose information is presented above on a combined basis, were eliminated. Any investment by Maiden NA or Maiden Holdings in subsidiaries that are not issuers or guarantors is not presented in the financial information below. Intercompany balances with subsidiaries that are not issuers or guarantors and any related party transactions were separately disclosed below and are not included in the total assets and total liabilities presented for Maiden NA and Maiden Holdings. The net income (loss) for Maiden NA and Maiden Holdings was due to interest and amortization expenses on the Senior Notes as well as general and administrative expenses. The net income (loss) in Maiden NA also reflects income tax expense incurred for the respective periods.

Summarized financial information of Maiden NA and Maiden Holdings as of June 30, 2023 and for the three and six months ended June 30, 2023 were as follows:


	Maiden NA		Maiden Holdings
	($ in thousands)
Total assets	$	6,071	$	8,706
Total liabilities	149,198		108,062
Amounts due from subsidiaries (not included in total assets above)	711		928
Amounts due to subsidiaries (not included in total liabilities above)	10,730		3,914
Related party loan payable (not included in total liabilities above)	—		279,890
Total revenue for the quarter-to-date period	967		2
Net income (loss) for the quarter-to-date period	851		(7,258)
Total revenue for year-to-date period	1,080		5
Net loss for year-to-date period	(1,113)		(17,020)

The ratio of Debt to Total Capital Resources at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was computed as follows:

($ in thousands) September 30, 2022 December 31, 2021
Senior notes - principal amount $ 262,500 $ 262,500
Maiden shareholders’ equity 327,393 384,257
Total capital resources $ 589,893 $ 646,757
Ratio of debt to total capital resources 44.5 % 40.6 %


($ in thousands)	June 30, 2023			December 31, 2022
Senior notes - principal amount	$	262,361		$	262,500
Maiden shareholders’ equity	269,290			284,579
Total capital resources	$	531,651		$	547,079
Ratio of debt to total capital resources	49.3		%	48.0		%

Off-Balance Sheet Arrangements

Certain of the Company's investments in limited partnerships are related to real estate joint ventures with interests in multi-property projects with varying strategies ranging from the development of properties to the ownership of income-producing properties. In certain of these joint ventures, the Company has provided certain indemnities, guarantees and commitments to certain parties such that it may be required to make payments now or in the future as further described in the "Notes to Condensed Consolidated Financial Statements (unaudited) Note 11. Commitments, Contingencies and Guarantees" included under Part I Item 1 "Financial Information" of this Form 10-Q.

As discussed above, at ~~September~~June 30, ~~2022,~~2023, guarantees of ~~$41.3~~$43.1 million have been provided to lenders by the Company on behalf of the real estate joint venture, however, the likelihood of the Company incurring any losses pertaining to project level financing guarantees was determined to be remote. Therefore, no liability has been accrued under ASC 450-20.

Non-GAAP Measures

As defined and described in the Key Financial Measures section, management uses certain key financial measures, some of which are non-GAAP measures, to evaluate the Company's financial performance and the overall growth in value generated for the Company’s common shareholders. Management believes that these measures, which may be defined differently by other companies, explain the Company’s results to investors in a manner that allows for a more complete understanding of the underlying trends in the Company’s business. The calculation, reconciliation to nearest GAAP measure and discussion of relevant non-GAAP measures used by management are as follows:

Non-GAAP operating ~~loss~~income was ~~$21.1~~$4.5 million for the three months ended ~~September~~June 30, ~~2022~~2023 compared to a non-GAAP operating ~~loss~~income of ~~$3.1~~$16.6 million for the same period in ~~2021. The reduction in the Company's non-GAAP operating results was~~2022, largely due to a$24.7 million of gains from repurchase of our preference shares in the second quarter of 2022. Excluding the gain from the repurchase of preference shares in the second quarter of 2022, our non-GAAP operating income increased by $12.6 million compared to the same period in 2022 largely due to higher non-GAAP underwriting ~~loss~~income as discussed below.

Non-GAAP underwriting income of ~~$18.9~~$1.5 million for the three months ended ~~September~~June 30, ~~2022,~~2023, compared to a non-GAAP underwriting loss of ~~$7.3~~$8.6 million ~~partly offset by gains of $6.0 million for preference share repurchases~~ for the same ~~respective~~ period in ~~2021.~~2022. The non-GAAP underwriting results in both respective periods included underwriting results in the AmTrust Reinsurance segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018, as well as loss development under the European Hospital Liability Quota Share, and underwriting losses in the Diversified Reinsurance segment of $3.1 million for the three months ended June 30, 2023 compared to a loss of $1.3 million for the same period in 2022.

Non-GAAP operating loss was ~~$11.4~~$3.4 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, compared to non-GAAP operating ~~earnings~~income of $58.1 million in 2021. The reduction in the Company's non-GAAP operating results was largely due to a non-GAAP underwriting loss of $30.1 million for the nine months ended September 30, 2022, compared to a non-GAAP underwriting loss of $17.9$9.7 million for the same respective period in ~~2021. Underwriting performance was offset by gains of~~2022 which included $28.2 million of gains from the repurchase of our preference shares ~~at market values~~in 2022.

Non-GAAP underwriting loss of $5.2 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 compared to ~~gains~~non-GAAP underwriting loss of ~~$87.2~~$11.2 million for ~~preference share repurchases during~~ the same period in ~~2021.~~

2022. The non-GAAP underwriting loss in both respective periods included underwriting results in the AmTrust Reinsurance segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018, as well as loss development under the European Hospital Liability Quota Share, and an underwriting loss in Diversified Reinsurance segment of $5.1 million for the six months ended June 30, 2023 compared to underwriting income of $0.2 million for the same period in 2022.

6268

Non-GAAP operating ~~loss~~income (loss) and Non-GAAP diluted operating ~~loss~~income (loss) per share ~~attributable~~available to common shareholders

Non-GAAP operating ~~loss~~income and Non-GAAP diluted operating ~~loss~~income per share ~~attributable~~available to common shareholders can be reconciled to the nearest U.S. GAAP financial measure as follows:

For the Three Months Ended September 30, 2022 2021
($ in thousands except per share data)
Net (loss) income available to Maiden common shareholders $ (8,160) $ 2,864
Add (subtract):
Net realized and unrealized investment losses 1,572 937
Foreign exchange and other gains (8,586) (4,116)
Interest in loss of equity method investments 373 810
Decrease in deferred gain on retroactive reinsurance under the LPT/ADC Agreement (6,259) (3,609)
Non-GAAP operating loss $ (21,060) $ (3,114)
Diluted (loss) earnings per share attributable to common shareholders $ (0.09) $ 0.03
Add (subtract):
Net realized and unrealized investment losses 0.02 0.01
Foreign exchange and other gains (0.10) (0.05)
Interest in loss of equity method investments — 0.01
Decrease in deferred gain on retroactive reinsurance under the LPT/ADC Agreement (0.07) (0.04)
Non-GAAP diluted operating loss per share attributable to common shareholders
$ (0.24) $ (0.04)
For the Nine Months Ended September 30, 2022 2021
($ in thousands except per share data)
Net income available to Maiden common shareholders $ 19,186 $ 101,426
Add (subtract):
Net realized and unrealized investment gains (2,848) (8,013)
Foreign exchange and other gains (19,121) (6,070)
Interest in loss (income) of equity method investments 2,143 (4,912)
Decrease in deferred gain on retroactive reinsurance under the LPT/ADC Agreement (10,722) (24,296)
Non-GAAP operating (loss) earnings $ (11,362) $ 58,135
Diluted earnings per share attributable to common shareholders $ 0.22 $ 1.17
Add (subtract):
Net realized and unrealized investment gains (0.03) (0.09)
Foreign exchange and other gains (0.22) (0.07)
Interest in loss (income) of equity method investments 0.02 (0.06)
Decrease in deferred gain on retroactive reinsurance under the LPT/ADC Agreement (0.12) (0.28)
Non-GAAP diluted operating (loss) earnings per share available to common shareholders
$ (0.13) $ 0.67


For the Three Months Ended June 30,	2023		2022
	($ in thousands except per share data)
Net (loss) income (attributable) available to Maiden common shareholders	$	(2,933)	$	25,752
Add (subtract):
Net realized and unrealized investment gains	(1,145)		(2,111)

Foreign exchange and other losses (gains)	2,621		(6,586)
Interest in (income) loss of equity method investments	(4,803)		3,041
Change in deferred gain on retroactive reinsurance under the LPT/ADC Agreement	10,727		(3,463)



Non-GAAP operating income	$	4,467	$	16,633

Diluted (loss) earnings per share (attributable) available to common shareholders	$	(0.03)	$	0.29
Add (subtract):
Net realized and unrealized investment gains	(0.01)		(0.02)

Foreign exchange and other losses (gains)	0.02		(0.08)
Interest in (income) loss of equity method investments	(0.05)		0.04
Change in deferred gain on retroactive reinsurance under the LPT/ADC Agreement	0.11		(0.04)



Non-GAAP diluted operating income per share available to common shareholders	$	0.04	$	0.19

For the Six Months Ended June 30,	2023		2022
	($ in thousands except per share data)
Net (loss) income (attributable) available to Maiden common shareholders	$	(14,261)	$	27,346
Add (subtract):
Net realized and unrealized investment gains	(2,150)		(4,420)

Foreign exchange and other losses (gains)	5,437		(10,535)
Interest in (income) loss of equity method investments	(4,752)		1,770
Change in deferred gain on retroactive reinsurance under the LPT/ADC Agreement	12,300		(4,463)


Non-GAAP operating (loss) income	$	(3,426)	$	9,698

Diluted (loss) earnings per share (attributable) available to common shareholders	$	(0.14)	$	0.31
Add (subtract):
Net realized and unrealized investment gains	(0.02)		(0.05)

Foreign exchange and other losses (gains)	0.05		(0.12)
Interest in (income) loss of equity method investments	(0.04)		0.02
Change in deferred gain on retroactive reinsurance under the LPT/ADC Agreement	0.12		(0.05)


Non-GAAP diluted operating (loss) income per share (attributable) available to common shareholders	$	(0.03)	$	0.11

6369

~~Non-GAAP Operating ROACE~~

~~Non-GAAP Operating ROACE for the three and nine months ended September 30, 2022 and 2021 was as follows:~~

For the Three Months Ended September 30, For the Nine Months Ended September 30,
($ in thousands) 2022 2021 2022 2021
Non-GAAP operating (loss) earnings $ (21,060) $ (3,114) $ (11,362) $ 58,135
Opening adjusted common shareholders’ equity 269,658 277,082 274,990 208,447
Ending adjusted common shareholders’ equity 242,859 273,565 242,859 273,565
Average adjusted common shareholders’ equity 256,259 275,324 258,925 241,006
Non-GAAP Operating ROACE (32.6) % (4.5) % (5.9) % 32.3 %

Non-GAAP Underwriting Results

The non-GAAP underwriting results for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 are as follows:


		For the Three Months Ended September 30,				For the Nine Months Ended September 30,					For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	($ in thousands)	2022		2021		2022		2021		($ in thousands)	2023		2022		2023		2022
Gross premiums written	Gross premiums written	$	5,380	$	6,821	$	(1,451)	$	7,865	Gross premiums written	$	6,875	$	3,339	$	7,711	$	(6,831)
Net premiums written	Net premiums written	$	5,222	$	6,953	$	(1,915)	$	7,518	Net premiums written	$	6,875	$	3,186	$	7,635	$	(7,137)
Net premiums earned	Net premiums earned	$	12,251	$	15,030	$	23,816	$	40,106	Net premiums earned	$	11,039	$	10,443	$	20,041	$	11,565
Other insurance revenue		368		138		888		946
Other insurance revenue, net										Other insurance revenue, net	78		469		19		520
Non-GAAP net loss and LAE(1)	Non-GAAP net loss and LAE(1)	(23,685)		(14,123)		(32,739)		(31,842)		Non-GAAP net loss and LAE(1)	(805)		(10,337)		(9,047)		(9,054)
Commission and other acquisition expenses	Commission and other acquisition expenses	(5,398)		(6,313)		(12,811)		(19,154)		Commission and other acquisition expenses	(4,945)		(4,885)		(9,180)		(7,413)
General and administrative expenses	General and administrative expenses	(2,422)		(1,990)		(9,288)		(7,975)		General and administrative expenses	(3,902)		(4,283)		(7,048)		(6,866)
Non-GAAP underwriting loss (1)		$	(18,886)	$	(7,258)	$	(30,134)	$	(17,919)
Non-GAAP underwriting income (loss) (1)										Non-GAAP underwriting income (loss) (1)	$	1,465	$	(8,593)	$	(5,215)	$	(11,248)

(1) Non-GAAP underwriting ~~loss~~income (loss) and non-GAAP net loss and LAE for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 are adjusted for prior year reserve development subject to the LPT/ADC Agreement. Please see "Key Financial Measures" section for the definitions of Non-GAAP underwriting loss and net loss and LAE.

The non-GAAP underwriting results include the impact of ~~favorable~~ prior year loss reserve development under the AmTrust Quota Share which is fully recoverable from Cavello under the LPT/ADC Agreement to show the ultimate economic benefit to the Company. As shown in the table above, adjusted for the ~~decrease~~increase in the deferred gain under the LPT/ADC Agreement of ~~$6.3~~$10.7 million and ~~$10.7~~$12.3 million during the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, the non-GAAP underwriting ~~loss~~income was ~~$18.9~~$1.5 million and ~~$30.1~~an underwriting loss of $5.2 million, respectively. This compared to a non-GAAP underwriting loss of ~~$7.3~~$8.6 million and ~~$17.9~~$11.2 million, respectively, when adjusted for the decrease of $3.5 million and $4.5 million in the deferred gain under the LPT/ADC Agreement ~~of $3.6 million and $24.3 million~~ during the three and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively.

The improvement in non-GAAP underwriting results ~~above were due to underwriting results~~was primarily the result of lower incurred losses in the AmTrust Reinsurance segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share ~~with~~for losses occurring after December 31, ~~2018 (including the additional ceding commission paid under the Partial Termination Amendment) as well as claims related to the European Hospital Liability Quota Share. Underwriting income in~~2018. The non-GAAP underwriting results were also driven by the Diversified Reinsurance segment which had an underwriting loss of $3.1 million and $5.1 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022 decreased by $2.0~~2023, respectively, compared to a loss of $1.3 million and ~~$0.3~~income of $0.2 million ~~compared to~~for the ~~three and nine months ended September 30, 2021, respectively.~~same respective periods in 2022.

Non-GAAP Net Loss and LAE

Adjusted for the increase in the deferred gain for the LPT/ADC Agreement for the three and six months ended June 30, 2023, the non-GAAP net loss and LAE decreased by $10.7 million and $12.3 million, respectively, as these amounts included adverse loss experience for AmTrust Quota Share reserves under the LPT/ADC Agreement which are ultimately recoverable from Cavello.

Adjusted for the decrease in the deferred gain for the LPT/ADC Agreement for the three and six months ended June 30, 2022, the non-GAAP net loss and LAE ~~for the three and nine months ended September 30, 2022~~ increased by ~~$6.3~~$3.5 million and ~~$10.7~~$4.5 million, respectively, ~~(2021 - $3.6 million and $24.3 million, respectively), due to~~as these amounts included favorable loss experience for AmTrust Quota Share reserves ~~subject to~~under the LPT/ADC Agreement which are ultimately recoverable from Cavello. ~~This adjustment is~~

These adjustments are reflected in the calculation of non-GAAP Loss and LAE below:

For the Three Months Ended September 30, For the Nine Months Ended September 30,
($ in thousands) 2022 2021 2022 2021
Net loss and LAE $ 17,426 $ 10,514 $ 22,017 $ 7,546
Less: favorable prior year loss development subject to the LPT/ADC Agreement (6,259) (3,609) (10,722) (24,296)
Non-GAAP net loss and LAE $ 23,685 $ 14,123 $ 32,739 $ 31,842


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
($ in thousands)	2023		2022		2023		2022
Net loss and LAE	$	11,532	$	6,874	$	21,347	$	4,591
Less: adverse (favorable) prior year loss development covered under the LPT/ADC Agreement	10,727		(3,463)		12,300		(4,463)
Non-GAAP net loss and LAE	$	805	$	10,337	$	9,047	$	9,054

Adjusted Shareholders' Equity, Adjusted Total Capital Resources, Adjusted Book Value per Common Share, and Ratio of Debt to Total Adjusted Capital Resources

The Adjusted Shareholders' Equity, Adjusted Total Capital Resources and Adjusted Book Value per Common Share at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 reflect the addition of the unamortized deferred gain under the LPT/ADC Agreement to the GAAP shareholders' equity as depicted in the computations below. The deferred gain under the LPT/ADC Agreement was ~~$35.1~~$57.7 million at ~~September~~June 30, ~~2022~~2023 compared to ~~$45.9~~$45.4 million at December 31, ~~2021, and~~2022, which relates to loss reserves subject to that agreement that are fully recoverable from Cavello.

The ~~decrease~~increase in the unamortized deferred gain under the LPT/ADC Agreement for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 is attributable to ~~$10.7~~$12.3 million in net loss and LAE recognized as ~~favorable~~adverse loss development in the Company's GAAP income statement for policies subject to the LPT/ADC Agreement. We believe the inclusion of this unamortized deferred gain under these metrics better reflects the ultimate economic benefit of the LPT/ADC Agreement, which will improve the Company's shareholders' equity over the settlement period under the terms of the agreement.

The Adjusted Shareholders' Equity, Adjusted Total Capital Resources and Adjusted Book Value per Common Share at December 31, 2021 also reflected the LP Investment Adjustment of $4.1 million, which pertained to the equity accounting related to the fair value of certain hedged liabilities in an equity method investment held by the Company wherein the ultimate realizable value of the asset supporting the hedged liabilities was not recognized at fair value until its sale during the nine months ended September 30, 2022. We believe that this adjustment recognized the future realizable value and reflected the ultimate economic benefit of this investment which was sold at a realized gain during the nine months ended September 30, 2022 and improved the Company's shareholders' equity over the hedged contract period of the investment.

Reconciliation of shareholders' equity to Adjusted shareholders' equity and Adjusted Total Capital Resources

The following table computes adjusted shareholders' equity and adjusted total capital resources by recognizing the unamortized deferred gain under the LPT/ADC Agreement at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022:


($ in thousands)	June 30, 2023		December 31, 2022		Change		Change %


Total shareholders' equity	$	269,290	$	284,579	$	(15,289)	(5.4)	%

Unamortized deferred gain on LPT/ADC Agreement	57,708		45,408		12,300		27.1	%
Adjusted shareholders' equity	326,998		329,987		(2,989)		(0.9)	%
Senior Notes - principal amount	262,361		262,500		(139)		(0.1)	%
Adjusted total capital resources	$	589,359	$	592,487	$	(3,128)	(0.5)	%

Non-GAAP Operating ROACE

Non-GAAP Operating ROACE for the three and six months ended June 30, 2023 and 2022 was as ~~well as the LP Investment Adjustment for realizable value of intangible asset in a limited partnership investment at December 31, 2021:~~follows:

($ in thousands) September 30, 2022 December 31, 2021 Change Change %
Preference shares $ 119,672 $ 159,210 $ (39,538) (24.8) %
Common shareholders' equity 207,721 225,047 (17,326) (7.7) %
Total shareholders' equity 327,393 384,257 (56,864) (14.8) %
LP Investment Adjustment — 4,083 (4,083) (100.0) %
Unamortized deferred gain on LPT/ADC Agreement 35,138 45,860 (10,722) (23.4) %
Adjusted shareholders' equity 362,531 434,200 (71,669) (16.5) %
Senior Notes - principal amount 262,500 262,500 — — %
Adjusted total capital resources $ 625,031 $ 696,700 $ (71,669) (10.3) %


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
($ in thousands)	2023			2022			2023			2022
Non-GAAP operating income (loss)	$	4,467		$	16,633		$	(3,426)		$	9,698
Opening adjusted shareholders’ equity	317,775			260,195			329,987			274,990
Ending adjusted shareholders’ equity	326,998			269,658			326,998			269,658
Average adjusted shareholders’ equity	322,387			264,927			328,493			272,324
Non-GAAP Operating ROACE	5.6		%	25.2		%	(2.1)		%	7.2		%

Reconciliation of Book Value per Common Share to Adjusted Book Value per Common Share

The adjusted book value per common share as reconciled for the recognition of the unamortized deferred gain under the LPT/ADC Agreement ~~as well as the LP Investment Adjustment for realizable value of intangible asset in limited partnership investment~~ at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was computed as follows:


		September 30, 2022		December 31, 2021			June 30, 2023		December 31, 2022
Book value per common share	Book value per common share	$	2.38	$	2.60	Book value per common share	$	2.65	$	2.80
LP Investment Adjustment		—		0.05

Unamortized deferred gain on LPT/ADC Agreement	Unamortized deferred gain on LPT/ADC Agreement	0.41		0.53		Unamortized deferred gain on LPT/ADC Agreement	0.57		0.45
Adjusted book value per common share	Adjusted book value per common share	$	2.79	$	3.18	Adjusted book value per common share	$	3.22	$	3.25

Ratio of Debt to Adjusted Total Capital Resources

Management uses this non-GAAP measure to monitor the financial leverage of the Company. This measure is calculated using the total principal amount of debt divided by the sum of adjusted total capital resources as computed in the table above. The ratio of Debt to Adjusted Total Capital Resources at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was computed as follows:


($ in thousands)	($ in thousands)	September 30, 2022			December 31, 2021			($ in thousands)	June 30, 2023			December 31, 2022
Senior notes - principal amount	Senior notes - principal amount	$	262,500		$	262,500		Senior notes - principal amount	$	262,361		$	262,500
Adjusted shareholders’ equity	Adjusted shareholders’ equity	362,531			434,200			Adjusted shareholders’ equity	326,998			329,987
Adjusted total capital resources	Adjusted total capital resources	$	625,031		$	696,700		Adjusted total capital resources	$	589,359		$	592,487

Ratio of debt to adjusted total capital resources	Ratio of debt to adjusted total capital resources	42.0		%	37.7		%	Ratio of debt to adjusted total capital resources	44.5		%	44.3		%

6571

Currency and Foreign Exchange

We conduct business in a variety of foreign (non-U.S.) currencies, the principal exposures being the euro and the British pound. Assets and liabilities denominated in foreign currencies are exposed to changes in currency exchange rates. Our reporting currency is the U.S. dollar, and exchange rate fluctuations relative to the U.S. dollar may materially impact our results and financial position. Our principal exposure to foreign currency risk is our obligation to settle claims in foreign currencies. In addition, in order to minimize this risk, we maintain and expect to continue to maintain a portion of our investment portfolio in investments denominated in currencies other than the U.S. dollar. We may employ various strategies (including hedging) to manage our exposure to foreign currency exchange risk. To the extent that these exposures are not fully hedged or the hedges are ineffective, our results of operations or equity may be adversely affected. At ~~September~~June 30, ~~2022,~~2023, no such hedges or hedging strategies were in force or had been entered into. We measure monetary assets and liabilities denominated in foreign currencies at period end exchange rates, with the resulting foreign exchange gains and losses recognized in the unaudited Condensed Consolidated Statements of Income. Revenues and expenses in foreign currencies are converted at average exchange rates during the period. The effect of the translation adjustments for foreign operations is included in AOCI.

Net foreign exchange ~~gains~~losses of ~~$8.6~~$2.6 million and ~~$20.5~~$4.7 million were generated during the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, respectively, compared to net foreign exchange gains of ~~$4.1~~$7.9 million and ~~$6.3~~$11.9 million for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively. The decrease in foreign exchange results for both the three and six months ended June 30, 2023 compared to the same respective periods in 2022 was due to a decline in the value of the U.S. dollar against the euro and the British pound.

At ~~September~~June 30, ~~2022,~~2023, net foreign exchange ~~gains~~losses were primarily driven by exposures to euro, British pound and other non-USD denominated net loss reserves and insurance related liabilities in excess of foreign currency assets. Our non-USD denominated liabilities at ~~September~~June 30, ~~2022~~2023 included reserve for net loss and LAE of ~~$281.7~~$313.5 million. ~~There was no new business written in non-USD currencies during the three and nine months ended September 30, 2022.~~ Our foreign currency asset exposures at ~~September~~June 30, ~~2022~~2023 include ~~$185.3~~$172.1 million of fixed maturity securities managed by our investment managers who have the discretion to hold foreign currency exposures as part of their total return strategy as well as ~~$24.9~~$22.6 million of equity method real estate investments denominated in Canadian dollars.

Effects of Inflation

The anticipated effects of inflation are considered explicitly in the pricing of the insured exposures, which are used as the initial estimates of reserves for loss and LAE. In addition, inflation is also implicitly accounted for in subsequent estimates of loss and LAE reserves, as the expected rate of emergence is in part predicated upon the historical levels of inflation that impact ultimate claim costs. To the extent inflation causes these costs, particularly medical treatments and litigation costs, to vary from the assumptions made in the pricing or reserving estimates, the Company will be required to change the reserve for loss and LAE with a corresponding change in its earnings in the period in which the variance is identified. The actual effects of inflation on the results of operations of the Company cannot be accurately known until claims are ultimately settled.

We continue to monitor inflationary impacts resulting from recent government stimulus, sharp increases in demand, labor force and supply chain disruptions, among other factors, on our loss cost trends. Our reserves predominantly consist of workers’ compensation, general liability, and hospital liability. These long tailed lines of business have been subject to the longer term trend of social inflation, but we have not observed significant impacts for the recently elevated levels of inflation. We proactively analyze available data and we incorporate trends into our loss reserving assumptions to ensure we are considerate of current and future economic conditions.

Governmental policy responses to inflation have significantly increased interest rates which, in the short term, have contributed to unrealized losses on our fixed income investments, particularly on our fixed maturity securities. There remains uncertainty around the rate and direction of inflation and we continue to monitor our liquidity, capital and potential earnings impact of these changes but remain focused on our asset allocation decisions as described in our "Business Strategy" section of Item 7 "Management’s Discussion and Analysis of Financial Condition and Results of Operations - Overview".

Inflation may also result in increased wage pressures for our operating expenses, as we remain focused on being a competitive employer in our market. Labor shortages arising from the conditions of the COVID-19 pandemic have contributed to uncertainty in attracting and retaining talent that may put pressure on higher wage costs. Currently, salaries and incentive compensation costs comprise more than one-half of our total general and administrative expenses and thereby could have a material impact our net operating results.

Off-Balance Sheet Arrangements

At ~~September~~June 30, ~~2022,~~2023, we did not have any off-balance sheet arrangements as defined by Item 303(a) (4) of Regulation S-K.

Recent Accounting Pronouncements

See "Part I, Item 1 - Notes to Condensed Consolidated Financial Statements (unaudited) Note 2. Significant Accounting Policies" for a discussion on recently issued accounting pronouncements not yet adopted.

Item 4. Controls and Procedures

Our management, with the participation and under the supervision of our Co-Chief Executive Officers and Chief Financial Officer, have evaluated the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by SEC rules and forms and that such information is accumulated and communicated to management, including our Co-Chief Executive Officers and Chief Financial Officer, to allow for timely decisions regarding required disclosures. Our Co-Chief Executive Officers and Chief Financial Officer have concluded that, as of the end of the period covered by this report, such disclosure controls and procedures were effective. Our management, including our Co-Chief Executive Officers and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide an absolute assurance that all control issues and instances of fraud, if any, within our Company have been detected.

During the most recent fiscal quarter, there were no changes in the Company's internal controls over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

6673

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

See "Part I, Item 1 - Notes to Condensed Consolidated Financial Statements (unaudited) Note 11. Commitments and Contingencies" for an update on legal matters. Except as disclosed above, there are no material changes from the legal proceedings previously disclosed in our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022.

Item 1A. Risk Factors

Our business is subject to a number of risks, including those identified in Item 1A. of Part I of our Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, that could have a material adverse effect on our business, results of operations, financial condition and/or liquidity and that could cause our operating results to vary significantly from period to period. The risks described in our ~~2021~~2022 Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also could have a material adverse effect on our business, results of operations, financial condition and/or liquidity.

There are no material changes from the risk factors previously disclosed in "Part I - Item 1A. Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, ~~2021.~~2022.

Item 2. Unregistered Sales of Equity and Use of Proceeds

Items 2. (a) and (b) are not applicable.

2. (c) Share Repurchases

On February 21, 2017, the Company's Board of Directors approved the repurchase of up to $100.0 million of the Company's common shares from time to time at market prices. The Company has a remaining authorization of $73.6 million for share repurchases at June 30, 2023. The table below details the repurchases that were made during the three months ended June 30, 2023, under the share repurchase authorization:


For the Three Months Ended June 30, 2023	Total number of shares repurchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Dollar amount still available under trading plan
					($ in thousands)
April 1, 2023 - April 30, 2023	—	$	—	—	$	74,245
May 1, 2023 - May 31, 2023	92,603	2.05		92,603	74,055
June 1, 2023 - June 30, 2023	207,027	2.07		207,027	73,626
Total	299,630	$	2.07	299,630	73,626

Subsequent to the three months ended June 30, 2023 and through the period ended August 8, 2023, the Company did not repurchase any additional common shares which represent tax withholding in respect of tax obligations on the vesting of performance based shares.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Executive Ownership and Sales

From time to time, some of the Company’s directors and executives may determine that it is advisable to diversify their investments for personal financial planning reasons, or may seek liquidity for other reasons, and may sell common shares of the Company in the open market, in private transactions or to the Company. To effect such sales, some of the Company’s directors and executives have previously entered into, and may in the future enter into, trading plans designed to comply with the Company’s Insider Trading and Outside Investments Policy and the provisions of Rule 10b5-1 under the Securities Exchange Act of 1934. The trading plans will not reduce any of the executives’ ownership of the Company’s shares below the applicable executive stock ownership guidelines. The Company does not undertake any obligation to report Rule 10b5-1 plans that may be adopted by any employee or director of the Company in the future, or to report any modifications or termination of any publicly announced plan.

Item 6. Exhibits.


Exhibit No.						Description
31.1						Section 302 Certification of CEO
31.2						Section 302 Certification of CFO
32.1						Section 906 Certification of CEO
32.2						Section 906 Certification of CFO
101.1						The following materials from Maiden Holdings, Ltd. Quarterly Report on Form 10-Q for the quarter ended ~~September~~June 30, ~~2022~~2023 formatted in Inline XBRL: (i) unaudited Condensed Consolidated Balance Sheets; (ii) unaudited Condensed Consolidated Statements of Income; (iii) unaudited Condensed Consolidated Statements of Comprehensive Income; (iv) unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity; (v) unaudited Condensed Consolidated Statements of Cash Flows; and (vi) Notes to unaudited Condensed Consolidated Financial Statements.

6775

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	MAIDEN HOLDINGS, LTD.
	By:
~~November 9, 2022~~August 8, 2023		~~/s/ Lawrence F. Metz~~
		Lawrence F. Metz President and Co-Chief Executive Officer

		/s/ Patrick J. Haveron
		Patrick J. Haveron ~~Co-Chief~~Chief Executive Officer and Chief Financial Officer (Principal Executive Officer)

		/s/ Mark O. Heintzman
		Mark O. Heintzman Senior Vice President - Finance (Principal Financial Officer)

6876


As of September 30, 2022	Series A		Series C		Series D		Total
Outstanding shares issued by Maiden Holdings	6,000,000		6,600,000		6,000,000		18,600,000







Less: Total shares held by Maiden Reinsurance	4,499,950		4,855,972		4,457,194		13,813,116
Total shares held by non-affiliates	1,500,050		1,744,028		1,542,806		4,786,884
Percentage held by Maiden Reinsurance	75.0	%	73.6	%	74.3	%	74.3	%